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ABSTRACT
Development of Quantitative Methods for Quality Assessment of
Islets of Langerhans
by Anna Pisania
Submitted to the Department of Chemical Engineering
on May 21, 2007, in partial fulfillment of
the requirements for the degree of
Doctor of Philosophy in Chemical Engineering
Transplantation of isolated islets of Langerhans has promising potential to cure
type 1 diabetes by inducing long-term normoglycemia and insulin independence. The
feasibility of clinical islet transplantations has been established according to the
Edmonton Protocol. However, results are variable, and it is not yet possible to predict
transplantation outcome from in vitro measurements with islet preparations. Currently,
islet enumeration is based on microscopic visualization after staining with a zinc-specific
binding dye (dithizone, DTZ) and manual counting with normalization on the basis of an
islet equivalent (IE), an islet with volume equivalent to that of a sphere with a 150 Pm
diameter. Islet viability is based on a live/dead staining test with two fluorescent dyes,
fluorescein diacetate (FDA) and propidium iodide (PI). These methods are operator-
dependent and prone to error due to the variability in islet size and shape and are not
predictive of transplantation outcome.
We developed quantitative assays that allowed reproducible evaluation of
meaningful properties that affect the clinical outcome in impure human islet preparations.
For purity estimation, we examined light microscopic (LM) morphological analysis of
1-jm sections to estimate the islet volume fraction and compared the results with those of
electron microscopy (EM) ultrastructural analysis on the same preparations. For
quantifying the total number of cells in a preparation, we developed an assay based on
nuclei counting and compared three different counting methods: (1) visual counting in a
hemacytometer and automatic counting by (2) aperture resistance measurements (Coulter
Multisizer II) and (3) flow cytometer measurements (Guava PCA). The methods differed
in the way nuclei were distinguished from fragments, accuracy, time required and range
of linearity. Total amount of tissue was also quantified by DNA measurements. A
theoretical framework was developed in order to combine volume fraction data from the
LM analysis with the total number of cells in the tissue from nuclei measurements in
order to estimate the total number of islets present in impure preparations. To evaluate
tissue viability, we used oxygen consumption rate measurements (OCR), an assay of
mitochondrial function. We developed a very small stirred chamber system (Micro
Oxygen Uptake System, Model FO/SYS210T, Instech Laboratories, Plymouth Meeting,
PA) specifically designed for measurements with islets. OCR measurements combined
with an assay of total amount of tissue quantification (nuclei counting or DNA analysis)
provide a measure of the tissue fractional viability. We used the methods we developed to
characterize a large number of islet preparations of different species prior to and
following culture. We also studied the transient response of cells and islets to various
stresses, as reflected by assays of different type. We found that membrane integrity tests
are poor indicators of the fractional viability of a cell sample, while mitochondrial
function assays identify cell death at its earlier stages.
We examined the predictive capability of the assays we developed through in
vivo studies. Ttransplantation experiments were performed with rat islets implanted into
mice and high purity fraction of human islets transplanted into mice. We found that OCR
measurements combined with a measure of total amount of tissue (nuclei or DNA) are
good predictors of the transplantation outcome.
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Chapter 1.
Introduction Into The World of
Islet of Langerhans
Diabetes mellitus is a very common disease nowadays. The number of people
diagnosed with diabetes is constantly increasing. The World Health Organization (WHO)
estimates that more than 180 million people worldwide have diabetes (1). This number is
likely to more than double by 2030. Almost 7 percent of the population in the United
States has diabetes mellitus, and even though 14.6 million have been diagnosed with the
disease, about 6.2 million people are unaware they have the disease (2). Diabetes is a
disorder of metabolism, in which the body does not produce or properly use insulin due
to malfunction of the pancreas or the cells. Insulin is the hormone that controls the entry
of glucose into the cells and functions in the regulation of the metabolism of
carbohydrates and fats, especially the conversion of glucose to glycogen. In people with
diabetes, the pancreas produces little or no insulin, or the body can not effectively use the
insulin it produces. Therefore, glucose builds up in the blood and does not enter into the
cells to help them grow. Finally, after it reaches a critical value, it overflows into the
urine and passes out of the body. Thus, the body loses its main source of fuel even though
the blood contains large amounts of glucose. The causes of diabetes continue to be a
mystery, although both genetics and environmental factors (obesity, lack of exercise)
appear to play important roles.
There are three main types of diabetes. Type 1 diabetes is an autoimmune disease,
where the insulin-producing 03 cells in the pancreas are attacked and destroyed by the
immune system. The pancreas then produces little or no insulin. People with type 1
diabetes need to take insulin daily to live. Type 2 diabetes is usually part of a metabolic
syndrome that includes obesity, elevated blood pressure, and high levels of blood lipids.
In type 2 diabetes, the pancreas is either producing not enough insulin or the cells ignore
it, and the body cannot use the insulin effectively, a condition called insulin resistance.
Therefore, eventually, the insulin production decreases and glucose builds up in the blood
and the body cannot make efficient use of its main source of fuel. Finally, gestational
diabetes develops only during pregnancy. Like type 2 diabetes, it occurs more often in
people with a family history of diabetes. Though it usually disappears after delivery, the
mother is at increased risk of getting type 2 diabetes later in life.
A lot of research is carried out in order to cure diabetes and manage its
complications. Major advances in this area include the development of quick acting
insulin analogs or external insulin pumps that deliver insulin without the need of insulin
injections. Pancreas transplantation also provides promising results but very strong drugs
are administered in order to prevent rejection of the transplanted organ. A less invasive
surgery would be transplantation of islets of Langerhans, the endocrine cells in the
pancreas that produce insulin. Islet transplantation has been of interest for a long time, as
summarized in a timeline (3) but it has been recent successes in the field that have made
it a popular, promising option for treatment of type 1 diabetes. In early 2000, researchers
at the University of Alberta in Edmonton, Canada, announced promising results with islet
transplantation in seven patients with type 1 diabetes (4). At the time of the report in New
Engand Journal of Medicine, 80% of the treated patients were insulin independent at one
year after the transplantation.
Islets of Langerhans constitute only 1-2% of the pancreas volume. They are
spheroidal aggregates with diameters typically ranging from 40 to 150 pm consisting of
about 1600 cells (Figure 1.1). The insulin-secreting P cells comprise about 60% on a
volume basis of the pancreatic islets. They are named after the German pathologist Paul
Langerhans (1847-1888), who discovered them in 1869. There are four other types of
cells in an islet besides the P cells: a cells that produce glucagon, which raises the level
of glucose (sugar) in the blood; 5 cells that produce somatostatin which inhibits the
release of numerous other hormones in the body; and pancreatic polypeptide (PP) cells
and Dl cells, about which little is known.
Figure 1.1. Scanning electron microscopy photograph of a typical isolated islet with
a mean diameter of 150 pm.
Following the initial report in 2000 from Edmonton of insulin independence in
the first seven patients treated with a new protocol (4), nearly 500 patients with type 1
diabetes received islet transplants at 43 institutions worldwide as of mid 2005, and high
rates of insulin independence were observed at 1 year in the leading transplant centers
(5). Despite these very promising results, various problems currently remain to be solved,
including the following.
* Initial insulin independence usually requires an average of 12000 islets/kg body
weight, or about 850000 islets for a 70-kg human, which corresponds to the islet
yield from two or more human cadavers (6, 7). For islet transplantation to be a
widely accepted treatment modality, it is essential that the donor/recipient ratio be
brought down to 1:1 (8). Although several centers report insulin independence
with some single donors (6, 8, 9), success with single donors is limited by the
quality of the islet preparation, which is related in part to the quality of the donor
pancreata (9, 10).
* Even experienced centers can obtain clinical-grade preparations in no more than
about 50% of islet isolations (11).
* Patients typically have glucose intolerance. It has been suggested that functional
capacity for insulin secretion is only about 20 to 40% of that in nondiabetic
patients (12, 13)
* There is a progressive loss of insulin independence over time, leaving only about
50% of patients still insulin free at 2 years and 10% at 5 years (6).
The entire process (from brain death of the donor and organ removal to the post
transplant period) can last several days, during which a variety of factors and sequential
insults can lead to a substantial loss in islet mass and viability (9). The quality of the
original islets of the donor, itself an important factor, can only decrease. Donor brain
death could exert a negative influence on islets by evoking the release of inflammatory
cytokines (14-17), but this postulate is based only on experiments in rodents with
extreme brain destruction. Hypoxia, or even anoxia, occurs to varying degrees during
pancreas retrieval, storage, and islet isolation. Mechanical and enzymatic disruption adds
stresses during islet isolation. Hypoxia likely occurs during most conventional islet
culture conditions and may be severe during islet shipment.
These stresses, in turn, lead to mitochondrial dysfunction-including excessive
levels of reactive oxygen species (among other possible sources of ROS), intracellular
redox imbalance, accumulation of reduced pyridine nucleotides, mitochondrial
membrane depolarization, cytochrome c release, and change in energy state resulting
from insufficient ATP generation. All of these are associated with activation (as cause
and/or effect) of apoptotic and necrotic pathways (18, 19). Last, following transplantation
islets are exposed to hypoxia until vascularization occurs and to presumed stress from the
immune system. It has been hypothesized that islets are further damaged by instant
blood-mediated inflammatory reaction that may be induced by inflammatory mediators
such as tissue factor and MCP-1 following contact of the islets with ABO-compatible
blood (8).
To move forward in development of improved methods, it is essential to have
assays to assess meaningful characteristics of islet preparations. Unfortunately, the tools
in clinical use today are rather blunt instruments. Currently used parameters are not
capable of quantifying the "dose" of islets transplanted and are not predictive of
transplantation outcome (20-22). Development of improved methods will have a number
of benefits in terms of facilitating the ability of practitioners to (1) predict transplantation
outcome, (2) improve islet isolation procedures, (3) make more efficient use of islets,
(4) standardize test conditions in research, and (5) facilitate FDA licensing (21, 23) and
insurance coverage.
Development of improved methods to characterize islet preparations prior
transplantation has been the focus of this thesis. In Chapter 1, we begin with a brief
introduction and description of the islet isolation process. We identify the areas of
interest in the islet quality field and the islet properties we want to be able to assess prior
transplantation.
1.1 Islet Isolation
1.1.1 Human Islets
The pancreas is surgically removed from the donor by a surgical team, stored in
University of Wisconsin (UW) preservation solution (24) on ice and shipped to the
processing facility. The pancreas may be stored by the so-called "two-layer method", in
which the pancreas floats at the interface between UW solution and oxygenated
perfluorocarbon (PFC)-an oxygen carrier-in order to reduce oxygen limitations and
ischemia. Extensive studies have been performed on the purported advantages provided
by the two-layer method (25-30) but recent measurements suggest that the current
technique provides little, if any, amelioration of oxygen supply limitations in the tissue
(31, 32).
In the islet isolation process (Figure 1.2), the pancreas is digested enzymatically
with mechanical agitation by automatic means or hand shaking. It was first described by
the laboratory of Lacy (33) in 1988, and since then several improvements have been
reported. Briefly, the pancreas is dissected from the duodenum, and the main and
accessory ducts are clamped and divided. An enzyme blend that includes collagenase is
injected through a cannula placed at the pancreatic duct to allow the organ to distend.
Collagenase was originally used as the dissociation enzyme but has been substituted in
most centers by Liberase, a standardized mixture of purified enzymes (primarily two
types of collagenase) from Roche Applied Sciences, because of improved islet yields
from human pancreata (34-36). After distension, the pancreas is cut into a number of
small pieces (typically 8 to 10) that are placed in the dissociation chamber, which is
called a Ricordi chamber. The chamber consists of an upper conical part that is separated
by a mesh from the lower cylindrical part, in which stainless steel spheres and the
pancreatic pieces are placed. The lower part has two inlets at its base, whereas the conical
part has an outlet at its top.
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Figure 1.2. Schematic diagram of human islet isolation.
The pancreas is distended with an enzyme blend and placed in the Ricordi chamber.
Through enzymatic digestion and mechanical disruption, islets are liberated from
the pancreas and purified with a density gradient centrifugation.
The pancreatic tissue is digested by a combination of enzymatic digestion at 370 C
and mechanical agitation of the spheres provided by manual or motorized shaking of the
chamber. The enzyme is circulated by a peristaltic pump through the chamber and
heating system, which allows the enzyme to be activated in the chamber. Continuous
flow allows the islets to be collected, when desired, from the top of the conical part of the
chamber after they are released. Cooling and dilution of the islets prior to collection
protects them from further enzymatic action. The outlet of the chamber where islets are
collected is periodically sampled to monitor the dissociation process and to decide when
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to stop the enzymatic digestion. At the end of the dissociation process, the cell aggregates
are collected in separate containers, and the pancreatic ducts and vessels are retained in
the cylindrical part of the chamber by the mesh.
In the final purification step, density gradient centrifugation is used to separate
the small islet fraction from the non-islet fraction (exocrine: duct, acinar), usually using a
specialized cell processor (COBE 2991 Cell Processor). The gradient medium used for
human islet isolations is Ficoll, and the density gradients are continuous (between 1 and
1.11 g/ml). At the end of the purification step, the upper layers usually contain highly
purified islets at a density of about 1.08 g/ml, whereas less pure and embedded islets are
found within more dense layers. The tissue is emptied into about 14 tubes or flasks, and
tubes 4 through 9 (in order of elution) contain most of the islet population. The content of
individual tubes is accessible for assays and experiments. Usually, all fractions
containing significant numbers of islets are combined in clinical preparations for
transplantation.
1.1.2 Rat and Porcine Islets
Isolation of rat pancreatic islets was first successfully performed and described by
Lacy and Kostianovsky, and current procedures are based on their method-a two-step
process involving digestion with collagenase followed by sedimentation (37). This
method was later modified to include discontinuous Ficoll gradient purification (38).
Some centers use different gradient media, such as Histopaque. The pancreas is dissected
from the surrounding tissue and stored in supplemented Hanks Balanced Salt Solution
(HBSS) or UW solution. The pancreas is distended in a similar way as for the human islet
isolation, placed in a 50-ml tube, and then digested with crude collagenase or the more
well-defined collagenase preparation known as LiberaseRl in a static incubation for
about 20 min in a water bath at 370C. After the digestion, cold medium supplemented
with serum is added to stop the digestion.
The tissue is washed in fresh medium and passed through a mesh (about 400 Atm)
to remove large fibrous pieces. The collected tissue is centrifuged, washed, and
resuspended in the density gradient medium with culture medium on top. Islets are
collected from the interface at a density about 1.077 g/ml. Islets are washed in fresh
medium two to three times and purified further with sedimentation.
Porcine islets are isolated in a manner similar to that of human islets (39-42).
Pancreata are distended with a collagenase solution and digested using a modified semi
automated method. The digestion takes place also at 370C and lasts 40 to 60 min. The
purification step also takes place with a Ficoll gradient in a COBE 2991 Cell Processor.
The density gradients are 1.11, 1.096, and 1.06 g/ml, and most of the islets are collected
between 1.11 and 1.096 g/ml. Some centers follow different protocols for porcine islets,
with a static incubation in a chamber similar to the Ricordi chamber. Islets isolated from
rat and porcine pancreata usually contain very little contamination by other pancreatic
cells. By contrast, human islet preparations that are transplanted typically consist of
about 50% non-islet components on average, largely acinar and duct cells (43-46).
1.2 What Do We Want to Know?
The general areas used to characterize islet preparations prior to transplantation
include (1) safety, (2) identity, (3) quantity, (4) viability, (5) potency, and (6) other. The
information needed reflects the answers to the following questions.
* Safety: Is the preparation sterile? Is it free from microbial cells, mycoplasma,
endotoxins, and other adventitious agents?
* Purity and composition: What fraction of the preparations is islet (endocrine) and
non-islet (exocrine) tissue? What is the cell composition (i.e., what fraction is
0 cells, non-p islet (a, 6, PP) cells, duct, and acinar cells)?
* Quantity: How much total tissue is present? What is the tissue volume? What is
the number of cells? What is the volume and number of cells of islet and non-islet
tissue? What is the volume and number fraction of the individual component
cells, especially P cells?
* Viabilioty. For the total tissue and for the islet tissue, how much is viable? What
fraction of the tissue is viable? How, indeed, do we define viability? How do we
determine what is alive now? How do we deal with cells that are alive now but
destined to be dead later because of irreversible commitment to the cell death
process?
* Potency and function: What is the insulin secretory capacity in terms of glucose-
stimulated insulin secretion? Do the islets cure diabetes when transplanted in a
laboratory animal?
* Other: Can anything be learned from gene expression profiling? Are there other
parameters of interest?
In this thesis, we focus in detail on the second through fourth of these areas. The
fifth area, potency and function, is also of interest but will only be briefly discussed.
Glucose-stimulated insulin secretion, as an indicator of islet function, measured with
freshly isolated islet preparations does not appear to correlate with transplantation
outcome (46). Transplantation of varying quantities of islets into the renal capsule of an
immunodeficient mouse has arguably been the standard for more than 15 years (47, 48)
for predicting clinical success, but the results are apparent only after a number of days
and are therefbre of retrospective value. Nonetheless, it is a potentially useful assay for
correlating potency or dose to transplantation outcome and for testing in vitro islet
quality assays.
1.3 Current Islet Assessment Methods
The islet field is increasingly feeling the need to develop and employ quantitative
methods to assess islet quality prior to transplantation. Even so, most of the islet centers
are currently using techniques developed a long time ago that do not provide meaningful
information on the islet quality. We summarize the current methods employed by most
islet centers to, assess purity, quantity, and viability of islet preparations.
* Purity: Purity is currently assessed visually after staining an aliquot of the islet
preparation with dithizone. Dithizone (diphenylthiocarbazone, DTZ) is a zinc-
specific binding dye used to discriminate islet from non-islet tissue by staining
islet cells red (49). An aliquot from the final islet preparation is stained and
incubated with DTZ for 3 min. All of the tissue is examined with microscopic
visualization and the volume fraction of red-stained islet tissue, (1I)DTZ, is
estimated. A typical aliquot of islet preparation stained with DTZ is shown in
Figure 1.3.
Quantity: Because early measurements of islet properties reported on a per islet
basis were scattered over a wide range (16), the concept of an islet equivalent (IE)
was introduced. An IE refers to the volume of a spherical islet with a diameter of
150 [tm and it standardized islet enumeration on the basis of volume. Aliquots of
the human islet preparation are stained with DTZ. Using a light microscope with
an eyepiece reticule containing a grid of squares 50 pm on a side, the number of
squares and the area occupied by each stained islet is determined, and the
diameter of a circle having about the same surface area is estimated for each islet.
The size distribution of the islets is usually quantified by two independent
observers within a range of 50 to > 500 jtm in 50 Rtm increments (ranges: 50-100,
100-150,
150-200, 200-250, 250-300, 300-350, and > 350 pim). A formula is used to
convert the number of islets in each 50-jim increment to a total islet volume VI by
assuming that the islets are spherical (48). NIE, the number of IE, is calculated as
VI/VIE, where VIE, the volume of an IE, is the volume of a sphere with a diameter
of 150 pim (VIE = 1.77x10 6 jim3). The same procedure is followed with rat islet
preparations except that the diameter of a circle with equivalent area is estimated
visually with an
Figure 1.3. Typical rat aliquot of islet preparation stained with dihizone and viewed
under a microscope.
DTZ stains islet cells red and therefore they can be distinguished from non-islet
cells.
* Viability: Viability of islet preparations is currently assessed with a membrane
integrity test, using two fluorescent dyes, fluorescein diacetate (FDA) and
propidium iodide (PI). FDA is a non-polar ester that passes through plasma
membranes and is hydrolyzed by intracellular esterases to produce free
fluorescein. Fluorescein is a polar molecule and is therefore unable to pass
through the intact membrane of a living cell. It accumulates inside living cells and
produces a green cytoplasmic fluorescence under appropriate excitation
conditions. The fluorescent dye most used is propidium iodide (PI) or ethidium
bromide (EB). Therefore, FDA causes live cells to fluorescen green under blue
light excitation (490 nm) and PI causes dead cells to fluorescen red. An aliquot of
the islet preparation is stained with FDA/PI and examined immediately in a light
microscope by focusing through different depth of the tissue. The volume fraction
of cells containing nuclei stained red is estimated. A typical islet sample stained
with FDA/PI is shown in Figure 1.4.
Figure 1.4. Typical aliquot of rat islet preparation stained with FDA/PI and viewed
under a microscope.
PI stains islet cells with compromised membranes red and therefore they can be
distinguished from cells with uncompromised membranes stained green by FDA.
Development of meaningful assays of islet preparations has proven to be a
challenge and is under study in several laboratories. Why are islet preparations so
difficult to characterize? There are several reasons.
* Islets are cellular aggregates with a variety of nonsymmetric shapes and wide size
distributions that are difficult to quantify accurately. Visual size estimation is
prone to error, is operator dependent, and has large intrinsic uncertainty.
* Human preparations have varying amounts of impurities. Distinguishing between
the properties of islet and exocrine tissue is difficult.
* The islet is a moving target. Islet volume decreases with time after isolation.
Stress repeatedly occurs during pancreas retrieval, storage, islet isolation, culture,
and shipment. Some cells are lost to apoptosis and necrosis. Recovered cells are
likely not representative of the original islet preparation.
Many techniques suitable for cells are inapplicable to islets because of their three-
dimensional structure. Unfortunately, the islets cannot be usefully dissociated into
dispersed cells by agitation and incubation with serine proteases such as trypsin because
30 to 50% of the cells are lost during dissociation (50-52). Cell damage may result from
initiation of apoptosis arising from separation of the cell membrane from the extracellular
matrix (53, 54), as has been demonstrated in trypsin dissociation of epithelial cells such
as hepatocytes (55). Thus, cells recovered from the dissociation process may not be
representative of cells in the original islet.
In the following chapters, we present methods we developed that are suitable for
characterizing islet preparations and address the issues mentioned above.
In Chapter 2, "Quantitative analysis of cell composition of human pancreatic islet
preparations", we describe the method we developed to assess purity and cell
composition of islet preparations. We used morphological analysis by electron
microscopy (EM) for accurate identification and quantification of cell types and
developed a framework of parameters and equations to convert this data to volume
fractions applicable to cells, islets, and the entire islet preparation. This is the first study
to employ EM to quantitatively characterize islets and the first to determine accurate islet
volume fractions (purity) of intact islet tissue in impure human preparations.
In Chapter 3, "Comparison of light and electron microscopy for measuring purity
of human pancreatic islet preparations", we describe a different method to assess purity
of islet preparations. We tested the hypothesis that light microscopy (LM) could be used
to measure islet volume fraction in impure clinical preparations. This is the first study to
use LM morphological analysis to accurately characterize purity of islet preparations. It
sets the stage for further work to make measurements with frozen sections in real time.
In Chapter 4, "Frozen Sections: A Promising Alternative to Plastic Sections for
Measuring Purity of Human Pancreatic Islet Preparations", we describe a protocol we
developed to produce frozen sections and some preliminary results that validate its
feasibility and applicability.
In Chapter 5, "Enumeration of islets by nuclei counting and light microscopic
analysis", we describe a method to assess islet quantity. We developed a method based on
nuclei counting (using the nucleic acid-binding dye 7-aminoactinomycin D, 7-AAD) for
measuring the total number of nuclei in islet preparations and combined it with LM
morphological analysis for estimating the volume fraction of islets in an impure
preparation.
In Chapter 6 "A quantitative membrane integrity test for islets of Langerhans",
we describe a method to assess islet membrane integrity. We developed a rapid,
quantitative assay of membrane integrity based on differential staining with 7-AAD and
nuclei counting.
In Chapter 7, "A stirred microchamber for oxygen consumption rate
measurements with pancreatic islets ", we describe a method to assess islet viability. We
developed and characterized a stirred microchamber for measuring oxygen consumption
rate (OCR) with small quantities of islets rapidly, accurately, and precisely. OCR
measurements could be used as an assessment method of islets prior transplantation.
In Chapter 8, "Characterization of islet and non-islet tissue prior to and following
culture", we use the methods we previously developed to characterize a large number of
rat, porcine, and human islet preparations prior to and after culture. We examine how
tissue quality and properties change in culture and compare findings between types of
tissue and centers.
In Chapter 9, "Dynamics of cell death evaluated by mitochondrial function,
apoptosis, and membrane integrity assays", we describe our study on the transient
response of cells and islets to various stresses, as reflected by assays of different type.
Assays of different type identified cell death at different stages. We found that compared
to mitochondrial function assays, membrane integrity tests can be poor indicators of the
fractional viability of a cell sample.
In Chapter 10, "Stimulation with exogenous substrates to assess islet function and
purity", we examine the effect of stimulation of exogenous substrates, in particular
glucose, during OCR measurements as a means to assess purity and function of impure
islet preparations.
We end with some conclusions of the current work presented and
recommendations for future work in Chapter 11. Finally, Chapter 12 is the appendix,
where supplemental material is provided, Chapter 13 is the nomenclature, and Chapter
14 contains the bibliography referenced throughout all chapters.
Each chapter is presented as an entity that can be read and understood on its own.
The subsections of each chapter include an introduction, where the current techniques
and their limitations are presented, a materials and methods section where we describe
the tissue used for the experiments, cell or islets, the existing methods applied and the
new ones developed, a results section where we present the findings of our tests
concerning the development and validation of the new assays as well as the application of
them on islet characterization, and finally a discussion section were we present an
overview of the study presented in the chapter and draw some conclusions. At the end of
each chapter, we include a note indicating contributions to the work performed by our
collaborators.

Chapter 2.
Quantitative Analysis of Cell Composition
of Human Pancreatic Preparations
In spite of the important recent progress with islet transplantation in the past 5
years, recipients typically have glucose intolerance and lose islet function over time (6,
10). There are still many questions about the exact characteristics of the islet preparations
that are transplanted, including critical parameters such as p-cell mass and viability.
Isolation of human islets has always presented a challenge, in part because, unlike other
species from which islets can be isolated with little contamination by other pancreatic
cells, human islet preparations typically consist of approximately 50% non-islet elements,
mainly acinar and duct cells (43-46).
Correlation of clinical outcome to characteristics of the initial islet preparation
would benefit by having accurate measurements of the cell composition and P-cell mass
of the transplanted material. A major goal is to develop methods to determine the number
of p cells and the volume of p cells in islet preparations transplanted into recipients. The
cell composition of human islets within the pancreas has been examined in a number of
studies (56-64). Measurements have been made with isolated islets that have been
cultured under conditions favoring P-cell enrichment (44) or shipped (65), and following
dissociation into single cells (46, 66) with inconsistent results. No measurements with
freshly isolated islets have been reported. There is a need for development and
standardization of assays to facilitate data analysis and to permit comparison of results
from multiple transplant centers. In this chapter, we have used ultrastructural analysis of
islet preparations and find it to be a valuable tool for assessing the cellular composition
and overall health of clinical islet preparations. These data in combination with
measurements of the packed cell volume of the preparation, together with estimates of
cell size and extracellular spaces, provide a means to calculate the total islet and 0-cell
volume in the preparation. These methods should be useful in the development of the
much-needed standardized characterization of islets prior to transplantation.
2.1 Materials and Methods
2.1.1 Islet Isolation Method
Cadaver pancreata were obtained from brain-dead donors by the New England
Organ Bank after obtaining informed consent from donor relatives. Donor characteristics
are described in Table 2.1. The islets obtained from the 33 pancreata were all used for
clinical transplants. Pancreata were preserved with University of Wisconsin (UW)
solution (Barr Pharmaceuticals, Pomona, NY); five were preserved using the two-layer
perfluorocarbon (PFC) method (25). Only pancreata with cold ischemia times 12 hr or
less (without PFC) or less than 18 hr with PFC preservation were processed for
transplantation. Islets were isolated by the Islet Resource Center of the Joslin Diabetes
Center using the standard collagenase/protease digestion method (4, 33). The pancreatic
duct was cannulated and distended with 40C collagenase/protease solution using
LiberaseTM HI (Roche Diagnostics, Indianapolis, IN), which has been specifically
formulated for use in human islet isolation procedures (36). The separation of islets from
exocrine tissue was performed using continuous density gradient centrifugation in a
COBE 2991 cell processor (Gambro BCT, Lakewood, CO). Estimated purity of islets in
each fraction was determined with representative aliquots stained with dithizone
(diphenylthiocarbazone, DTZ), and the packed cell volume (Vpc) of each fraction was
determined. Fractions containing islets with a total packed cell volume of less than 5 ml
were combined and resuspended in final wash medium (CMRL, Mediatech, Herndon,
VA) to a total volume of 255 ml in a 250 ml tube.
To measure Vpc, the tube was centrifuged (Model RC 3C Plus, Sorvall, Ashville,
NC) at 920 rpm (248xg) for 1 min at 40 C. The supernatant medium was aspirated
carefully to the pellet surface. To a 10 ml pipette (Fisher Scientific, Pittsburgh, PA)
graduated in 0.1 ml increments was added 9.0 ml of final wash medium. Medium was
added to the pellet, which was resuspended by mixing without inclusion of any bubbles
and then carefully aspirated into the pipette. The packed cell volume Vpc was determined
from the difference between the final and initial volumes in the pipette. The mixture in
the pipette was returned to a 250 ml tube and brought to 255 ml with final wash medium.
In this final preparation, the cellular aggregates were kept in suspension by repeated
inversion of the tube, and aliquots were taken for vital staining, DNA content, membrane
integrity, purity and islet enumeration by dithizone staining, and morphological analysis.
Table 2.1. Donor characteristics and processing data from 33 clinical preparations.
For some parameters, data from only 32 preparations are presented, as noted.
Characteristic Mean + SEM Range N
Donor age 51.5 ± 1.5 31 - 67
Donor body mass index (BMI) 28.7 ± 1.0 21.4 - 47.6
Duration acute illness (hr) 37.6 ± 5.9 1 - 129
Duration brain death (hr) 15.7 ± 1.1 0.7 - 27
Cold ischemia time (hr) 7.5 + 0.5 4 - 16.3
Pancreatic: weight (g) 85.5 ± 3.8 45 - 144
Digestion time (min) 19.6 + 0.7 12 - 28
Undigested tissue remaining 25.2 + 2.6 2 - 65 32
PCV of total tissue recovered 42.7 ± 2.5 18 - 92
in all fractions (ml)
Fraction with impermeable 90 ± 1 80 - 95 32
membranes (% PI negative)
DNA in final pellet (mg) 11.1 ± 1.1 2.92 - 24.3 32
2.1.2 Morphological Analysis
From the final islet preparation, a 0.5 ml aliquot of the 255 ml total islet
preparation was fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4,
osmicated, divided into two samples and embedded in plastic (Araldite). Semithin
(1-pm) sections were stained with toluidine blue for initial evaluation of purity and
quality of islets. Secretory granules of islet endocrine cells were too small to be seen with
light microscopy, but the zymogen granules of acinar cells were very evident (Figure
2.1), which allowed acinar contamination to be easily identified.
Ultrathin sections to be taken to the electron microscope (EM) were cut from the
same blocks. Sixteen micrographs per sample were taken systematically to cover the
section, using 1900x magnification to give a total of 32 micrographs per islet preparation.
A magnification of 1900x provided adequate sampling with a minimum of 500 cells; with
photographic printing (final magnification 4375x), the granule morphology of the cells
could be distinguished on the micrographs. Cell boundaries on each micrograph were
determined to indicate the number of cells; then each cell was assigned to a category of 3,
non-p endocrine, acinar, or ductal cells. With electron microscopy (EM), acinar cells,
islet cells (p, and the non-P cells a, 6 and PP), and duct cells could be definitively
identified, and thus cell composition determined (Figure 2.2). Occasional dead cells or
endothelial cells were also identified and characterized as "other". The resulting cell
composition was based on number, not volume, of cells counted from both samples and
yielded the number fraction of each category. We estimate that the cells identified by EM
were derived from about 25 or more islets in each preparation.
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Figure 2.1. Toluidine blue stained 1-pm plastic sections of purified human islet
preparations.
Dilations of the vascular spaces are evident in light micrographs of freshly isolated
islets (A-C); these spaces partially collapse within 24 hr of culture at 370C (E-H).
The vascular spaces of fresh human islets comprise about 14% of the islet volume
(Chapter 3). Acinar clumps (D, H) are distinguishable from the islets and are
initially compact (D) and do not show volume change with 24 hr culture (H). Panel
G shows necrosis of islet even after 24 hr in culture.
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Figure 2.2. Electron micrographs of pellets of purified islet preparations showing
characteristics of the different cell types.
p cells can be definitively identified by electron dense granules, often with crystals, with
space between the granule limiting membrane and the hormone giving a typical "halo."
Non-n cells have granules without halos: the glucagon producing a cells have
homogenous electron dense granules; the somatostatin producing 6 cells are less
homogeneous in density of the granules. For the exocrine tissue, the acinar cells contain
large dense zymogen granules and large amount of stacked ER whereas the ductal cells
contain few organelles, inclusions or granules.
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2.1.3 Islet Purity in a Preparation Determined by Three Methods
a) Purity estimated as volume fraction with DTZ
Dithizone (diphenylthiocarbazone, DTZ, Sigma-Aldrich, St. Louis, MO), a zinc-
specific binding dye, was used to discriminate islet from non-islet tissue by staining islet
cells (49). DTZ was dissolved in dimethylsulfoxide (DMSO, ICN Biomedicals Inc.,
Costa Mesa, CA) as a 10x stock solution (2.5 mg/ml) and diluted with Hanks Balanced
Salt Solution (HBSS, Mediatech) for the lx working solution. An aliquot of 250 pl from
the final islet preparation was transferred to a 60 mm Petri dish containing 3 ml of DTZ
working solution and incubated with gentle swirling for 3 min. All of the tissue was
examined with microscopic visualization and the volume fraction of red-stained islet
tissue, (DI)DTZ, was estimated.
b) Purity determined as cell number fraction by EM
The cell composition of an islet preparation was determined by counting the
different cell types as described above. The number fraction fi of each cell type i was
calculated by dividing the number of each cell type ni by the total number of cells
counted (nTc). In addition, the number fraction of all cells that were islet (0 and non-p)
cells flc and the fraction of islet cells that were p cells fplc were calculated (see Equation
A- 1 to Equation A- 6 of Appendix A).
c) Purity determined as volume fraction using cell number fraction, cell volume,
and extracellular volume fraction
The first step is to convert number fraction data to a volume fraction basis in
order to compare with results of many other studies. Appendix A contains a
comprehensive framework of Equation A- 7 to Equation A- 20 and parameters for
conversion between number fraction and volume fraction measurements, which is briefly
summarized here. The first step is conversion to cell volume fraction denoted by j. An
important result, Equation A- 18, is
VIC nIc VIc VIC
Equation 2-1 =Ic c n -
VTC nTC VTC VTC
where the islet cell volume fraction ýic is the volume of islet cells Vic divided by the total
volume of all cells VTC, and ~ic and VTC are the average volumes per cell for islet cells
and for the total of all cells respectively. The notation fic is the number fraction of all
islet cells. Equations used to calculate these quantities are given in Appendix A, and
estimates of volume per cell are given in Table A. 1. Volumes for P and non-0 cells
(assumed to have properties of a cells) are taken from measurements with freshly
isolated and purified rat islets (50, 67). P cells are assumed to have a volume of 950 gm3
and islet non-0 cells to be 400 gmm3. The average volume of acinar cells in the pancreas is
within the 1300 to 1800 .Im3 range reported for the adult rat (68-70), and it is assumed
that about 20 to 25% of the volume in freshly isolated preparations is lost from
degranulation. Thus, the volume of acinar cells is assumed to be 1200 pim3; duct cells are
small and assumed to be 200 pm3 .
Another important quantity is fljc, Equation A- 20, the fraction of the islet cell
volume comprised of 13 cells
fp v1
Equation 2-2 ~I f
The second step is to develop expressions for volume fractions based on total tissue
volume, including extracellular space (see Equation A- 21 to Equation A- 34 of the
Appendix). It is important to appreciate that the volume fraction of islet tissue includes
the extracellular space, while the islet cell volume fraction does not. A key result,
Equation A- 30, for estimating the volume fraction of islet tissue in a preparation 0I from
the islet cell volume fraction ýic is
0Ic
1- O IEC
Equation 2-3 I eC
IC 1 -0I C
1 - IEC 1-(NIEC
where (iIEC and ONIEC are the volume fractions of extracellular space in islet and non-islet
tissues, respectively. The volume fraction of islet tissue occupied by 1 cells (0i),
Equation A- 32, is
Equation 2-4 O•I = ýpIC (1- )IE )
The notation cIEC is the volume fraction of islet extracellular space within the islets.
Equations are given in Appendix A (Equation A- 33 and Equation A- 34) for calculating
the number of all cells nIE and the number of 1 cells nplE in an islet equivalent (IE).
2.1.4 Islet and p-cell Volume in a Preparation Determined by Two Methods
a) Determination of islet volume as islet equivalents (IE) by conventional counting
with DTZ staining
Two representative aliquots of 100 tl each were taken from the final human islet
preparation and incubated with DTZ working solution as described for volume fraction
determination by DTZ staining. Using a light microscope with a Bausch and Lomb
micrometer disc (31-16-08) eyepiece reticule containing a grid of squares of 50 gtm on a
side, the number of squares and the area occupied by each stained islet was determined,
and the diameter of a circle having about the same surface area was estimated for each
islet. The size distribution of the islets was quantified by two independent observers
within a range of 50 to > 500 jpm in 50 gtm increments (ranges: 50-100, 100-150,
150-200, 200-250, 250-300, 300-350, and > 350 ipm). A formula was used to convert the
number of islets in each 50-grn increment to a total islet volume VI by assuming that the
islets are spherical (48). NIE, the number of IE, was calculated as VINIE, where VIE, the
volume of an IE, is the volume of a sphere with a diameter of 150 Pm
(VIE = 1.77x106 gm 3). The same procedure was followed with rat islet preparations
except that the diameter of a circle with equivalent area was estimated visually with an
optical micrometer in the microscope
b) Islet and i-cell volume derived from packed cell volume (Vpc) and void fraction
estimates
The packed cell volume VPC of the centrifuged pellet, which consists of
aggregates of islet and non-islet tissue, also contains microscopic void spaces between
the aggregates with a void volume Vvpc and a void volume fraction OvPc=Vc/VcNpc.
(Equation A- 35 to Equation A- 43 of Appendix A). The volume of tissue VT in the
packed cell pellet, Equation A- 36, is given by
Equation 2-5 VT = (1- DvPc ) Vpc
and the volume of islet tissue VI, is therefore
Equation 2-6 V, = 01 VT
where OI is the volume fraction of islets in the preparation. From knowledge of VI, the
volumes of islet cells and p cells as well as the numbers of islet equivalents, islet cells,
and p cells can be calculated (see Equation A- 37 to Equation A- 42). An interesting
result, Equation A- 43, is
Equation 2-7 Vp = ~•Ic (1-D IEC ) V1
Equation 2-7 predicts that the total volume (or number) of P cells Vp is directly
proportional to islet volume (or number of islet equivalents) in a preparation if the islet
P-cell volume fraction pjic is constant.
2.1.5 Measurement of the Void Fraction of Packed Cell Pellet
The void volume fraction of the packed cell pellet OvPc was determined by
measuring the distribution space of mannitol, which does not enter cells (71), in pellets
from freshly isolated rat islets. PCV was measured as described for human islets except
that 12 ml of rat islet suspension was centrifuged in a 15 ml Eppendorf tube, 1 ml
medium was added, and the suspension aspirated into a 2 ml serological pipette (0.01 ml
subdivision, Falcon). An 80 jtl pellet was reconstituted to 2 ml with medium, transferred
to a glass vial that had been coated by evaporation of a 14C-mannitol solution
(9.2 giCi/ml, 1.25 mM), and incubated at room temperature for 20 min with occasional
swirling. Aliquots of 0.45 ml were transferred to 0.5 ml microtubes, centrifuged again, a
0.025 ml sample of the supernatant was taken, and the remaining supernatant carefully
removed. The pellet and supernatant samples of known volume were assayed by liquid
scintillation counting (LS 6000 Multi-Purpose Scintillation Counter, Beckman Coulter,
Fullerton, CA). By assuming that radioactivity equilibrated between the supernatant and
the distribution volume VD in the pellet, comprised of packed cell void space and
extracellular space in the islet, the fractional distribution volume OD was calculated from
VD Cp
Equation 2-8 ( D VPC CS
where Vpc is the known volume of the pellet that is counted and Cp and Cs are the
radioactivity concentration (dps/ml) in the pellet and supernatant respectively. The void
volume fraction in the pellet was then calculated from
Equation 2-9 OvpC + IEC (1 - (DVc ) (DD
In one experiment with rat islets, the mannitol fractional distribution volume was
OD = 0.50, yielding Ovpc = 0.30. Thus, 70% of the packed volume was taken up by
tissue and 30% by void space.
2.1.6 Islet Vital Staining
A fluorescent dye inclusion/exclusion assay was employed to assess membrane
integrity. Briefly, 250-[tl aliquots were taken from the 255-ml islet preparation,
resuspended in 5 ml of PBS solution in a 60 mm Petri dish and 10 [l of a solution
containing 9.9 mg/ml fluoroscein diacetate (FDA) and 0.5 mg/ml propidium iodide (PI)
solutions was added. The tissue was examined immediately in a light microscope by
focusing through different depth of the tissue. The volume fraction of cells containing
nuclei stained red was estimated.
2.1.7 DNA Determination
From 255 ml of the final islet preparation suspension, 2 aliquots of 250 pl each
were taken for DNA content measurement. Islet preparations were resuspended in 1 ml
of high salt buffer and sonicated. DNA levels were measured using an ELISA method on
a DyNA 200 fluorometer (FL600 micro-plate reader, Bio-Tek®, Winooski, VT) using
Hoechst 33258 dye (Sigma).
2.1.8 Statistics
Data are reported as mean ± SEM (standard error of the mean). Correlations were
determined using the Pearson product moment correlation coefficient. Statistical
significance was assessed with the two-tailed Student t test.
2.2 Results
2.2.1 Large Intraislet Vascular Spaces of Freshly Isolated Islets Demonstrated by
Light Microscopy
Light microscopic evaluation of toluidine blue stained 1-jIm plastic sections,
generated in preparation for EM, can provide information about islet purity and health
(Figure 2.1). Notably, freshly isolated islets have large intraislet vascular spaces, which
make up approximately 14% of islet volume, as shown in Chapter 3. These result from
the collapse of the capillary lumens and dilation of the resulting intraislet vascular
channels. After only 24 hr in 370 C culture, the islets are more compact with residual
vascular spaces partially filled with perivascular (endothelial, macrophages, etc) cells and
dead endocrine cells. In addition, some areas of necrosis can be discerned after 24 hr in
culture. The collapse of the vascular channels contributes to the loss of islet mass often
seen after islet culture.
2.2.2 Determination of Cell Composition and Number Fraction by Electron
Microscopy (EM)
Identification of ultrastructural characteristics allows definitive identification of
the different cell types within a preparation. P cells have distinctive granules with an
electron dense core containing insulin crystals surrounded by a lighter halo. Additionally,
human p cells have characteristic lipid inclusions (72). The non-P cells (a, 8, and PP) in
islets have more homogenous granules without the crystalline structure and without the
halos of 0 cells. Although these three non-P islet cells can be distinguished from one
another by granule morphology, they were classified together as non-3 islet cells for
quantitation purposes. Acinar cells have easily identifiable large electron dense zymogen
granules and stacks of endoplasmic reticulum. Duct cells are identified by their smaller
size, shape, reduced ER and lack of granules. Examples of these cell types can be seen in
Figure 2.2. In addition to these cell types, there are small numbers of endothelial cells,
stromal cells, leukocytes, dead cells and neuronal elements that together made up less
than 5% of the total cell population in these preparations. When cell composition is
based on number, rather than volume of cells, the number fraction fi of each cell type is
the number ni of cells of type i divided by the total number of cells nTc, as is summarized
in Table 2.2. The basis for these calculations is found in Equation A- 1 to Equation A- 6
in the Appendix. The fractional P-cell contribution to islet cell number, fpic
(Equation A- 19) was 73.6 ± 1.7 % with most of the values being close to this number;
the coefficient of variation was only 0.13. There was, however, a surprisingly low value
of 41.0 % (the only sample that contained significant islet amyloid, suggestive of a type 2
diabetic donor), which was an outlier; the next lowest value was 53.3 %.
Table 2.2. Number fraction of cell types in 33 islet preparations determined by EM.
Cell Category Definition Mean 1 SEM Range COV
Beta (fp) np/nTC 0.356 + 0.021 0.131 - 0.637 0.35
Non-Beta (fNp) nNP/nTc 0.126 + 0.100 0.036 - 0.269 0.44
Total Islet (fic) nic/nTc 0.483 ± 0.026 0.126 - 0.853 0.31
Beta Cells in Islets (fpic) np/nic 0.736 + 0.017 0.410 - 0.839 0.13
Acinar (fA) nA/nTC 0.253 _ 0.018 0.054 - 0.416 0.40
Duct (fD) nD/nTC 0.227 ± 0.015 0.016 - 0.384 0.37
Other (fo) no/nTc 0.038 ± 0.004 0.004 - 0.118 0.64
Total Non-Islet (fNIC) nNIC/nTC 0.517 + 0.026 0.026 - 0.833 0.26
2.2.3 Cell Volume Fraction Determination
The cell number fraction data determined by EM (Table 2.2) was coupled with
estimates of the volume of each cell type and the extracellular volume in tissue in order
to estimate the volume fraction of islets in a preparation; this latter quantity provided the
basis for comparison with our measurements using DTZ staining and with other values in
the literature. The first step was conversion of islet cell number fraction data to a volume
fraction estimate using Equation A- 18. Recognizing that the volume of each cell type
was the product of the number of cells and the volume per cell of that type, Equation A- 7
to Equation A- 12 of the Appendix led to definitions of volume fractions ýic and lNIC for
islet and non-islet cells, respectively, as the total volume of each cell type divided by the
total volume of all cells (Table 2.3). Next, the average cell volume for islet (Vic)and
non-islet (VNIC)cells and for the total of all cells (VTC) were evaluated as the volume of
cells of a particular type divided by the number of cells of that type, Equation A- 13 to
Equation A- 17. The average volume for islet cells over all preparations was 805 ± 9 jtm3
(Table 2.3). The ratio ic /VTC averaged 1.09 ± 0.01. Because P cells are larger than
islet non-3 cells, it is not surprising that the volume fraction of 0 cells in islets was larger,
pjic = 0.865 ± 0.011, Table 2.3), than the number fraction fpic = 0.736 ± 0.017
(Table 2.2). The average volume for non-P cells was 679 ± 19 pmn3 , which reflects the
mixture of large acinar cells and much smaller duct cells.
2.2.4 Consideration of Extracellular Volume
In order to convert cell volume fraction estimates into tissue volume fraction
estimates, which provide a measure of purity, the extracellular volumes VIEC and VNIEC
within the islet and non-islet tissue domains were accounted for by Equation A- 21 to
Equation A- 32 in the Appendix, and the results are summarized in Table 2.3. It is
important to make the distinction between the volume of cells in an islet and the total
tissue volume of an islet; the latter includes extracellular volume, which results in a
larger volume. Thus, the volume of whole islets, which contained both the vascular and
other extracellular spaces, as a fraction (DI of the total volume of the entire preparation
was 0.551, whereas the volume of islet cells as a fraction 4Ic of the total cell volume in
the preparation was 0.522. The volume of 0-cells as a fraction IOp of the volume of islet
tissue was 0.612 ± 0.002.
2.2.5 Number of Islet Cells and P Cells per IE
The number of islet cells nIE and p cells npIE per islet equivalent were calculated
with Equation A- 33 and Equation A- 34. niE averaged of 1560 cells with a range of
1430 - 1980 cells and npIE averaged 1140 P cells (Table 2.3). The range reflected
differences in P cell to non-p cell ratio in individual preparations. For example, the value
nIE = 1980 islet cells came from the preparation with the fewest number of P cells (41%),
which means that the majority of cells were the smaller non-3 cells.
Table 2.3. Volume fraction of cell types in 33 islet preparations determined by EM
and the theoretical number of cells in an islet equivalent (IE).
Parameter Definition
Average Cell Volume
Islet (VIc)
Non-islet (VNIc)
Total (VTc)
Size Ratio
/ Cells in Islets
Cell Volume
Fraction (~pic)
Islet Volume
Fraction (prI)
Islet Cells and Islets
Islet Cells in All
Cells (ýic)
Islet in All Tissue
(OI)EM
Vic/nic
VNIc/nNIc
VTc/nTc
VIC /VTc
Vp/Vic
V1 /VI
VIc/VTc
VI/(VI+VNI)
Mean ± SEM
805 ± 9
679 ± 19
745 ± 12
1.09 ± 0.01
0.865 ± 0.011
0.612 ± 0.008
0.522 ± 0.029
0.551 ± 0.029
Range
632-895
490 - 873
547 - 878
0.97- 1.22
0.635 - 0.956
0.449 - 0.676
0.195 - 0.892
0.216 - 0.904
Number of Cells per IE
Number of Total Cells (nIE)
Number of P Cells (nplE)
Islet Volume Fraction by DTZ
Islet Tissue in All Tissue (OII)DTZ
1560 ± 20
1140 ± 15
0.68 ± 0.03
1430 - 1980
837- 1260
0.30 - 0.95
COV
0.07
0.16
0.09
0.07
0.07
0.07
0.31
0.29
0.07
0.07
0.26
2.2.6 Islet Volume Fraction (Purity) Estimated by DTZ versus EM Determination
of Cell Composition
Transplanted human islet preparations are typically accompanied by many acinar
and duct cells. Purity has traditionally been estimated by examination of preparations
stained with DTZ, a technique that has the advantage of rapid assessment. In our study,
the DTZ method gave erroneously high values (Figure 2.3) when compared with the
more rigorous approach of the whole islet volume fraction based on EM determination of
cell composition. Moreover, the DTZ method gave an average value of 68 ± 3 % while
the whole islet volume fraction averaged 55.1 ± 2.9% (Table 2.3). In only three of 33
cases was the DTZ estimate lower than that estimated from cell composition
measurements using EM. A similar overestimation by the DTZ approach was previously
found with immunostaining methods (46, 66).
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Figure 2.3. Volume fraction (purity) data for individual islet preparations.
Volume fraction estimated by visual impressions of DTZ-stained preparations are
plotted versus volume fraction estimated from cell composition as determined by
EM together with estimates of volume per cell and extracellular volume fractions.
The latter estimates were determined using Equation 2-3. The dashed line is the line
of identity.
2.2.7 Comparison of Two Methods to Characterize Entire Islet Preparations and
Estimate the Number of IE
Measurements of packed cell volume Vpc together with the pellet void volume
fraction ((DvPc = 0.30) provided estimates of the total tissue volume of the islet
preparations. Using the volume fraction of islets determined from EM measurements,
parameters characterizing the entire preparation were calculated from Equation A- 35 to
Equation A- 43, including volumes of islets, number of islet equivalents, and volume of P
cells (Table 2.4). We also estimated number of IE as determined traditionally by counting
DTZ-stained aliquots of tissue preparations as described in Materials and Methods. Data
from these two methods are compared in Figure 2.4. Correlation between the two
methods was poor, and many estimates from DTZ staining were substantially higher. The
traditional DTZ staining method gave significantly higher average values,
423000 ± 20000 IE versus 350000 ± 24000, p = 0.007 for the EM/PCV method
(Table 2.4). In the end, success of a transplant is thought to depend upon the number of
transplanted P cells and the equally important 1-cell potency and health (73). From our
calculations, we estimate that the mean number of 3 cells transplanted was 397 million
and that the volume of 1 cells was 0.38 ml (Table 2.4).
Table 2.4. Volume and number characteristics of 33 islet preparations determined
from EM and PCV measurements.
Parameter Mean ± SEM Range COV
Volume (ml) of islet preparations and components
Packed Cell Pellet (Vpc) 1.81 ± 0.19 0.60- 5.00 0.59
Total Tissue in Pellet (VT) 1.27 ± 0.13 0.42 - 3.50 0.59
Non-Islet Tissue (VNI) 0.65 ± 0.10 0.08- 2.54 0.90
Islet Tissue (VI)* 0.62 ± 0.04 0.25 - 1.25 0.40
Beta Cells (Vp) 0.38 ± 0.03 0.14- 0.74 0.39
Numbers of lE in islet preparations
PCV/EM (NIE)PCV/EM 350000 ± 24000 139000- 690000 0.40
DTZ Staining (NIE)DTZ 423000 + 20000 243000 - 570000 0.28
Number of/f Cells in Preparations
From PCV/EM np (x10 6) 397 150- 776 0.39
* The average value of VI for all preparations is smaller than the product of (IVT because
the averaging process gives greater weight to preparations with larger values of VT that
tend to have smaller values of DI.
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Figure 2.4. Comparison of two methods for counting the number of islet equivalents
in an islet preparation.
The ordinate is the number of IE determined by conventional DTZ staining and
visual counting, and the abscissa is the value obtained by the EM/PCV method using
Equations (A35-A38). The dashed line is the line of identity. Linear regression of the
data gives a correlation coefficient R2 = 0.14.
2.2.8 Estimation of p-cell Volume from Knowledge of IE Number
Estimates of total 3-cell volume are plotted in Figure 2.5 versus total islet volume
(expressed as the number of IE) as suggested by Equation 2-7. The two parameters
correlate very closely because the p-cell volume fraction amongst islet cells ýpic is
maintained within a very tight range with a coefficient of variation of only 0.07
(Table 2.3). Figure 2.5 is useful for understanding how p-cell volume in an islet
preparation relates to the islet volume. This concept is of practical value because by
knowing the islet volume (or equivalently IE number), one can easily estimate the p-cell
volume used for a transplant by using the mean value of Spic = 0.865 in Equation 2-7.
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Figure 2.5. Correlation between P-cell volume and the number of IE.
The number of IE is determined with the EM/PCV method, and plotted as suggested
by Equation 2-7. The solid line is the best-fit estimate by linear regression with a
correlation coefficient R 2=0.96.
2.2.9 DNA Content of Tissue Pellets
The average DNA content in the final pellet for transplantation was 11.1 mg
(Table 2.1). The total number of cells nTc in the final pellet, evaluated from
Equation A- 3 using Equation A- 13 and Equation A- 24 for islet cells and
Equation A- 14 and Equation A- 26 for non-islet cells, is given by
(1- IEC )VI (1- NIEC)VNI,Equation 2-10 nTC = + VNICVIC VNIC
Equation 2-10, together with Dmc = 0.29 and ONIEC = 0.19, respectively, Vic and
VNIC = 805 and 679 Lm 3, respectively (Table 2.3), and VI and VNI = 0.62 and 0.65 ml,
respectively (Table 2.4), was used to calculate nTc = 1.37x109 cells or 8.1 pg DNA/cell,
which is higher than the accepted value of 6.5 pg /cell (74, 75) but lower than a previous
measurement with human islet preparation, as discussed in Chapters 5 and 8 and in (46).
Such high values suggest the presence of residual, undegraded DNA released from dead
cells.
The packed cell volume Vpc = 42.7 ml (Table 2.1) of tissue recovered in all
fractions corresponds to VT = 29.9 ml tissue from Equation 2-5 and a mass of 32.9 g
using a density of 1.1 g/ml. Together with 25.2 g undigested tissue (Table 2.1), the total
tissue accounted for in all forms was 58.1 g compared to an average pancreas weight of
85.5 g. On average, 27.4 g or 32% of the initial mass was lost or destroyed, a finding
consistent with the high level of DNA we measured.
2.2.10 Correlations Between Donor Characteristics and IE Yield
With the number of IE determined with the EM/PCV method, IE did not correlate
with age (r = -0.165), BMI (r = -0.020) or pancreatic weight (r = 0.113). As expected, IE
correlated inversely with cold ischemia time (r = -0.391, p < 0.01), and, unexpectedly,
positively with the duration of illness (r = +0.376, p < 0.01).
2.3 Discussion
The islet transplantation field is challenged with the need of finding better ways
to standardize methods for determining the composition of islet preparations. This study
focused upon new ways to assess pancreatic tissue preparations that have been digested
and purified for islet transplantation. Electron microscopy was used to definitively
identify 0 cells, non-1 cells, acinar cells and duct cells. By counting a sufficient number
of cells, reliable estimates of cell composition expressed as number fraction were
obtained. We showed how the number fraction data from EM is converted to a volume
basis by use of cell volume estimates from the literature and our own observations. These
estimates for cells were then put on a basis of total tissue volume by incorporating
literature estimates of extracellular volume fraction in islet and non-islet tissue, leading to
estimates of islet volume fraction, which is the basis for conventional purity estimation.
Lastly, we used measurements of packed cell volume and pellet void fraction to
determine the total volume of tissue in an islet preparation from which the volume and
number of islets and 1 cells were estimated. We have used these methods and
calculational framework to analyze the properties of 33 freshly isolated human islet
preparations used for clinical transplants.
This is the first study to use ultrastructural analysis for quantifying the cell
composition of freshly isolated islet preparations. All previous studies with isolated
islets or islets within pancreatic tissue have used immunohistochemical staining. A few
studies have reported results in terms of number fraction, e.g. fpIc, the number of p cells
relative to the number of all islet cells; most have reported volume fraction, e.g. OpI, the
volume of 0 cells relative to the volume of islet tissue (including extracellular space),
which is the quantity obtained from stereological point counting. These different bases
arise from methodological differences and have invariably been ignored in comparing
data. In some studies, other volume fraction quantities are reported and manipulation of
the data using equations in Appendix A is necessary to convert the data to DpI. The
difference between the volume fraction oip and the number fraction fpic is significant
because of the large difference in cell volumes. We note that the two parameters are
related; combination of Equation A- 19, Equation A- 20, and Equation A- 32 yields
VIC
Using DIEc = 0.29 (Appendix A), vp = 950 gm3 (Table A. 1), and V~c = 805 Rim3 (Table
2.3) in Equation 2-11 leads to (Io = 0.838 fpic. Thus Ip1 is about 16% smaller than fpjc.
Most importantly, Opi can thus be estimated from measurements of fpic and vice versa.
Literature values for p-cell content in human islets are summarized and compared
with this study in Table 2.5. Data are tabulated as reported or after conversion to either
CpIi or fpic. Data from one study (44) with islets cultured up to 4 weeks gave the volume
fraction p cells among islet cells ýpic = 0.80 (and the corresponding P-cell volume
fraction (lr = 0.57), which is 8% lower than our measurements of 0.865 (Table 2.3). In a
second study with islets that had been shipped and then cultured for 48 hr (65), the p-cell
volume fraction in islets was 0.54, 12% lower than our result. The reason for these
discrepancies is unclear and may reflect a difference between freshly isolated and
cultured islets as well as effects of shipping. In one study with dissociated islet cells (46),
the number fraction of p cells (fplc) among islet cells was 0.57, 31% lower than our
measurement of 0.74 (Table 2.2). An even lower value of 0.51 was reported with laser
scanning cytometry of dissociated islet cells (66). Perhaps shear forces caused by
mechanical agitation lead to selective loss of fragile P cells, thus distorting measured islet
cell composition. In rodent islets, the dissociation process leads to immediate loss of
about 50% of the P cells (52). Islet composition in human pancreata has been reported in
a number of studies. In a recent study (64), laser scanning confocal microscopy produced
a P-cell number fraction of 0.55, 26% lower than our measurement. This difference may
result from methodological differences: only cells that had a clearly labeled nucleus
were counted (64) because cell borders are difficult to see with confocal microscopy.
Because the nucleus volume is comparable but the total volume of 0 cells is more than
twice that of non.- cells (Table A. 1), the probability of seeing a nucleus in an arbitrary
1-jim optical section is higher in non-p than in 3 cells, thereby leading to a measurement
of a smaller number fraction of 1 cells than is actually present. In eight other studies of
islets within the pancreas with conventional histological tissue sections, Dpi averaged
0.64 ± 0.07 (range 0.52-0.75), which is not significantly different from our result
(0.612 + 0.008). We conclude that the p-cell composition of freshly isolated islets is
similar to that of islets in the pancreas.
One potential source of error in all methods for characterizing islet preparations is
the extent to which the very small initial sample may not be representative of the much
larger volume of the entire preparation. To minimize such error, we followed a consistent
procedure to keep the suspension evenly distributed during sampling by repeated
inversion of the tube. To minimize errors associated with ultrastructural analysis from
EM micrographs, we examined at least 500 cells. The small coefficient of variation
(COV) for number fraction fpic (Table 2.2) and volume fraction pr, among all islet cells
(Table 2.3), together with the similarities of mean values between isolated islets and
islets within in the pancreas (Table 2.5), are consistent with the samples being
representative of the P-cell content of islets and suggest that the data reflect a reliable
value for p-cell content of intact, freshly isolated islets.
Purity assessments by visual estimation after DTZ staining were 24% higher on
average than the value estimated by EM (Table 2.3), and individual measurements were
often much higher (Figure 2.3). This is not surprising since the two-dimensional
observations with normal light microscopy used with DTZ staining can lead to an
overestimate of the three-dimensional estimate of volume fraction. Furthermore,
estimates from DTZ staining are subject to considerable observer variability, as
evidenced by experienced individuals trained in the same manner often having
differences that are sometimes more than 20% (76).
With an accurate estimate of islet volume fraction based on the EM cell
composition measurement, the total volume of islet tissue can be determined from a
measurement of total tissue volume. In this study, we used measurements of packed cell
volume of the entire preparation combined with a measurement of pellet void fraction to
estimate total tissue volume (expressed as number of IE). Measurements of islet volume
with the standard counting method using DTZ-stained islets correlated poorly with values
estimated from the EM/PCV measurements and were usually substantially higher
(Figure 2.4). On average, the volume from DTZ counts was 21% higher than from
EM/PCV (Table 2.4). In addition to the subjectivity of the measurement, visual counting
of DTZ stained islets led to an overestimate of volume because the actual shape of the
islets is not spherical (30, 77), which has been confirmed by approximating islets as
ellipsoids of revolution and measuring the three half axes (78, 79). When islets are
examined on a surface, the smallest dimension is usually not observed because it is
pointing upwards towards the microscope in the most stable configuration. Estimation of
a radius as the largest half axis or as the geometric mean (i.e. the radius of a circle with
the same area) leads to an estimated spherical volume that is higher than the actual
volume. Other sources of error that may contribute to poor correlation are experimental
errors in the Vpc measurement and uncertainty in the estimate of the pellet void fraction,
for which additional measurements with human islet preparations are needed.
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An important finding of the EM cell composition measurements is the small
variability of the P-cell volume fraction pjic and (Ipi from one sample to another, as
reflected in the small coefficient of variation. This leads to the highly linear correlation
between p-cell volume Vp and islet volume VI in Figure 2.5, and it means that a
reasonable estimate for Vp in a particular islet preparation can be obtained by using the
mean value 0pi = 0.612 ± 0.008 together with a measurement of VI. We have used PCV
measurements in this study, but Equation 2-7 (Vp = ýpc (1- (IIEC)VI) is useful with any
valid measurements of VI.
There is much interest in how much of the islet tissue in pancreata is recovered
during the isolation process. Two recent studies reported that P cells occupy an average
of about 1.9% of pancreas volume (61, 80). Assuming a tissue density of 1.1 g/ml, the
volume of 3 cells from a pancreas weighing 85.5 g (Table 2.1) would be 1.48 ml. Using
(pi = 0.61 ml P cells /ml islets (Table 2.3), the volume of islets VI is 2.4 ml islets, which
corresponds to NIE = VI/VIE = 1.3 million IE per pancreas. With an average yield of
about 350000 IE (Table 2.4), less than 30% of the original number of IE is being
recovered on average in the islet preparations. This finding is consistent with the high
level of DNA (Table 2.1) and tissue loss we observed.
This chapter introduced new approaches to the assessment of cell composition
and purity in islet preparations that allows estimations of islet and P-cell number and
volume prior to transplantation. While this work relied on EM analysis done after the
transplants, these new quantification approaches can be applied using light microscopy
(Chapter 3) and may be applicable with frozen sections (Chapter 4) to estimate purity in
the hours prior to transplantation.
Contributions: This work was initiated at Joslin Diabetes Center. The EM analysis was
performed by Dr Susan Bonner-Weir, the preparation of the 1-lm and ultrathin sections
was carried out by Chris Cahill (Joslin DERC), the islet isolation, handling, and packed
cell volume measurements were performed by the Islet Core (Jack J. O'Neil, Abdulakdir
Omer, Vaja Tchipasvilli, Ji Lei), and Michael Hirshman helped with measurements of the
void fraction of packed cell pellets.

Chapter 3.
Comparison of Light and Electron
Microscopy for Measuring Purity of
Human Pancreatic Islet Preparations
Even though much progress has been made in transplantation of islets of
Langerhans for treatment of patients with type 1 diabetes (4), success rates and large
scale applicability of islet transplants are hindered by a number of issues, such as islet
availability and single donor success limitations (6, 8, 9), glucose intolerance (12, 13),
and loss of insulin independence over time (6). Among the most important problems is
the lack of quality control measures that correlate with the transplantation outcome (20,
82, 83). Estimation of the volume fraction of islets and the total volume of islet tissue is
of particular importance prior to transplantation. Human islet preparations are more
difficult to characterize than those obtained from rat, porcine or other animals because
they usually contain a large fraction of non-islet tissue.
The current method for estimating the volume fraction of islets in impure
preparations is based on microscopic visualization. Tissue aliquots are stained with
dithizone (diphenylthiocarbazone, DTZ) and examined by light microscopy (49). DTZ is
a zinc-specific binding dye that stains the 3 cells of islets red so that islets can then be
visually differentiated from exocrine tissue, which is not stained by DTZ. Purity
assessment by DTZ is made by rough visual estimates of the volume fraction of tissue
stained red. The method is operator dependent, and usually grossly overestimates islet
purity (46). More detailed studies of human islet cell composition have been carried out
with immunohistochemical methods (44, 45, 56-59, 61-66, 80) using different
microscopy techniques, including confocal microscopy of whole islets and laser scanning
cytometry of dispersed islet cells, but the volume fraction of islets in an islet preparation
was not determined in any of these studies.
In Chapter 2, we used morphological analysis with electron microscopy (EM) for
accurate identification of cell types and quantitation of cell composition in 33 islet
preparations used for clinical transplants. Together with estimates of cell number
fraction, cell volume, and extracellular volume fraction, a framework of equations was
developed to convert number fraction data to volume fraction estimates including the
volume fraction of islets in a preparation. Multiplication of this product by the total tissue
volume led to an estimate of the total islet volume. Furthermore, p-cell volume was
linearly proportional to total islet volume because the 3-cell volume fraction amongst
islet cells was maintained within a tight range.
The key parameter for all of these estimates is an accurate measurement of the
islet volume fraction. Because the skills needed for ultrastructural analysis are not readily
available at some islet laboratories, we explored alternatives. In this study, we
hypothesized that morphological analysis by light microscopy (LM) with conventional
stains could be used to distinguish between islet and non-islet tissue, thereby allowing
determination of islet volume fraction. In the previous EM study, blocks of epoxy-
embedded islet samples were cut into 1-pm sections that were stained and examined by
LM prior to cutting ultrathin sections for EM. In this study, 1-pm sections that were
available from 27 of the 33 islet preparations were examined by LM morphological
analysis, and the volume fraction of islets was determined directly by stereological point
counting. This study is the first to make direct, quantitative measurements of the volume
fraction of intact islets in an isolated islet preparation. Comparison of data from LM
measurements with estimates from EM measurements for the same samples revealed
excellent agreement for islet volume fractions greater than 0.3. This finding means that
islet volume fraction can be measured accurately by common LM techniques and sets the
stage for further refinement of LM analysis in real time with frozen sections.
3.1 Materials and Methods
3.1.1 Islet Isolation
Islets were isolated from cadaver pancreata obtained from the New England
Organ Bank as previously in Chapter 2. Briefly, pancreata were preserved with
University of Wisconsin (UW) solution (Barr Pharmaceuticals, Pomona, NY); five were
preserved using the two-layer perfluorocarbon (PFC) method (25). Pancreata with cold
ischemia times only 12 hr or less without PFC or less than 18 hr with PFC preservation
were processed for transplantation. Islets were isolated by the Islet Resource Center of
the Joslin Diabetes Center using the standard collagenase/protease digestion method (4,
33). The pancreatic duct was cannulated and distended with 40C collagenase/protease
solution using Liberase TM HI (Roche Diagnostics, Indianapolis, IN) (36). Islets were
separated from exocrine tissue using continuous density gradient centrifugation in a
COBE 2991 cell processor (Gambro BCT, Lakewood, CO). Fractions containing islets
were combined and resuspended in final wash medium (CMRL, Mediatech, Herndon,
VA) to a total volume of 255 ml in a 250 ml tube. From this final suspension, aliquots
were taken for various assays, including estimation of purity by staining with dithizone
(diphenylthiocarbazone, DTZ) and morphological analysis by EM and LM.
3.1.2 Volume Fraction Islets by DTZ Staining
DTZ (Sigma-Aldrich, St. Louis, MO), a zinc-specific binding dye, was used to
discriminate islet from non-islet tissue by staining islet f3 cells (49). DTZ was dissolved
in dimethylsulfoxide (DMSO, ICN Biomedicals Inc., Costa Mesa, CA) as a 10x stock
solution (2.5 mg/ml) and diluted with Hanks Balanced Salt Solution (HBSS, Mediatech)
for the lx working solution. An aliquot of 250 il from the final islet preparation was
transferred to a 60 mm Petri dish containing 3 ml of DTZ working solution and incubated
with gentle swirling for 3 min. All of the tissue was examined with microscopic
visualization by focusing through different depths of the tissue, and the volume fraction
of red-stained islet tissue, (0r)DTZ, was estimated.
3.1.3 Morphological Analysis
Morphological analysis was carried out by EM or LM using a standard procedure.
A 0.5-ml aliquot from the final 255-ml islet preparation was placed into a microfuge
tube, fixed in 2.5% (v) glutaraldehyde in 0.1 M phosphate buffer, pH 7.4 at room
temperature for 2 hr and then at 40 C overnight, washed with a 0.1 M phosphate buffer,
pH 7.4 post-fixed for 1 hr in a 2% (w/v) solution of osmium tetroxide (Electron
Microscopy Services, Hatfield, PA) in 0.1 M phosphate buffer, pH 7.4, washed again in
the same phosphate buffer, and stored at 40C prior to processing for plastic embedding.
The fixed tissue was divided into two samples that were then dehydrated using ascending
concentrations of ethanol (50 to 100%). Tissue was cleared with two changes of
propylene oxide (Thermo Fisher Scientific, Waltham, MA). Infiltration of epoxy resin
(EMS) into tissue samples was carried out using a mixture of propylene oxide and
Araldite 502 epoxy resin (1:1) for several hours before being placed into a vacuum
desiccator overnight. The tissue samples were then removed from the microfuge tubes,
placed into BEEM capsules (EMS), embedded in fresh Araldite 502 epoxy resin, and
placed into a 600C curing oven for 48 hr. The sample blocks were removed from the
oven, trimmed, and 1-pm sections were cut with an ultra-microtome (LKB Nova,
Brommer, Sweden) using glass knives. The sections were then adhered to glass slides
using heat before being stained with 1% toluidine blue (Thermo Fisher Scientific) and
viewed under an Olympus BH2 light microscope. Secretory granules of islet endocrine
cells were too small to be seen with light microscopy, but the zymogen granules of acinar
cells were evident, which allowed acinar contamination to be easily identified on the
1-ýim thin plastic sections initially used as a preliminary assessment for sections to be
taken to the electron microscope. These 1-1am sections were reanalyzed in this study as
described subsequently.
3.1.4 Electron Microscopy
For ultrastructural determinations (EM), ultrathin (100 nm) sections of islets were
stained with lead citrate and uranyl acetate and photographed on an electron microscope,
as previously described in Chapter 2. An ultrathin section from each block was viewed
with EM, and 16 micrographs were taken systematically covering each section (total 32
micrographs per islet preparation) using 1900x magnification for analysis of
500-800 cells. With photographic printing (final magnification of 4375x), cells were
distinguished based on their ultrastructure and granule morphology. Cell boundaries were
identified, and each cell was classified as islet cell, including P and non-P endocrine cells,
or non-islet cell, including acinar and ductal cells (Chapter 2). The resulting cell
composition was based on number, not volume, of cells and yielded the number fraction
fi of each cell type defined as the number ni of cells of type i divided by the total number
of cells, nTc. The islet cell number fraction fic is the number of P and non-P endocrine
cells divided by the total number of cells, (np + nNp)/nTc.
3.1.5 Light Microscopy
In light microscopy, as shown in Figure 3.1, islet tissue was distinguished from
non-islet tissue (exocrine or ganglia) by its cordlike pattern of cells often around vascular
spaces, lack of visible granulation, and occasional visible small lipid droplets, whereas
the exocrine tissue was in the form of either large sheets of simple columnar ductal
epithelia or clumps of duct and acinar tissue. The acinar tissue initially was granulated
with large stained granules, although after several days of culture these were less
pronounced; the small ducts were only faintly stained and surrounded by acinar tissue.
The 1-jim sections were analyzed at 420x by stereological point counting (84) with a
90-point grid covering adjacent, non-overlapping fields. The nature of the tissue was
determined at each point intercepts of the grid with tissue. Freshly isolated islets had
large dilated vascular spaces, and two approaches were explored to take these spaces into
account: (1) vascular space was included as part of the islet domain, or (2) vascular space
was analyzed separately.
We define the number of points falling on islet tissue as PI, non-islet tissue as PNI,
and vascular space as Pv. If the vascular space is included as part of the islet, the volume
fraction of islets ar can be calculated from
Pl +PvEquation 3-1 (I) =
P +Pv +PM
where the numerator is the number of points falling within the domain of islets and the
denominator is the total number of points over tissue.
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Figure 3.1. Identification between islet and non-islet tissue by light microscopy from
plastic sections.
Photographs were taken in an Olympus BH2 microscope from three different
sections. (A) Islet tissue is characterized by its cordlike pattern around vascular
spaces (five white areas) and small lipid droplets. (B) Acinar tissue is granulated
with dark stained zymogen granules (dark blue spots) and light stained duct tissue
is surrounded by acinar tissue. (C) Three clumps of duct tissue lightly stained
surrounded by darker stained acinar tissue. (D). Islet (left and top right) and
non-islet tissue (bottom right, same as panel B) as seen together in the 1-pm
sections. Magnification bar = 20 jpm (A), (B), (C) and 50 pm (D)
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If the vascular space is analyzed separately,
space and calculate the islet volume fraction exclusive
Equation 3-2
then we first ignore the vascular
of islet vascular spaces from
IXV - PI +PNI
The tissue is then reanalyzed at higher magnification
fraction, (Fvi in the islets from
(830x) to obtain the vascular void
Equation 3-3 PV1  +P,
The islet volume fraction can then calculated from
Equation 3-4 I = xv
-
+1-
Equation 3-4 is equivalent to Equation 3-1, as can be verified by substituting
Equation 3-2 and Equation 3-3 into Equation 3-4. The second method, Equation 3-2
through Equation 3-4, was employed here because it provided more consistent results.
We counted a total of 500-800 points on one section for each preparation, which
yielded a predicted standard error equal to 3-5% of the mean value for preparations with
about 50% islet purity (84).
3.1.6 Interconversion Between Islet Number and Volume Fractions
As previously described in Chapter 2, the islet cell number fractions fic obtained
from EM measurements were converted to islet tissue volume fractions (DI)EM (based on
total tissue volume) using estimates of cell volumes and the extracellular volume
fractions of islet and non-islet tissue in order to compare with islet tissue volume
fractions obtained from DTZ staining (ODI)DTZ and from LM point counting measurements
((I)LM-
3.1.7 Statistics
Results are expressed as mean + SEM (standard error of the mean) unless
indicated otherwise.
3.2 Results
3.2.1 Vascular Void Fraction
Slides of 1-pm sections were analyzed by LM for estimation of the vascular void
volume fraction (Dvi in fresh islets. Figure 3.2 shows the frequency distribution obtained
from this analysis. The vascular void volume fraction varied from 0.05 to 0.21 and
averaged 0.14 ± 0.01 for the 27 freshly isolated clinical preparations. This is similar to
the value of 0.14 measured in rat islets fixed in situ (85). When human islets are cultured,
the vascular space collapses partially after 24 hr culture (Chapter 2), leading to a lower
vascular void volume fraction. After 24 hr of culture, the vascular volume in rat islets
collapses completely (86).
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Figure 3.2. Frequency distribution of the vascular void volume fraction Ovi by LM
for 27 freshly isolated clinical preparations.
3.2.2 Comparison Between Islet Volume Fraction Determined by Three Methods
Estimates of the islet volume fraction by EM, LM, and DTZ staining were made
with each preparation. For each slide examined by LM, the vascular space and the islet
volume fraction exclusive of islet vascular spaces were first analyzed separately
according to Equation 3-2 and Equation 3-3, respectively; the islet volume fraction
(OI)LM, which included all components that comprised the islet tissue domains, was then
calculated using Equation 3-4.
The frequency distributions of the islet volume fraction measured by (A) EM,
(B) LM, and (C) DTZ staining are shown in Figure 3.3. The islet volume fractions
Y Li.
measured by EM follow a normal distribution. The mode of the distribution corresponds
to an islet volume fraction in the range 0.45-0.55. The mode is the same for islet volume
fraction obtained by LM, but the data scattered about a normal distribution and there are
more values at the lower end. The distribution of islet volume fractions measured by DTZ
staining is skewed to the right with a mode in the range of 0.75-0.85.
The islet volume fraction by EM is plotted against the measured value from LM
for each of the 27 preparations in Figure 3.4. All of the data are close to the line of
identity for ((I))LM greater than about 0.3. The data correlate linearly with R2 = 0.95 if all
data are included or R2 = 0.97 if the three preparations with low purity ((DI)LM <0.3) are
excluded. The three preparations for which islet volume fraction (1I)LM was lowest were
associated with a substantial fraction of islets that were embedded or engulfed in large
pieces of tissue, making it harder to identify and distinguish islet tissue from exocrine
tissue.
The islet volume fraction estimated by DTZ staining is plotted against that
measured by LM in Figure 3.5. The data display an upward shift relative to the line of
identity. For 24 out of the 27 batches, the estimate from DTZ staining is higher than that
from LM, and the two data sets correlate poorly. Similar findings are obtained if the islet
volume fraction by DTZ staining is compared against that calculated from EM
(Chapter 2).
Number fraction of cells by EM and volume fraction of islets by EM, LM, and
DTZ staining are summarized in Table 3.1. The mean islet volume fraction by EM and
LM are 0.554 + 0.034 and 0.523 ± 0.038, respectively, and the two sets of data are not
significantly different (p < 0.05). The mean islet volume fraction by DTZ, 0.68 + 0.04, is
about 30% higher than that by LM and 23% higher than that by EM, and these findings
are significant at p < 0.001. If the three preparations with low purity ((Q1 )LM < 0.3) are
excluded, then the mean islet volume fraction by EM and LM are even closer,
0.591 ± 0.030 and 0.572 ± 0.030, respectively, and are not significantly different
(p < 0.05). The mean islet volume fraction by DTZ, 0.72 ± 0.03, is about 26% higher than
that by LM and 22% higher than that by EM (p< 0.001 for both EM and LM).
Table 3.1. Number fraction cells by EM and islet volume fractions by EM, LM, and
DTZ staining.
A. All 27 human islet preparations.
Number Fraction Cells by EM
Mean
SD
COV
SEM
Islet
fic
0.484
0.163
0.34
0.031
Non-Islet
fNIC
0.516
0.163
0.32
0.031
Volume Fraction of Islets
EM
((I)EM
0.554
0.177
0.32
0.034
LM
((I)LM
0.523
0.195
0.37
0.038
DTZ
((DI)DTZ
0.68
0.19
0.28
0.04
B. Data from 24 human islet preparation with data for (DI)LM <0.3 excluded.
Number Fraction Cells by EM
Islet
fic
0.518
0.138
0.27
0.028
Non-Islet
fNIC
0.482
0.138
0.29
0.028
Volume Fraction of Islets
EM
((I)EM
0.591
0.149
0.25
0.030
LM
((I)LM
0.572
0.145
0.25
0.030
DTZ
((I)DTZ
0.72
0.15
0.21
0.03
Mean
SD
COV
SEM
8 A. EM
7
6
5
4
3
2
1
0
8
7
6
5
4
3
2
1
0
8
7
6
5
4
3
2
1
0
I i.
0 0.2 0.4 0.5 0.5 1.0
Islet Volume Fraction
Figure 3.3. Frequency distribution of the islet volume fraction by (A) EM, (B) LM,
and (C) DTZ staining.
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Figure 3.4. Calculated islet volume fraction by EM is plotted against the measured
islet volume fractions by LM.
The dashed line is the line of identity. The calculated islet volume fraction by EM
correlates linearly with that measured by LM. Linear regression of the data gives a
correlation coefficient R = 0.95 for all data and R2 = 0.97 without three data points
for (MDI)LM less than 0.3.
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Figure 3.5. Estimated islet volume fraction by DTZ staining is plotted against the
measured islet volume fractions by LM.
The dashed line is the line of identity. In many cases, the measurement from DTZ
staining was much higher than that from LM point counting and provided a gross
overestimation of islet purity. Linear regression of the data gives a correlation
coefficient R2 = 0.67.
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3.3 Discussion
The islet transplantation field is in need of tests that will provide meaningful
information for islet quality assessment. One of the most important parameters for
characterizing a human clinical islet preparation is its purity, which is the volume fraction
of islet tissue in the preparation. In Chapter 2, we examined the use of ultrastructural
analysis (EM) with ultrathin sections to quantify cell composition in human pancreatic
islet preparations. EM provided accurate measurements of the number fraction of islet
cells in impure preparations, and the data were used to estimate the volume fraction of
islets. A drawback of EM is the training and experience required to be able to produce
the images for analysis and to categorize each cell type.
In this study, we examined the use of LM analysis of 1-ipm sections to obtain the
islet volume fraction in impure preparations by stereological point counting. LM analysis
requires less extensive training; a slide of plastic sections can be analyzed within 10 min.
We compared EM and LM for estimation of the islet volume fraction in impure
preparations. In our previous study in Chapter 2, we developed a mathematical
framework and used it to convert cell number fraction data to tissue volume fraction in
order to be able to compare data obtained from the different analysis methods. In this
chapter, we compared islet volume fraction measurements obtained by LM to values
estimated from EM cell number fraction measurements as well as data obtained by the
standard DTZ staining method for 27 freshly isolated clinical preparations. Our results
(Figure 3.3, Figure 3.4, and Table 3.1), demonstrate that LM point counting provides
accuracy and precision equivalent to that of individual cell counting by EM. Moreover,
our results also indicate that the standard method of DTZ staining grossly overestimates
the islet volume fraction in the preparation (Figure 3.3, Figure 3.5, and Table 3.1). These
findings are important because they show that use of LM to analyze 1-jim sections, which
is easier to learn and employ, provides data comparable to that obtained by EM. Results
obtained by both LM and EM show the large error incurred currently by use of the DTZ
staining method.
We also performed the first quantitative measurements of the vascular void
volume fraction in fresh human islets (Figure 3.2). The average value, 0.14 ± 0.01, was
comparable to that previously measured in rat islets. This value applies to freshly isolated
human islets and will decrease for islets that have been cultured for several days because
of the partial collapse of these spaces with time in culture.
The excellent agreement between islet volume fraction by LM and that calculated
by EM validates the use of LM stereological point counting for determining islet purity.
Even though LM requires less training and less time for analysis, 3 days are required
before the plastic sections are available for analysis because of the time required to cure
the polymer. This renders morphological analysis by LM and EM useful only for a
retrospective assay, the results of which will be known after transplantation. Nonetheless,
the excellent results obtained with LM using plastic-embedded sections suggest that more
rapid techniques, such as the use of frozen sections, preliminary results on which are
presented in Chapter 4, may allow measurements to be made in real time prior to
transplantation.
Contributions: This work was done in collaboration with Joslin Diabetes Center. The
EM analysis was done by Dr Susan Bonner-Weir, and the preparation of the 1-jm and
ultrathin sections was carried out by Chris Cahill (Joslin DERC).
Chapter 4.
Frozen Sections: A Promising Alternative
to Plastic Sections for Measuring Purity of
Human Pancreatic Islet Preparations
As previously mentioned in Chapters 2 and 3, knowledge of the islet volume
fraction and the volume of total islet tissue are of particular importance prior to
transplantation. The current method of purity estimation by dithizone staining (49)
usually overestimates the islet volume fraction of an impure preparation. The use of
ultrastructural analysis by electron microscopy (EM) with ultrathin sections for cell
composition quantification in human pancreatic islet preparations provided accurate
measurements of the number fraction of islet cells in impure preparations that can then be
converted using a mathematical framework to the volume fraction of islets (Chapter 2).
However, EM requires extensive training and experience to identify cell types as well as
long preparation time to produce the images for analysis. On the other hand, the analysis
of 1-pm sections by light microscopy (LM) to obtain the islet volume fraction in impure
preparations by stereological point counting (Chapter 3) required less extensive training,
shorter analysis time, and provided results of equivalent accuracy with EM. Even so, the
time required to produce the 1-ptm sections was 3 days, and therefore rendered the assay
a retrospective one. Nonetheless, more rapid techniques, such as the use of frozen
sections, may allow measurements to be made in real time prior to transplantation.
Frozen sections have been used for a variety of tissues (87-93) to assess histology
and pathology, especially as a tool for cancer diagnosis, in a quick and reliable way. The
widespread application however includes only pieces of tissue and not cell or islet
preparations. During freezing, tissue must be protected to minimize formation of ice
crystals. The piece of tissue must be frozen as quickly as possible or cryoprotected prior
to freezing more slowly. Freezing can be achieved by immersion of the tissue in
isopentane cooled in its freezing point by liquid nitrogen (N2), placing on a metal block
already brought to the temperature of liquid N2 (or solid carbon dioxide, liquid helium),
and other means that have been extensively investigated (94-96).
In this study, we investigated use of frozen sections, obtained from islet
preparations, destined for LM analysis as a way to minimize time requirements for
preparation of plastic sections.
4.1 Materials and Methods
4.1.1 Islet Isolation
Islets were isolated from cadaver pancreata obtained from the New England
Organ Bank as previously described (Chapter 2). Briefly, pancreata were preserved with
University of Wisconsin (UW) solution (Barr Pharmaceuticals, Pomona, NY) and with
the two-layer perfluorocarbon (PFC) method (25), if necessary. Islets were isolated by
the Islet Resource Center of the Joslin Diabetes Center using the standard
collagenase/protease digestion method (4, 33). The pancreatic duct was cannulated and
distended with 40C collagenase/protease solution using LiberaseTM HI (Roche
Diagnostics, Indianapolis, IN) (36). Islets were separated from exocrine tissue using
continuous density gradient centrifugation in a COBE 2991 cell processor (Gambro BCT,
Lakewood, CO). Fractions containing islets were combined and resuspended in final
wash medium (CMRL, Mediatech, Herndon, VA) to a total volume of 255 ml in a 250 ml
tube. From this final suspension, an aliquot of 30 ml was separately handled for further
sample processing. From the 30 ml, aliquots were taken for various assays, including
estimation of purity by staining with dithizone (diphenylthiocarbazone, DTZ) and
preparation and analysis of plastic and frozen section by light microscopy (LM).
4.1.2 Preparation of Plastic Sections
Plastic sections of 1-gpm thickness destined to be analyzed by LM were prepared
using a standard procedure (Chapter 2). A 0.5-ml aliquot from the 30-ml islet preparation
was placed into a microfuge tube, fixed in 2.5% (v) glutaraldehyde in 0.1 M phosphate
buffer, pH 7.4 at room temperature for 2 hr and then at 40C overnight, washed with a
0.1 M phosphate buffer, pH 7.4 post-fixed for 1 hr in a 2% (w/v) solution of osmium
tetroxide (Electron Microscopy Sciences, Hatfield, PA) in 0.1 M phosphate buffer,
pH 7.4, washed again in the same phosphate buffer, and stored at 40C prior to processing
for plastic embedding. The fixed tissue was divided into two samples that were then
dehydrated using ascending concentrations of ethanol (50 to 100%). Tissue was cleared
with two changes of propylene oxide (Thermo Fisher Scientific, Waltham, MA).
Infiltration of epoxy resin (EMS) into tissue samples was carried out using a mixture of
propylene oxide and Araldite 502 epoxy resin (1:1) for several hours before being placed
into a vacuum desiccator overnight. The tissue samples were then removed from the
microfuge tubes, placed into BEEM capsules (EMS), embedded in fresh Araldite 502
epoxy resin, and placed into a 600C curing oven for 48 hr. The sample blocks were
removed from the oven, trimmed, and 1-pm sections were cut with an ultra-microtome
(LKB Nova, Brommer, Sweden) using glass knives. The sections were then adhered to
glass slides using heat before being stained with 1% toluidine blue (Thermo Fisher
Scientific) and viewed under an Olympus BH2 light microscope.
4.1.3 Preparation of Frozen Sections
A 0.5-ml aliquot from the 30-ml islet preparation (- 500 - 1000 islet equivalent
(IE)/aliquot) was placed into a microfuge tube, washed twice in Phosphate Buffered
Saline without calcium or magnesium (PBS, Mediatech, Herndon, VA) to remove any
serum present, and fixed for 30 min in 1 ml of cool formalin (10%) at room temperature
(Sigma Aldrich, St Louis, MO). Tissue was then washed in PBS and 1 ml of 30% (w/v)
sucrose (Fischer-Scientific, Pittsburg, PA) in PBS was added. Incubation with the sucrose
solution offered cryoprotection and prevented the formation of ice crystals that would
replace the tissue architecture with a meaningless array of cell-sized holes. The aliquot
was incubated in sucrose solution at 40C for 1.5 hr or until all islets had settled at the
bottom of the microtube forming a pellet. The supernatant was then carefully removed to
the surface of the pellet. The microtube was then cut in half to shorten the distance from
the pellet at the bottom of the tube to the edge of the microtube using a sharp pair of
scissors. The pellet was then carefully scooped out of the microtube using a tooled
sharpened resin-impregnated applicator. Tissue was slowly moved to the edge of the tube
and then transferred from the tip of the applicator to the center of a cassette designed for
frozen blocks (Fisher Scientific). Once all the tissue was transferred to the center of the
block, cool optimal cutting solution (OCT, Tissue-Tek, Electron Microscopy Sciences)
was injected through a 20G1/2 needle (Becton Dickinson, Franklin Lakes, NJ) in the
block. The OCT was injected from the periphery of the block towards the center slowly
and only around the tissue, not directly on top of the tissue, to prevent it from splitting
apart. By pouring the OCT outwards towards inwards the center of the block, the tissue
keeps its compact shape as a sphere in the center of the block and therefore results in a
tight circular shape on the slide after sectioning. The frozen block cassettes were
immediately transferred on dry ice (-80 0C), where they were left for about 20 min or until
the OCT had completely frozen and solidified. The frozen block was then ready to be
sectioned.
The frozen block was sectioned using a standard procedure. Briefly, the block
was transferred in a cryostat (HM 500 Microm, GMI, Inc., Ramsey, MN) at -200C for
about 10 min before sectioning to allow for temperature equilibration. The block was
then carefully sectioned (10-tm thick) using a sharp blade. Sections were placed on
positively charged microscope slides (Superfrost®/Plus, Fisher Scientific) and placed in
a slide box in the cryostat.
Two different staining protocols were examined. Staining with hematoxylin was
the fastest protocol but the analysis of the slides required experience in morphology in
order to be able to characterize the tissue as islet and non-islet tissue. As soon as slides
were taken out of the cryostat, they were dipped in PBS and then transferred in a Coplin
jar that contained filtered hematoxylin (Harris Hematoxylin, Sigma Aldrich). The slides
incubated in hematoxylin for 2.5 - 3 min and then washed 3 times in 1.2% (g/v) sodium
borate (NaBO 4, Fisher Scientific) in three consecutive Coplin jars). Slides were left in the
final wash for 5 min. A cover slip (Fisher Scientific) was placed on the slide using
glycerol. The edges of the cover slip were brushed with nail polish in order to prevent it
from sliding around.
Slides were otherwise stained with a combination of methyl green (MG, DAKO,
Carpinteria, CA) and dithizone (DTZ, Sigma Aldrich). Methyl green was used as a
counter stain to stain all nuclei a green-grey color while DTZ stained only islet tissue red.
Tissue was circled using a Super PAP Pen (The Binding Site, Inc Slides) and slides were
dipped in PBS. A drop of MG was placed on the tissue for about 30 sec and the slides
were then rinsed in PBS. The slides were then placed in a humidified chamber and a drop
of DTZ dissolved in dimethylsulfoxide (DMSO, ICN Biomedicals Inc., Costa Mesa, CA)
as a 10x stock solution (2.5 mg/ml) and diluted with Hanks Balanced Salt Solution
(HBSS, Mediatech) for the lx working solution was placed on top of the tissue. The
chamber was covered and the tissue incubated with DTZ for 1.5 hr. The slides were then
rinsed in PBS three times and covered in the same way as slides stained with
hematoxylin. We also examined covering the slides with Crystal Mount (Sigma Aldrich),
an aqeous mounting medium, in order to be able to use them for future staining.
Slides for morphological analysis from frozen sections were prepared in about
4-5 hr. After staining with either method, slides were ready to be analyzed under an
Olympus BH2 light microscope.
4.1.4 Volume Fraction Islets by DTZ Staining
DTZ (Sigma-Aldrich), a zinc-specific binding dye, was used to discriminate islet
from non-islet tissue by staining islet f3 cells (49). An aliquot of 250 gl from the final islet
preparation was transferred to a 60 mm Petri dish containing 3 ml of DTZ working
solution and incubated with gentle swirling for 3 min. All of the tissue was examined
with microscopic visualization by focusing through different depths of the tissue, and the
volume fraction of islet tissue stained red, (cI)DTZ, was estimated.
4.1.5 Volume Fraction Islets by Morphological Analysis
For LM morphological determinations, 1-jim plastic sections stained with
toluidine blue or 10-jim frozen sections stained with hematoxylin were analyzed at 420x
by stereological point counting (84) in which islet and non-islet tissue are distinguished
at positions defined by a grid of points covering adjacent, non-overlapping fields as
previously described in Chapter 3. Briefly, islet tissue was distinguished from non-islet
tissue (exocrine or ganglia) by its cordlike pattern of cells (often around vascular spaces),
lack of visible granulation, and occasional visible small lipid droplets, whereas the
exocrine tissue was in the form of either large duct-sheets or folded sheets of polarized
columnar epithelia or clumps of small duct and acinar tissue. The acinar tissue was
initially granulated with large stained granules, although after several days of culture
these were less pronounced, and the small ducts were only faintly stained and surrounded
by acinar tissue. These characteristics are shown in Figure 3.1 for slides obtained from
1-[tm sections. Tissue type on frozen sections can be distinguished based on the same
characteristics. However, frozen sections stained with hematoxylin, shown in Figure 4.1,
produced slides that did not look as crisp as the thinner 1-jtm sections, due to the greater
thickness. The points that lay in the islet and non-islet tissue were counted to obtain the
volume fraction of islet tissue.
Figure 4.1. Representative photograph of slide from frozen section of human islets
stained with hematoxylin analyzed by LM.
Intercepts of tissue with a 90-point grid are counted as islet, non-islet, or vascular
space based on tissue morphology using stereological point counting. Tissue on the
right hand side is islet while the tissue at the bottom left corner is non-islet.
Magnification bar 50 gm.
4.1.6 Volume Fraction Islets by MG/DTZ Staining
For LM analysis based on color distinction, 10-jtm frozen sections stained with
MG/DTZ were also at 420x by stereological point counting (84). Knowledge of
morphology was not required because the distinction was based on the color of the tissue.
The islet tissue was stained red and the non-islet tissue had a light green-grey color.
Representative figures from the MG/DTZ staining protocol for a sample of human islets
is shown in Figure 4.2.
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Figure 4.2. Representative photograph of slide from frozen section of human islets
stained with MG/DTZ analyzed by LM.
Intercepts of tissue with a 90-point grid are counted as islet, non-islet, or vascular
space based on color of the tissue using stereological point counting. Tissue on the
right site, brightly stained red, is islet tissue while tissue on the bottom left corner,
stained grey-green, is non-islet tissue. Magnification bar 50 pm.
4.2 Results
4.2.1 Comparison Between Staining Protocols for Frozen Sections
Photographs of slides obtained from frozen sections of one preparation of human
islets are shown in Figure 4.1 and Figure 4.2. Two different staining protocols were
examined, one with hematoxylin (Figure 4.1) and the other with a combination of dyes,
MG and DTZ (Figure 4.2). The ease and short incubation times (less than
10 min) of the hematoxylin staining are counterbalanced by the requirement of
knowledge of morphology in order to analyze the slides and characterize the tissue as
islet or non-islet. On the other hand, even though staining with MG/DTZ includes longer
incubation periods and a slightly more tedious protocol, the ease of analysis of the slide,
based just on the color of the tissue, makes it a very promising one. Both staining
protocols have limitations and advantages. Tissue on slides obtained from frozen sections
can not be as crisp and clear as the ones obtained from thin 1-ptm sections due to the
greater thickness. Moreover, because of the different processing in obtaining the block of
tissue and the slides, categorizing tissue from frozen sections stained with hematoxylin
may require different criteria than that from 1-Rtm sections stained with toluidine blue,
explained in detail in Chapter 3. Analyzing slides from frozen sections stained with
MG/DTZ does not require knowledge of morphology and no additional criteria because it
is purely based on color. Even so, some parts of the tissue remain tough to categorize
because the color may not by dark red (islet) or grey-green (non-islet) but a fainter hue of
red (light pink). In that case, knowledge of morphology will help clarify the type of
tissue. The results presented are preliminary and qualitative. We have not yet quantified
islet volume fraction by stereological point counting with the two staining protocols. We
have been able to produce reproducible samples from the same islet preparation and
reproduce the preparation and staining protocol with different islet preparations.
4.3 Discussion
In this preliminary study we explored the use of frozen sections to estimate islet
volume fraction of impure islet preparations in real time. We developed a protocol that
offers cryoprotection of the tissue with a sucrose solution so that tissue structure remains
intact. We were able to obtain a block of islet suspension in OCT, ready for sectioning
within 2.5 hr. After sectioning, which should last about 30 min for a well-trained
researcher, slides can be stained with two different protocols. One requires knowledge of
morphology for tissue discrimination in islet versus non-islet and the other does not. Both
have some limitations at this stage, but preliminary results show that the technique is
very promising. Optimization and fine tuning of the parameters involved in the staining
process will result in slides that can be easily and rapidly analyzed by stereological point
counting with light microscopy. Future studies need to be performed to quantify and
compare islet volume fraction obtained by frozen sections to that obtained by 1-pm
sections for a number of human islet preparations of different purities. Different staining
protocols can also be explored. An interesting idea would be to apply insulin
immunostaining, a rapid protocol performed for laser captured islets, as has been
suggested by investigators in the field (97). Choice of staining protocols needs to be
studied further and it will depend on the specific needs and requirements of each
laboratory.
Contributions: This work was done in collaboration with Joslin Diabetes Center. Dr
Susan Bonner-Weir offered useful suggestions for the protocol development, and Chris
Cahill and Alla Pinkwasov (Joslin DERC) offered useful suggestions for the protocol
development and help in the sectioning training as well as the preparation of some
1-pm and frozen sections.

Chapter 5.
Enumeration of Islets by Nuclei Counting
and Light Microscopic Analysis
Transplantation of islets of Langerhans is emerging as an attractive alternative to
whole pancreas transplantation for a subpopulation of patients with Type I diabetes (4,
98, 99). Improvements in pancreas procurement, preservation, islet isolation, culture, and
transplantation are being pursued (23, 98, 100, 101), but progress is hindered by the
absence of meaningful measures of islet dose and quality (16, 83, 102, 103), one of the
most fundamental of which is the total amount of tissue in an islet preparation.
Estimation of the volume of a pure islet preparation is challenging; it becomes even more
difficult with human islet preparations that typically consist of about 50% non-islet
components (43-46).
Islets are spheroidal clusters of cells that vary in size and shape. Early
measurements of islet properties reported on a per islet basis were scattered over a wide
range (16). The concept of an islet equivalent (IE), the volume of a spherical islet with a
diameter of 150 glm, standardized islet enumeration on the basis of volume and reduced
variability (48, 104, 105). Several methods have been used to estimate the volume of
islets in an impure islet preparation. Routine determination is currently carried out by
staining islets with dithizone (diphenylthiocarbazone, DTZ) (49), followed by
microscopic visualization of size and manual counting. Usually, one dimension is
estimated, such as the diameter of a circle having the same area as that of the islet. Islet
diameters are divided into groups of 50-jm increments, and an average conversion factor
is used to estimate the volume for all of the islets within each 50-jim range (7). This
oversimplified calculation leads to even more inaccuracy (30, 77) because the volume is
calculated assuming that the islet is a perfect sphere, which can lead to gross errors
depending on the actual shape of the islet, and use of a single conversion factor over a
large increment can add additional error. Furthermore, measurements that differed by as
much as 40% between different operators occurred in one unpublished multicenter study
(76). Digital image analysis offers potential improvement over visual counting because it
reduces operator bias, and each islet is accounted for. A linear, though scattered,
correlation is achieved between islet tissue volume and insulin and/or DNA content (40,
106-108). The volume measurement is based on a two dimensional area estimate and the
assumption that the islet is a sphere or ellipsoid of revolution, neither of which is true
(109, 110).
An alternative approach is to make separate measurements of (1) the total amount
of tissue (e.g. total volume or number of cells) in a preparation and (2) the fraction of the
tissue that is islet tissue. The two measurements are then used to calculate the total
amount of islet tissue in the preparation. Measurement of the change in electrical
resistance as a particle passes through an aperture provides an estimate of the particle
volume. In the one study with human islets using the Coulter Multisizer II (111), the IE
estimate was substantially smaller than by visual counting, most likely because the
volumes of ion-permeable tissue spheroids register as incorrectly low volume values.
DNA measurement for quantifying the total amount of tissue in an islet preparation is
common and does not suffer from the errors of visual counting (16, 112, 113). However,
DNA standards are unstable over periods of months and different standards give different
results, which can lead to significant error. Furthermore, residual DNA released from
dead cells in freshly isolated preparations can be a problem. Total protein measurement
suffers from issues similar to that for DNA, and dry weight measurements require time
and specialized balances for measurements with a small number of islets (16). We
showed in Chapter 2 that measurements of the volume of the packed cell pellet could be
used to estimate the volume of tissue in an islet preparation, but uncertainty in the void
fraction of the pellet requires further study. There remains a need for a fast, accurate, and
precise method for measuring the total amount of tissue in an islet preparation.
Nuclei counting is a standard method for accurate enumeration of individual cells
(114, 115), and release of nuclei from cells disrupted with citric acid occurs without
nuclei breakdown or losses. With addition of a surfactant, nuclei counts can be used to
quantitavely assess cell number in suspensions of cell aggregates (116). In this study, we
first examine nuclei counting following cell disruption for measuring the total number of
cells in rat islet preparations as well as suspensions of fTC3 and INS-1 cells. Nuclei are
quantitated by visual counting with a hemocytometer and with two automated methods,
aperture electrical resistance measurement and flow cytometry, and the results are
compared. Comparison with DNA analysis using different dyes demonstrates the
superiority of nuclei counting. We use nuclei counting to determine the number of IE in
pure rat islet preparations and compare the data with DTZ staining/manual counting.
In the second part of this study, we combine nuclei counting and light microscopy
(LM) analysis to determine the number of (IE) in 12 freshly isolated human islet research
preparations. We showed in Chapter 3 that LM morphological analysis of 1-gm plastic
sections by stereological point counting provides estimates of the islet volume fraction in
impure preparations with accuracy and precision comparable to that obtained by electron
microscopic ultrastructural analysis of ultrathin sections. In this chapter, we show how
the framework of relationships we developed in Chapters 2 and 3 is used to combine the
islet volume fraction measurements from LM with the total number of cells measured
with nuclei counting to estimate the total volume of islet tissue in an impure islet
preparation. We compare the number of IE obtained by LM/nuclei counting to the
standard method of DTZ staining/manual counting and to a combination of LM analysis
and packed cell volume (PCV) measurements that we employed in Chapter 2. These data
demonstrate that the current standard DTZ staining method substantially overestimates
the number of IE and that nuclei counting with LM analysis provides an attractive
alternative.
5.1 Materials and Methods
5.1.1 Culture of Cell Lines and Islets
Mouse insulinoma 3TC3 cells (117), derived by introducing an SV40 T-antigen
into embryonic cells of transgenic mice, were cultured in tissue culture flasks in DMEM
medium (Mediatech, Herndon, VA, USA) supplemented with 10% (v/v) fetal bovine
serum (FBS, Mediatech), 100 U/ml penicillin (Sigma-Aldrich, St. Louis, MO, USA),
100 gg/ml streptomycin (Sigma), and 10 mM HEPES (Mediatech), in a humidified 5%
CO2 incubator at 37"C. Rat insulinoma INS-1 cells (118) were cultured in tissue culture
flasks in RPMI medium with 11.1 mM D-glucose (Mediatech) supplemented with 10%
FBS, 100 U/ml penicillin, 100 gg/ml streptomycin, 10 mM HEPES, 2 mM L-glutamine
(Mediatech), 1 mM sodium pyruvate (Mediatech), and 50 gM 2-mercaptoethanol
(Sigma).
Rat islet preparations were isolated by the Islet Core at Joslin Diabetes Center
from male Srague-Dawley rats using collagenase digestion/ficoll purification (37). Rat
islets were cultured in tissue culture flasks in the same supplemented RPMI medium as
for INS-1 cells. Human islet preparations (80% and 30% purity) provided by the Islet
Core at Joslin Diabetes Center were cultured in CMRL 1066 (Miami formulation,
Mediatech) supplemented with 10% (v/v) FBS.
5.1.2 Human Islet Isolation.
Islets were isolated as described previously in Chapter 2 from cadaver pancreata
that were preserved with University of Wisconsin (UW) solution (Barr Pharmaceuticals,
Pomona, NY, USA), some using the two-layer perfluorocarbon (PFC) method (25).
Pancreata with cold ischemia times of 12 hr or less without PFC or less than 18 hr with
PFC preservation were processed. Islets were isolated by the Islet Resource Center of the
Joslin Diabetes Center using the standard collagenase/protease digestion method (4, 33).
The pancreatic duct was cannulated and distended with 40C collagenase/protease solution
using LiberaseTM HI (Roche Diagnostics, Indianapolis, IN, USA) (36). Islets were
separated from exocrine tissue using continuous density gradient centrifugation.
Fractions containing islets were combined and resuspended in final wash medium
(CMRL, Mediatech) to a total volume of 255 ml in a 250 ml tube. From this final
suspension, aliquots were taken immediately for various assays, including DTZ staining
for volume fraction estimation and manual counting for islet enumeration, LM
morphological analysis, and nuclei counting. Two 0.5 ml aliquots were taken for
morphological analysis by LM and fixed immediately. In this study, aliquots for DNA
analysis were taken from samples received about 4 to 6 hr after isolation was complete
and were immediately frozen for subsequent measurement. The samples examined in this
study by LM analysis, DTZ staining, and PCV measurement were from 12 freshly
isolated preparations deemed suitable only for research because they did not meet
specifications for clinical preparations (usually insufficient number of IE).
5.1.3 Cells and Nuclei for Counting
Cell suspensions were prepared by removing medium from the tissue culture
flasks, adding 0.05 ml/cm 2 of 0.05% (w/v) trypsin in 0.53 mM EDTA solution
(Mediatech), and incubating at 370C for 7 min (PTC3) or 3 min (INS-1). Trypsin
solution was removed, culture medium (0.13 ml/cm2) was added, cells were detached by
gently tapping the flask, and the resulting suspension was stored on ice. The dispersion
process resulted in single cells with occasional small aggregates. If left on ice for more
than 2 hr after trypsinization, the PTC3 cells tended to clump; the INS-1 cells also tended
to clump but at a slower rate. Cell counting was performed within 30-45 min after
tryspinization to avoid clumping.
Islet suspensions were mixed by vortexing, and an aliquot was removed for nuclei
preparation. Unless otherwise specified, about 160 IE (based upon an estimate of
1560 cells per IE) were sampled using narrow-orifice (about 0.6 mm inside diameter (id))
pipette tips for 0-200 lA (USA Scientific, Ocala, FL). Selected experiments were carried
out with wide-orifice (2 mm id) pipette tips, 0-200 Vtl (Fisher Scientific, Hampton, NH)
and medium-orifice (1 mm id) pipette tips for large volumes, 200-1000 gll (USA
Scientific, Ocala, FL).
Nuclei were prepared from cells and islets by adding equal 100-1Ol volumes of
sample and of a lysis solution containing 0.1 M citric acid (Sigma) and 1% (v/v)
Triton X-100 (Sigma) to a 1.5 ml microtube. The mixture was incubated at room
temperature for 5 min with vortex mixing every 1.5-2 min. The islet mixture was then
placed in a 1-ml syringe and rapidly forced through a 26G3/8 needle (Becton Dickinson,
Franklin Lakes, NJ) 10 consecutive times. Unless otherwise specified, 105 cells and
160 IE (2.5x10 5 cells) were used for each sample analyzed.
5.1.4 Counting Methods
a) Visual Counting with Hemacytometer
For counting cells, a cell suspension volume of 200 gl was stained with 200 gl of
0.4% (v/v) solution of trypan blue (TB) and diluted with Dulbecco's Phosphate Buffered
Saline (D-PBS, Invitrogen, Carlsbad, CA, USA) to a concentration between 5 and
15x10 5 cells/ml. A 12-tl sample was loaded onto a hemacytometer (Hausser Scientific,
Horsham, PA, USA) and counted using 40x magnification (119, 120). Both stained and
unstained cells were counted to obtain total cell number. Triplicate samples were
prepared, and for each sample about 250 cells were counted on each side of the
hemacytometer (total about 500 cells).
For counting nuclei, crystal violet (Sigma) was added to the lysed samples to a
final concentration of 0.1% (w/v). Unless otherwise specified, the samples were then
diluted with D-PBS to a concentration between 5 and 15x10 5 nuclei/ml, loaded onto a
hemacytometer, and counted using 40x magnification. Typically, about 500 nuclei were
counted for each sample, and triplicate samples were prepared and counted for each
measurement.
b) Aperature Resistance Measurement
A Coulter Multisizer II (Beckman-Coulter, Miami, FL, USA) was used to
determine the size distribution of particles suspended in a solution by monitoring the
electrical current between two electrodes on either side of a 100-pm diameter aperture
that allowed detection of particles with a diameter of 2.0 to 60 ptm. The instrument was
calibrated with standardized beads (CC Size Standard L 43 certified NIST traceable latex
beads, Beckman-Coulter). A known volume of the nuclei sample was diluted with 40%
glycerol in ISOTON II diluent (Beckman-Coulter) to achieve the desired concentration in
a volume of 20 ml. A sample volume of 500 pl was drawn through the aperture, and the
resulting series of current pulses was analyzed by the AccuComp computer program
(Beckman-Coulter) to produce a volume distribution and the sample concentration.
c) Flow Cytometer
Unless otherwise specified, isolated nuclei were diluted with D-PBS to a
concentration no higher than 5x10 5 nuclei/ml, stained with 7-aminoactinomycin D
(7-AAD, Molecular Probes, Eugene, OR), a fluorescent dye with a high affinity for
nucleic acids, at a final concentration of 0.01 mg/ml for at least 2 min at room
temperature, and then analyzed using a flow cytometer (Guava Personal Cell Analysis
(PCA) system, Guava Technologies, Hayward, CA). Proper instrument performance was
verified by running the Guava CheckTM application with the Guava Check Kit reagents
(Guava Technologies). The 7-AAD fluorescence was detected in photomultiplier 2
(PM2). Typically, PMI voltage was set at 430 V and PM2 voltage at 450 V. PM2
threshold was usually set between 70 and 100, depending upon the intensity of stained
nuclei. Forward scatter (FSC) gain was set at 4x, and FSC gate was set to about 100.
Nuclei typically exhibited FSC intensities of greater than 100, and debris (events with
FSC intensity less than 100) were excluded. Scatter plots of 7-AAD intensity and FSC
were initially viewed with Guava Express software. Data from 7-AAD-stained nuclei
samples were acquired using the Guava ViaCount application of CytoSoft software.
Dilution factors and original sample volumes were entered as appropriate for each
sample. The number of nuclei events appeared in the "Total Cells/mL" section of the data
table. Unless otherwise specified, 1000 events were acquired per sample in triplicate. The
flow cytometer was used exclusively for nuclei counting with the 12 human islet research
preparations.
5.1.5 DNA Analysis
DNA concentration was quantified by fluorospectrophotometry using the
CyQUANT@ Cell Proliferation Assay Kit (Invitrogen), which is based on the strong
fluorescence enhancement that the CyQUANT GR dye undergoes when bound to cellular
nucleic acids. Fluorescence resulting from CyQUANT dye binding to RNA was
eliminated by pre-treating the samples with DNAse-free RNAse (Sigma). The
fluorescence intensity was linearly related to the concentration of nucleic acids in the
sample.
Cells or islets were suspended in 200 •l D-PBS at a concentration between 4x10 3
and 4x10 5 cells/ml or 50 - 250 islets/ml and frozen at -200C before DNA quantification.
To 10 ml of the cell-lysis buffer (Component B, Invitrogen) was added 90 ml cell
culture-grade water (Mediatech), RNAse of final activity 1.35 Kunitz units/mL (Sigma),
0.037 g EDTA (Mallinckrodt, Hazelwood, MO, USA), and 1.05 g NaCl to create a
supplemented lysis buffer. The mixture was sterile filtered after all components
dissolved. Before assay, the samples were lysed by adding 200 Cl supplemented cell-lysis
buffer to 200 •l cell suspension. DNA was extracted by sonicating (Branson Sonifier
450, Branson Ultrasonics Corp., Danbury, CT, USA) each test sample three consecutive
time periods, each for 10 1-s cycles. A diluent was prepared consisting of 50%
supplemented cell-lysis buffer and 50% D-PBS. If necessary the test sample was further
diluted with diluent. Test sample volumes of 100 •l were plated in a 96-well plate along
with samples for a nine-point DNA standard curve ranging in concentration from 0-1000
ng/ml (appropriately diluted with diluent) using X DNA standard (Invitrogen) prepared
fresh every three months. Each sample on the calibration curve, as well as each test
sample, was run in triplicate and the results averaged. A 50-gl volume of fluorescent dye
(Component A, Invitrogen), was added to 10 ml of the diluent, and 100 •l of this dye
solution was added in each well. The fluorescence was measured with 480 nm excitation
and 520 nm emission wavelengths in a plate reader (FLUOstar/POLARstar Galaxy,
BMG Labtechnologies, Inc., Durham, NC).
For comparison purposes, DNA was also quantified with the PicoGreen® dsDNA
Quantitation Kit (Invitrogen). The procedure, X DNA standard, and lysis buffer were the
same as for the CyQUANT assay; only the dye was different.
5.1.6 Morphological Analysis
As previously described in Chapter 3, a 0.5 ml aliquot was fixed in 2.5%
glutaraldehyde 0.1 M phosphate buffer, pH 7.4, divided into two samples, dehydrated,
cleared, embedded in plastic (Araldite), and cured. Blocks were trimmed, and 1-jim
sections were cut, stained with toluidine blue, and examined by LM. Islet tissue was
distinguished from non-islet tissue (exocrine or ganglia) by its cordlike pattern of cells
often around vascular spaces, lack of visible granulation, and occasional visible small
lipid droplets, whereas the exocrine tissue was in the form of either large sheets of simple
columnar ductal epithelia or clumps of duct and acinar tissue. The acinar tissue in freshly
isolated tissue was granulated with large stained granules. The 1-1am sections were
analyzed at 420x by stereological point counting (84) with a 90-point grid covering
adjacent, non-overlapping fields. At point intercepts of the grid with tissue, the nature of
the tissue was determined, and the volume fraction of islet tissue was calculated as
previously described in Chapter 3.
5.1.7 Number of IE from Nuclei Counting Data and LM Morphology
To estimate the number of IE in an impure preparation, nuclei counting
measurements are combined with morphological observations by light microscopy. The
calculation procedure is summarized in Figure 5.1. LM morphological analysis by
stereological point counting produced measurements of the volume fraction 0r of islet
tissue in the preparation. To make use of this information, we employ the framework of
equations and parameters we developed in Chapter 2. In the first step, data for Di is
converted to PIc, the volume fraction of islet cells amongst all cells, exclusive of
extracellular space. The two quantities are related by
ýIC
1- IEC
Equation 5-1 I -= iC -IC
+
1
- (DIEC 1- (DNIEC
where DIEC and ONIEC are the volume fractions of extracellular space in islet and non-islet
tissue, respectively. With values of DIEC and ONIEC equal to 0.29 and 0.19 respectively,
Equation 5-1 may be rearranged to yield
1.24 ~ICEquation 5-2 lIC = 1.43 - 0.19 01
In the second step, ljc is converted to the number fraction of islet cells ýjc by the relation
Equation 5-3 fic TC • IC
VIC
where VTC /VIC =0.925 is the ratio of the average volume per cell for all cells in a human
islet preparation divided by the average value for islet cells as determined for 33 clinical
islet preparations (Chapter 2). The total number of all cells in the preparation, obtained
by nuclei counting, is then used to estimate the number of islet cells from the estimate of
fic and its definition
nlCEquation 5-4 fic 
=
nTC
Lastly, the number of IE in the preparation NIE is determined from
nIC
Equation 5-5 NIE =
nIE
where nIE = 1560 cells per IE (Chapter 2).
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Figure 5.1. Calculation of number of islet cells and islet equivalents in impure
human islet preparations from nuclei counting and LM morphological analysis.
5.1.8 Volume Fraction Islets by DTZ Staining
Dithizone (diphenylthiocarbazone, DTZ, Sigma), a zinc-specific binding dye, was
used to discriminate islet from non-islet tissue by staining islet cells (49). DTZ was
dissolved in dimethylsulfoxide (DMSO, ICN Biomedicals Inc., Costa Mesa, CA, USA)
as a 10x stock solution (2.5 mg/ml) and diluted with Hanks Balanced Salt Solution
(HBSS, Mediatech) for the lx working solution. An aliquot of 250 pl from the final islet
preparation was transferred to a 60 mm Petri dish containing 3 ml of DTZ working
solution and incubated with gentle swirling for 3 min. All of the tissue was examined
with microscopic visualization by focusing through different depths of the tissue, and the
volume fraction of red-stained islet tissue, (FI)DTZ, was estimated.
5.1.9 Number of IE from Conventional DTZ Staining and Visual Counting
Two representative aliquots of 100 pl each were taken from the final 255-ml
human islet preparation and incubated with DTZ working solution as described for
volume fraction determination by DZT staining. Using a light microscope with a Bausch
and Lomb micrometer disc (31-16-08) eyepiece reticle containing a grid of squares
50-pm on a side, the number of squares and the area occupied by each stained islet was
determined, and the diameter of a circle having about the same surface area was
estimated for each islet The size distribution of the islets was quantified by two
independent observers within a range of 50 to > 500 pm in 50 pim increments (ranges:
50-100,
100-150, 150-200, 200-250, 250-300, 300-350, and > 350 gm). A formula was used to
convert the number of islets in each 50-jtm increment to a total islet volume VI by
assuming that the islets are spherical (7). NIE, the number of IE, was calculated as VINIE,
where VIE, the volume of an IE, is the volume of a sphere with a diameter of 150 jim
(VIE = 1.77x106 jm 3). The same procedure was followed with rat islet preparations
except that the diameter of a circle with equivalent area was estimated visually with an
optical micrometer in the microscope.
5.1.10 Number of IE from PCV Measurements and LM Morphology
The packed cell volume Vpc in the entire preparation was measured. The tube
containing the preparation was centrifuged at 248xg for 1 min at 40C. The supernatant
medium was aspirated carefully to the pellet surface. To a 10 ml pipette (Fisher
Scientific, USA) graduated in 0.1 ml increments was added 9.0 ml of final wash medium.
Medium was added to the pellet, which was resuspended by mixing without inclusion of
any bubbles and then carefully aspirated into the pipette. Vpc was determined from the
difference between the final and initial volumes in the pipette. The total tissue volume VT
was determined from
Equation 5-6 VT = (1- vpC ) VPC
where (DvP = 0.3 is the void volume fraction of the packed cell pellet. The volume of
islet tissue is determined from the total tissue volume with
Equation 5-7 V, = (IiVT
where the volume fraction islets DI is obtained directly form the LM morphological
analysis. Finally, the number of IE is calculated from
Equation 5-8 N I
where VIE = 1.77x106 jim3 is the volume of an IE, which is the volume of a sphere with a
diameter of 150 jim.
5.1.11 Statistics
Straight lines through the origin were fitted to the data by linear least squares
regression. Unless specified otherwise, precision was reported as standard deviation for
sample means and error bars and as the standard error of the estimate of the slope for
fitted slopes. The significance of differences in means and slopes of straight lines was
evaluated by two-sided Student t tests.
5.2 Results
5.2.1 Comparison of Counting Methods
a) Visual and Graphical Output
Cell disruption by citric acid produced a suspension of individual nuclei; no
clumping of two or more nuclei was observed (Figure 5.2 and Figure 5.3). The
suspension also contained cell debris and fragments that were more pronounced with
islets than with cells and more pronounced in low purity than in high purity preparations.
When counting with a hemacytometer, intact normal nuclei as well as a small fraction of
nuclei shrunken during apoptosis were included, but not any smaller fragments. Aperture
resistance measurements with the Coulter Multisizer II (121) produced a size distribution
with two, slightly overlapping populations, and the position of the minimum was taken as
the point separating the larger nuclei from the smaller fragments (Figure 5.2A and
Figure 5.3A). The flow cytometer produced scatter plots with two populations. Although
there was some overlap in forward scatter intensity, only the nuclei displayed high
7-AAD fluorescence intensity, thereby permitting a clean separation of nuclei from
fragments.
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Figure 5.2. Output of each counting method for nuclei from high purity human
islets.
(A) Photomicrograph of visual image for counting nuclei from these islets. During
counting with a hemacytometer, the image was defocused slightly to maximize
contrast around the border of each nucleus. (B) Nuclei size distribution from human
islets measured at a concentration of 2x104 nuclei/ml by the aperture resistance
method using a Coulter Multisizer II. The diameter registered by the aperture
resistance measurement is smaller than the actual size (see Figure 5.2A) because the
nuclear envelope is permeable to ions (121), which carry electrical current. (C) Flow
cytometer plot of 7-AAD fluorescence intensity versus forward scatter intensity
using the Guava PCA system with stained nuclei from human islets. Nuclei are in
the population of events with high forward scatter (> 100) and high 7-AAD intensity
(> 100). Image was obtained with Guava Express software and 1000 events in the
nuclei quadrant. Output of each counting method for nuclei from rat islets was
essentially identical to that for high purity human islets.
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Figure 5.3. Output of each counting method for nuclei from low purity human islets.
(A) Photomicrograph of visual image for counting nuclei from these islets.
(B) Nuclei size distribution from human islets measured at a concentration of
2x10 4 nuclei/ml by the aperture resistance method using a Coulter Multisizer II.
(C) Flow cytometer plot of 7-AAD fluorescence intensity versus forward scatter
intensity using the Guava PCA system with stained nuclei from human islets. The
relatively higher density of incidents at low 7-AAD intensity (<100) as compared to
Figure 5.2C results from the relatively larger concentration of cellular fragments in
the low purity preparation. The same trend is reflected in the size distribution of
particles less than 3 lpm in diameter from aperture resistance measurements in
Figure 5.2 and Figure 5.3.
b) Enumeration Data
INS-1 cells were suspended and disrupted to form a stock nuclei suspension.
Aliquots were diluted to produce samples covering a wide range of concentrations that
were counted by each of the three methods. The measured nuclei concentration is plotted
in Figure 5.4 as a function of the calculated concentration over four orders of magnitude.
The calculated concentration was determined as follows: Each measured concentration
was multiplied by its dilution factor to provide an estimate of the concentration in the
original nuclei stock solution. The average of the estimates over the range
1-5xl 05 nuclei/ml for the Guava PCA and 2-7x 104 nuclei/ml for the Coulter Multisizer II
agreed within 2%, and the combined average was taken as the stock nuclei concentration,
from which all other values were calculated using the known dilution factors. The same
data are plotted in Figure 5.5 and Figure 5.6 on linear coordinates over different
concentration ranges to illustrate where each counting method departs from linearity.
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Figure 5.4. Measured versus calculated concentration of nuclei from INS-1 cells
counted by all three methods and plotted on log-log coordinates.
Each sample was measured without further dilution in triplicate
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Figure 5.5. Measured versus calculated concentration of nuclei from INS-1 cells
counted by all three methods and plotted on linear coordinates for concentrations
up to 2x10 s5 nuclei/ml.
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Figure 5.6. Measured versus calculated concentration of nuclei from INS-1 cells
counted by all three methods and plotted on linear coordinates for concentrations
up to 106 nuclei/ml.
The concentration measured visually with a hemacytometer varied linearly with
calculated concentration over the entire concentration range but was uniformly slightly
higher than the line of identity (dashed line). The best-fit straight line through the origin
yielded a slope of 1.11 ± 0.03 (Figure 5.5). The data from the Guava PCA agreed well
with the line of identity up to about 5x10 5 nuclei/ml (Figure 5.6), above which the data
began to deviate from linearity. The Coulter Multisizer II data also followed the line of
identity but deviated from linearity above 7x10 4 nuclei/ml (Figure 5.5). These deviations
arose from coincident events (two nuclei registering in the sensing zone at the same time),
which increase with concentration. The Coulter Multisizer II also could not be used
accurately at less than about 104 nuclei/ml, since it gave erroneously high readings (data
not shown).
The higher concentration measured with the hemacytometer was explored further
using data from three different operators. Data analogous to that in Figure 5.4, Figure 5.5,
and Figure 5.6 from multiple batches of cells (n=4) and islets (n=3) yielded a slope of
1.16 ± 0.02 for nuclei counted by hemacytometer and flow cytometer. A single
measurement with nuclei from human islets counted with the hemacytometer and flow
cytometer yielded a ratio of 1.17 ± 0.04, and a single measurement with rat islets gave a
ratio of 1.08 ± 0.07. Lastly, experiments were performed in which nuclei and the cell
suspension from which they were prepared were counted with a hemacytometer.
Suspensions from three separate batches of f3TC3 cells and two of INS-1 cells were
C
prepared, several of which were diluted to provide a wide range of concentrations. Six
aliquots were taken from each cell suspension; three were analyzed for nuclei
concentration and three for cell concentration, all using the hemacytometer. The data,
plotted as nuclei concentration versus cell concentration (Figure 5.7), fits a straight line
with a slope of 1.07 ± 0.02. Taken together, these data indicate that nuclei concentration
measured by visual counting with a hemocytometer produces estimates that are high by
about 7 to 17% (average of all data 12 ± 5%), presumably because of the presence of
large cellular fragments, particles, and debris that appear as nuclei by visual counting but
are not registered as nuclei by the two other counting methods.
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Figure 5.7. Nuclei concentration versus cell concentration for INS-1 and PTC3 cells.
Both concentrations were measured by visual counting with a hemacytometer. The
fitted line through the origin has a slope of 1.07 ± 0.01.
The precision of nuclei concentration measurement improved with an increase in
the number of nuclei counted, as shown in Figure 5.8 for hemacytometer and flow
cytometer measurements. The coefficient of variation data for both counting methods,
though scattered, was consistent with the prediction for data that follows a Poisson
distribution, as is expected for counting data (122).
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Figure 5.8. Coefficient of variation from triplicate counts versus number of nuclei
(from INS-1 cells) counted by hemacytometer and flow cytometer.
Straight line is the coefficient of variation predicted by data that follows a Poisson
distribution.
All three methods could be carried out relatively rapidly. Starting with a nuclei
suspension sample, which itself took about 5 min to prepare, visual counting of 500
nuclei (250 on each side of a hemacytometer) took about 10 min. Measurement with the
Coulter Multisizer took an additional 5 min for sample preparation and about 1 min for
counting 1000 nuclei. The Guava PCA, required 2 min for sample preparation and took
about 10 sec for counting 1000 nuclei using a sample loaded at about 2.5x10 5 nuclei/ml.
To determine how the number of islets sampled and the pipette tip employed
affected the precision of nuclei measurement, samples of different volume were taken
from islet stock solutions prepared from four batches of islets, and nuclei were prepared
and diluted to the same concentration within each batch. The coefficient of variation
(COV) was lower with the medium- and wide-orifice pipette tips than with the narrow-
orifice pipette tips; it decreased as the number of IE in the original sample increased
(Figure 5.9) and was about 6% or less when 160 or more IE were sampled, which
provides a reasonable balance between acceptable precision and use of a small number of
islets.
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Figure 5.9. Coefficient of variation versus the number of rat IE (estimated assuming
1560 cells per IE) sampled using three different kinds of pipette tips.
Within each of four batches, each sample was taken from the same islet stock
solution, and 1000 nuclei were counted with the flow cytometer. Below about 200 islets
counted, the narrow orifice pipette tip produced a higher COV than the other two pipette
tips.
c) Comparison of Flow Cytometer Data with DNA Analysis
The slope of the standard curve (plotted as absorbance versus DNA concentration)
measured with the same X DNA standard was relatively constant for about 3 months and
then increased about 25% over the next 2-month period. That increase would be mirrored
by a concomitant decrease in measured DNA, as was verified with measurements of DNA
controls. Subsequently, we replaced the DNA standard every three months.
DNA concentration was linearly proportional to the nuclei concentration
measured in aliquots prepared from the same suspensions of PTC3 cells and rat islets.
Serial dilutions of stock suspensions from four batches of cells and two batches of islets
were prepared, and aliquots were taken for DNA analysis and nuclei counting, by flow
cytometer, each in triplicate. Values measured with the CyQUANT dye, 6.2 ± 0.6 and
6.4 ± 0.8 pg/cell for 3TC3 cells and rat islets, respectively, were significantly higher
(p < 0.05) than corresponding values measured with PicoGreen dye, 5.6 ± 0.8 and
4.9 ± 0.9 pg/cell for 3TC3 cell and rat islets, respectively. Measurements made with
CyQUANT dye over a 3-year period with 37 different batches of rat islets yielded
6.5 ± 1.9 pg/cell (Figure 5.10A). Measurements performed with 26 preparations of freshly
isolated human islets yielded 6.9 ± 2.3 pg/cell (Figure 5.10B). These values are
comparable to the expected value of about 6.5 pg/cell for human DNA (74, 75). Similar
measurements with human islets received from various centers after being shipped (22
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preparations) yielded 8.5 ± 2.3 pg/cell (Figure 5.10C). These data suggest that some islet
cells may die during shipment and release DNA that is not completely degraded and
contributes to the higher measured value. This is another reason why assay of DNA alone
may not provide an accurate measurement of the number of cells in an islet preparation
and why nuclei may provide better accuracy.
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Figure 5.10. Distributions of DNA content per cell (pg DNA/cell).
(A) 37 rat islet preparations, (B) 26 freshly isolated human islet preparations, and
(C) 22 human islet preparations received after shipment.
5.2.2 Comparison of Two Methods to Determine NIE of Rat Islets
The number of IE in 27 rat islet preparations was determined by the standard
method of DTZ staining with manual counting by microscopic visualization and by LM
morphological analysis and nuclei counting. All rat islet preparations were of high purity.
NIE determined by DTZ staining is plotted versus NIE determined by LM/nuclei counting
in Figure 5.11. The data is scattered; 23 of 27 estimates of (NIE)DTZ lie above the line of
identity, which means that DTZ staining/manual counting overestimates the number of
NIE in comparison to LM analysis/nuclei counting, in some cases substantially. The slope
of the best-fit straight line is 1.23 ± 0.09, and the ratio of the mean values is 1.60,
corresponding to a 60% overestimate by DTZ staining.
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Figure 5.11. Number of IE by DTZ staining/manual counting versus number of IE
by LM/nuclei counting for 27 rat islet preparations.
The average NIE was 18000 ± 6000 for DTZ staining and 13000 ± 7000 for LM/nuclei
counting. The solid line is from linear regression of the data through the origin. The
dashed line is the line of identity.
5.2.3 Comparison of Three Methods to Determine NIE Of Human Islets
We compared the number of IE obtained by three different methods:
(1) measurements of islet volume fraction by LM morphological analysis together with
the total number of cells by nuclei counting; (2) DTZ staining with manual counting by
microscopic visualization; and (3) measurements of islet volume fraction by LM together
with packed cell volume measurements for 12 freshly isolated human islet research
preparations. The average volume fraction of islets was 0.59 ± 0.21 by LM morphological
analysis and 0.72 + 0.22 by DTZ staining. The substantially higher value by DTZ staining
is consistent with our previous observations in Chapters 2 and 3. The number of IE
measured by each of the three methods is compared in Figure 5.12, in which NmI
determined by both the DTZ staining and LM/PCV methods is plotted versus NIE
determined by LM/nuclei counting. For 11 out of the 12 sets of data (preparations), both
DTZ staining/manual counting and LM/PCV substantially overestimate the number of IE,
as reflected by the slopes of the best-fit straight lines. On average, DTZ staining
overestimates the LM/nuclei counting measurement by 92%. The slope for DTZ staining
is 15% higher than that for LM/PCV, which is comparable to the 21% higher estimate for
DTZ staining relative to that from EM/PCV measurements in our study with 33 clinical
islet preparations (Chapter 2).
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Figure 5.12. Comparison of three methods for NIE determination for 12 research
preparations of freshly isolated human islet preparations.
NIE by DTZ staining/manual counting (closed symbols) and IE by LM/PCV (open
symbols) are plotted against NIE by LM/nuclei counting. The straight lines are from
linear regression of the data through the origin. On average visual counting
substantially overestimated the number of IE compared to LM/nuclei counting by
about 92% as shown by the slope of the straight line fit to the data. A similar trend
is observed with LM/PCV with an overestimation of 67% compared to LM/nuclei
counting. The mean values of NIE for all preparations were 87000, 167000, and
154000 for LM/nuclei counting, DTZ staining, and LM/PCV, respectively.
5.3 Discussion
Determination of the amount of tissue in an islet preparation, whether by volume
or number of cells, has been a problem in all areas of islet investigation and is especially
crucial in islet transplantation. Our study demonstrates that nuclei counting provides a
rapid, accurate, and precise method for enumeration of the total number of cells in an
islet preparation. Nuclei counting combined with islet volume fraction measurements
from morphological analysis using light microscopy is a novel method for accurately
determining the volume of islet tissue in a freshly-isolated impure islet preparation.
We initially considered dissociating islets with trypsin and counting the cells
liberated. However, this approach was not quantitative, some cells were lost, and
substantial fractions of the original islet cells were not recovered as single cells (data not
shown), which is consistent with previous reports (51, 52, 74). Instead, we first disrupted
the cells with a combination of citric acid, which disrupts the cell membrane but not the
r
nucleus, and shear, which frees the nucleus from the cytoplasm, followed by staining
with crystal violet, which sharpens the nuclear image (114). The resulting suspension
contained no aggregates of nuclei but did contain cellular debris and fragments.
We investigated three methods for counting nuclei, all of which could be used in a
satisfactory way. They differed in the way nuclei were distinguished from fragments, the
resulting accuracy, the time required for a measurement, and the range over which the
measurement was linear with nuclei concentration. Visual counts with a hemacytometer
were linear over the entire concentration range studied but were higher than the other two
methods by about 12 ± 5% because of the inability of the eye to consistently distinguish
fragments from true nuclei. This was confirmed by visual counting of aliquots of cells
and nuclei prepared from the same cell suspension. Measurement with a flow cytometer
(Guava PCA) and aperature resistance (Coulter Multisizer II) deviated from linearity
above concentrations of about 5x10 5 and 7x10 4 nuclei/ml, respectively. Aperture
resistance measurements distinguished fragments from nuclei purely on the basis of size.
The flow cytometer plots with nuclei prepared from islets revealed the presence of a
small population of unstained particles producing forward scatter (which depends on
particle size and granularity) comparable to that of the stained nuclei that contained
DNA. By setting the 7-AAD fluorescence intensity gate sufficiently high, it was possible
to eliminate virtually all of the fragments.
In addition to providing the most accurate measurement, the flow cytometer was
also rapid. Once nuclei samples were prepared (5 min) and stained (2 min), only seconds
were required for concentration measurement. Aperture resistance measurements
required 5-min sample preparation, and visual counting took about 10 min. It would have
been possible to eliminate most of the debris and fragments by repeated centrifugation in
order to make visual counting more accurate, but that procedure would have substantially
lengthened sample preparation time (114).
Nuclei concentration measurements can be made with any flow cytometer. We
selected the Guava PCA system because it has a small footprint, can be operated with
minimal training, and, most importantly, requires less than 20 [l sample volume, which
allows use of a minimal quantity of islets. The small sample requirement arises because
the sample is analyzed while flowing through a microcapillary. There is no sheath fluid,
which is used in flow-activated cell sorters that require a much larger sample volume.
Precision of measurements made by visual counting and by the flow cytometer
approximately followed Poisson statistics (Figure 5.8). The better precision of the flow
cytometer as compared to visual counting arose because it was possible to make many
more counts in a reasonable time period. The precision of counting nuclei from islets was
determined largely by Poisson statistics so long as 160 or more IE were sampled
(Figure 5.9). The coefficient of variation increased with a smaller sample because of
heterogeneity in islet sizes as well as sampling errors. The latter were minimized by
using a larger pipet orifice.
We compared nuclei counts by flow cytometry with cell DNA analysis, using two
commonly-used fluorescent dyes. With CyQUANT, we obtained 6.4 - 6.5 pg DNA/cell,
which is comparable to estimates for human cells (6.6 and 6.4 pg/cell for female and
male, respectively) (75). Pipeleers et al. (74) reported 7.3 and 5.7 pg/cell for rat islet a
and p cells, respectively. If we assume that islets are comprised of 65% of 0 cells, and the
remainder has the properties of a cells, there would be 6.7 pg/cell on average for rat
islets, which is 3% higher than we obtained. This agreement supports the accuracy of
both flow cytometer nuclei counts and DNA analysis with CyQUANT dye. Conversely,
we obtained significantly lower DNA concentrations per cell with PicoGreen (p < 0.05),
whereas others have observed opposite trends, which illustrates the difficulties of using
DNA analysis for measurement of the amount of tissue in islet preparations when
different dyes are used. In addition, DNA analysis requires several hours for completion,
whereas nuclei counting is much faster. The instability observed in the X DNA standard,
which leads to a reduction in DNA measured over periods of months, is another potential
source of error. For these reasons, we conclude that nuclei counting is a more accurate
and convenient method than DNA measurement for enumeration of cells in islet
preparations. Furthermore, we observed values of DNA/cell that were higher than
expected with human islet preparations that were received after shipment in this study
and with measurements made immediately after isolation in our previous study (Chapter
2). In both cases, the increased DNA/cell suggests the presence of residual, undegraded
DNA released from dead cells. These high values present an additional complexity in
using DNA content for measuring the total number of cells in an islet preparation but
measurement of the ratio of DNA/cell may be informative with regard to occurrence of
recent cell damage in the preparation.
We used highly purified rat islet preparations to test the enumeration method
developed here. The number of IE determined by DTZ staining and manual counting
with microscopic visualization was on average about 60% higher than that determined by
LM morphological analysis and nuclei counting. Because these preparations were always
in excess of 95% pure, purity was not an issue, and the overestimation must have been
due to errors in volume estimation by DTZ staining with microscopic visualization along
with the presence of some dying cells in the interior of the islets. In contrast, nuclei
counting provides a direct measurement of the number of cells that have intact nuclei.
Dying cells that retain some structure despite no longer having intact nuclei are not
counted.
We also measured the number of IE in 12 freshly isolated human islet research
preparations using nuclei counting combined with LM morphological analysis of plastic
sections, which we have shown has accuracy and precision equivalent to that of EM
analysis of ultrathin sections (Chapter 3). We compared these measurements to estimates
obtained by the standard method of DTZ staining/manual counting and by LM analysis
combined with PCV measurements, a method for estimating total islet volume we
explored previously in Chapter 2. DTZ staining/manual counting and LM/PCV
measurements overestimated the number of IE in 12 preparations by an average of about
92 and 67% respectively.
We attribute the large overestimation of the current standard method of DTZ
staining/manual counting as compared to LM/nuclei counting to three factors:
(1) Difficulty in identification of the stained islet tissue in impure islet preparations may
add additional error to that associated with the volume measurement. (2) The presence of
some dying cells that occupy volume but no longer have intact nuclei may lead to an
overestimation of the volume of tissue available for affecting transplantation outcome. In
this regard, nuclei counting may be a better measure for the amount of healthy cells in an
islet preparation. (3) Volume quantitation by visual estimation of islet size under a
microscope may be substantially inaccurate because small errors in the estimate of the
islet diameter lead to large errors in the estimate of the volume. Moreover, the method is
prone to systematic error because the actual shape of islets is not spherical (30, 77),
which introduces an upward bias leading to overestimation of volume. To illustrate the
potentially large magnitude of this effect, we make use of data on the three largest
dimensions in mutually perpendicular directions (obtained by rotating islets with a
micropipette) measured in 97 rat islets using a microscope with a calibrated reticule (74).
An average islet is represented in Figure 5.13 as an ellipsoid with three different half-
axes a, b, and c. The shape of the islet was determined by using the average measured
ratios of b/a=0.82 and c/a =0.60 for freshly isolated rat islets (74). If the ellipsoid lies on
a surface with its smallest axis c perpendicular to the surface, the most likely stable
configuration, it appears to the viewer during visual size estimation as an ellipse with half
axes a and b, leading to estimation of the radius of an equivalent circle (Figure 5.13). The
ratio of the volume of the equivalent sphere having this radius to the true volume of the
ellipsoid is about 1.5. Use of the largest measured half-axis for the sphere radius leads to
an overestimation of 100%. Thus, the assumption of spherical islets for the purpose of
calculating islet volume could account for all or a substantial part of the error incurred by
the conventional DTZ staining/manual counting technique.
Overestimation of islet volume by the LM/PCV method may also arise from the
presence of dying cells that occupy volume but do not have intact nuclei. In addition, the
pellet void volume fraction may actually be substantially larger than the value of 0.3 used
in estimating the total tissue and islet tissue volumes from Equation 5-3 and
Equation 5-4. If a larger value for pellet void volume fraction is used, the estimated islet
tissue volume is smaller. Further work to solidify the value of pellet void volume fraction
is warranted.
We have shown that LM morphological analysis combined with nuclei counting
provides an accurate, precise, and objective measurement of the number of IE in impure
preparations. The nuclei counting method can be employed using a bench top flow
cytometer in 10 min. LM analysis of plastic sections requires 10 min, but the preparation
of the sections takes 3 days. LM analysis of frozen sections, even though it requires some
validation, would allow this method to be used in real time assessment of the
enumeration of islet equivalents. Our findings suggest that islet volume measured with
the currently-employed DTZ staining/manual counting method grossly overestimates the
volume of islet tissue representing cells with intact nuclei. Compared to measurement by
that standard method, the substantially lower value from LM/nuclei counting may be a
more accurate indicator of functional islet mass, which is the important parameter for
islet transplantation.
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Figure 5.13. Average rat islet represented as a scalene ellipsoid with three half-axes
a = 1.0, b = 0.82, and c = 0.60 (74) shown in four different orientations.
The ellipsoid has a volume of (4/3)cabc. (A) Top view. Ellipsoid is lying on a surface
in its most stable configuration. It appears to the viewer as an ellipse with half axes
a and b and a surface area equal to nab. (B) Side view. Ellipsoid from (A) is rotated
900 around its largest axis and appears as an ellipse with half axes a and c. (C) End
view. Ellipse from (A) is rotated 900 around its shortest axis and appears as an
ellipse with half-axes b and c. (D) Angled view. Ellipsoid is shown with arbitrary
angled orientation. In (A), a circle with the same area (Tr 2) as the ellipse would have
a radius r equal to (ab)1/2, and the equivalent sphere would have a volume
(4/3)n(ab) 3/2 . The ratio of the calculated volume of this equivalent sphere divided by
the actual volume of the ellipsoid is (ab)3 /2/c = 1.51.
Contributions: The aliquots for the nuclei counts for the human isolations were prepared
by the Islet Core at Joslin Diabetes Center (Abdulkadir Omer, Ji Lei, Vaja Tchipasvilli,
Gaurav Chandra, and Vassileios Kostaras).
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Chapter 6.
A Quantitative Membrane Integrity Test
for Islets of Langerhans
The integrity of cell membranes in a preparation of islets of Langerhans is
currently most commonly assessed by microscopic observations of cells within intact
tissue stained with fluorescent dyes such as fluorescein diacetate (FDA) and propidium
iodide (PI) (105, 123), although SYTO-13/ethidium bromide have been suggested to be
superior (83, 105, 124). The results of this dye exclusion test are commonly taken as a
measure of viability and are routinely used as one of the product release criteria for
clinical islet transplantation and also in assessing islet quality for research purposes
(124). An aliquot of the final islet preparation is stained, and a sample is viewed under a
fluorescence microscope by focusing through the tissue to visually estimate the fraction
of cells that are stained with PI. This method is particularly challenging because of the
difficulty in assessing staining within a three-dimensional structure. As a consequence,
the estimate of the fraction of cells with intact membranes is subjective, operator-
dependant, and therefore prone to error.
We have developed an alternative membrane integrity test based on differential
staining of nuclei with fluorescent dye before and after cell disruption. An aliquot of the
islet preparation is incubated with a high affinity DNA-binding dye that does not
normally enter cells, and the nuclei of membrane-permeable cells are stained. The tissue
is disrupted by chemicals and shear, and the liberated nuclei are counted for stained
nuclei with a flow cytometer as described for enumeration of cells in islet preparations in
Chapter 5, yielding the number of cells with permeable membranes in the original intact
tissue. The nuclei are then incubated with dye, and all the nuclei are stained and counted,
103
yielding the total number of cells. The ratio of the two quantities is the fraction of islet
cells in the islet preparation with compromised membranes.
In this chapter, we examined differentially stained nuclei counting for
quantitatively measuring the fraction of cells with compromised membranes in rat islet
preparations as well as 1TC3 and INS-1 cells. Mixtures of unstressed and heat-killed
cells were analyzed by nuclei staining and the results were compared with a conventional
membrane integrity test (trypan blue exclusion) and a common viability assay (MTT).
Similar mixtures of islets were analyzed by nuclei staining and MTT. The results
demonstrated that this new assay provides a rapid, accurate, and precise quantitative
estimate of the fraction of cells in islet preparations that have compromised membrane
integrity.
6.1 Materials and Methods
6.1.1 Culture of Cell Lines and Islets
Mouse insulinoma 3TC3 cells (117), derived by introducing an SV40 T-antigen
into embryonic cells of transgenic mice, were cultured in tissue culture flasks in DMEM
medium (Mediatech, Herndon, VA, USA) supplemented with 10% (v/v) fetal bovine
serum (FBS, Mediatech), 100 U/ml penicillin (Sigma-Aldrich, St. Louis, MO, USA),
100 jig/ml streptomycin (Sigma), and 10 mM HEPES (Mediatech), in a humidified 5%
CO2 incubator at 37"C. Rat insulinoma INS-i cells (118) were cultured in tissue culture
flasks in RPMI medium with 11.1 mM D-glucose (Mediatech) supplemented with 10%
FBS, 100 U/ml penicillin, 100 jig/ml streptomycin, 10 mM HEPES, 2 mM L-glutamine
(Mediatech), 1 mM sodium pyruvate (Mediatech), and 50 pM 2-mercaptoethanol
(Sigma).
Rat islet preparations were provided by the Islet Core at Joslin Diabetes Center
(Boston, MA). Islets were isolated from male Srague-Dawley rats using collagenase
digestion/ficoll purification (37). Rat islets were cultured in tissue culture flasks in the
same supplemented RPMI medium as INS-1 cells.
6.1.2 Cell Preparations
Cell suspensions were prepared by removing medium from the tissue culture
flasks, adding 0.05 ml/cm2 of 0.05% (w/v) trypsin in 0.53 mM EDTA solution
(Mediatech), and incubating at 370C for 7 min (PTC3) or 3 min (INS-1). Trypsin solution
was removed, culture medium (0.13 ml/cm2) was added, cells were detached by gently
tapping the flask, and the resulting suspension was stored on ice. Cells were dispersed
individually with the exception of occasional small aggregates. If left on ice for more
than 2 hr after trypsinization, the 3TC3 cells tended to clump; the INS-1 cells also tended
to clump but at a slower rate.
6.1.3 Cell Enumeration by Nuclei Counting
Nuclei were prepared from cells and islets by adding equal 100 Pl volumes of
sample and of a lysis solution containing 0.1M citric acid (Sigma) and 1% (v/v)
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Triton X-100 (Sigma) to a 1.5 ml microtube. The mixture was incubated at room
temperature for 5 min with vortex mixing every 1.5 - 2 min. The islet mixture was then
placed in a 1-ml syringe and rapidly forced through a 26G3/8 needle (Becton Dickinson,
Franklin Lakes, NJ, USA) 10 consecutive times. Isolated nuclei were diluted with
Dulbecco's Phosphate Buffered Saline (D-PBS, Invitrogen) to a concentration no higher
than 5x10 5 nuclei/ml, stained with 7-aminoactinomycin D (7-AAD, Invitrogen), a
fluorescent dye with a high affinity for nucleic acids, at a final concentration of
0.01 mg/ml in D-PBS for at least 2 min at room temperature, and then analyzed using a
flow cytometer (Guava Personal Cell Analysis (PCA) system, Guava Technologies,
Hayward, CA) as previously described in Chapter 5.
6.1.4 Membrane Integrity by 7-AAD Differential Staining
PI, Sytox Orange, and 7-AAD were initially evaluated with this assay. 7-AAD
gave the best results and was selected for further work. As illustrated in Figure 6.1,
aliquots of 100 •l of cells or islets (about 2.5x106 cells/ml or 1600 IE/ml) were mixed
with 5 .dl of lmg/ml 7-AAD in D-PBS to stain the nuclei in cells with compromised
membranes. Samples were incubated on ice for 20 min. Unbound 7-AAD was removed
by washing twice with 1 ml of D-PBS and centrifuging (AllegraTM 2IR Centrifuge,
Beckman-Coulter, Miami, FL, USA) at 300xg for 5 min (cells) or 3 min (islets). After the
final wash, the pellet was resuspended in 100 pl of D-PBS, mixed with 100 gil of a lysis
solution, sheared, and diluted with D-PBS to a concentration no higher than
5x10 5 nuclei/ml. A sample of the partially stained nuclei suspension was then counted
immediately in a flow cytometer (or stored on ice for less than 15 min before counting) to
yield the number of cells with permeable membranes (NI). A 200 gtl sample of the nuclei
suspension was mixed with 200 gtl of 0.02 mg/ml 7-AAD in D-PBS for 2 min at room
temperature to stain all the previously unstained nuclei. The sample of stained nuclei was
counted in the flow cytometer, and the total number of nuclei (N2) in the original aliquot
was calculated. The fraction f of cells with compromised membranes was estimated as
the ratio of the initially stained nuclei (NI) to the total number of nuclei (N2), f=NI/N 2.
The fraction of cells with impermeable cell membranes was defined as g = 1 - f. The
ratio of N2 determined from this two-step procedure to the total number of nuclei
determined from the single-step cell enumeration procedure was 0.95 ± 0.03, thereby
indicating that loss of nuclei from the additional handling was very small. Triplicate
measurements from a single cell or islet sample took about 30 min.
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Figure 6.1. Illustration of protocol for membrane integrity measurements with
7-AAD differential staining used in this study.
In the first step, cells or islets are stained with 7-AAD. Cells are disrupted with a
lysis solution and shear, and nuclei are counted to give the number of membrane-
permeable cells in the original suspension (N1). In the second step, the nuclei are
stained with 7-AAD to label all cells, and the total number of cells are counted (N2).
The fraction f of permeable cells is f= N1/N2.
6.1.5 Membrane Integrity by Trypan Blue
For visual estimation of membrane integrity, a cell suspension volume of 200 •l
was stained with 200 gl of 0.4% (v/v) solution of trypan blue (Sigma) and diluted with
D-PBS to a concentration between 5 and 15x10 5 cells/ml. A 12 gtl sample was loaded
onto a hemacytometer (Hausser Scientific, Horsham, PA, USA) and counted using 40x
magnification (119, 120). Both stained and unstained cells were counted, and the fraction
of cells that were unstained, indicating impermeable membranes, was calculated.
Triplicate samples were prepared, and for each sample about 250 cells were counted on
each side of the hemacytometer (total about 500 cells).
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6.1.6 Cell Viability by MTT Assay
The number of viable cells in cell or islet suspensions was measured with the
water soluble tetrazolium compound 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (Vybrant® MTT Cell Proliferation Assay Kit, Molecular
Probes, USA), which was reduced and converted into an insoluble formazan purple
crystalline precipitate as a result of the pyridine nucleotide-dependent redox state of live
cells (125-131). After centrifugation and aspiration of supernatant, a known number of
cells or islets were resuspended in 100 gll of D-PBS containing 20 mM glucose and
transferred to the wells of a 96 well plate. A volume of 20 tpl of 5 mg/ml MTT reagent
(Molecular Probes) was added to each well, and the plate was incubated at 370 C for 4 hr
in a humidified chamber. A 100 Atl volume of a lysis solution (9% (w/v) sodium dodecyl
sulfate in 0.01 M HC1) was added to each well and incubated at 370C for about 18 hr in a
humidified chamber to dissolve the precipitates. The absorbance was measured at a
wavelength of 570 nm in an ELISA plate reader (FLUOstar/POLARstar Galaxy, BMG
Labtechnologies, Inc., Durham, NC). The MTT absorbance was directly proportional to
the number of viable cells and was divided by the total number of cells used in the
measurement (determined by nuclei counting) to give the MTT absorbance per cell.
6.1.7 Heat-killed Cells or Islets
Cell or islet suspensions were split in two parts, each of which was placed in a
15 ml tube. One tube was placed in a shaking water bath (model YB-521, McGaw Park,
IL, USA) at 600C for 45 min, and the other tube was stored on ice. After this time period,
the membranes of almost all heat-treated cells were disrupted and became permeable to
7-AAD. Mixtures of the heat-killed and undamaged tissue were prepared by adding
different volumes from each tube. The mixtures formed for these experiments consisted
of 100, 66, 33 (or 100, 75, 50, 25), and 0% heat-killed tissue. Aliquots of mixtures of
cells or islets were analyzed with three different methods, membrane integrity by 7-AAD
differential staining, membrane integrity by trypan blue staining (cells only) and cell
viability by MTT assay.
6.1.8 Statistics
Each measurement was run in triplicate. Data are expressed as mean ± standard
deviation. Error bars represent standard deviation. For ratios involving two parameters,
the standard deviation of the ratio was calculated from a propagation of error analysis.
Statistical significance was determined by two-sided Student t test for p < 0.05.
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6.2 Results
6.2.1 Dye Selection
Before choosing 7-AAD for the differential staining, the assay was also
performed with PI and Sytox Orange. PI and Sytox Orange both leaked out of the stained
nuclei and into the previously unstained nuclei during and following the cell disruption
step much faster than 7-AAD. Mixtures of stained and unstained nuclei with all three
dyes were counted in the flowcytometer at various time intervals after cell disruption.
Nuclei stained with 7-AAD were stable for at least 15 min if stored on ice compared to
less than 3 min for nuclei stained with PI. Nuclei stained with Sytox Orange were not
stable long enough to complete the lysis and data acquisition steps.
6.2.2 Cells
Two preparations (batches) of P3TC3 cells and one batch of INS-1 cells were split,
and one portion of cells was heat-treated at 600C to kill the cells. Mixtures of heat-
treated and untreated controls were prepared and analyzed for membrane integrity by
7-AAD differential staining and trypan blue staining and for cell viability by MTT assay.
Data from 7-AAD differential staining measurements were obtained with five
batches of cells and three batches of islets. There was variability in each batch of the
fraction of cells that were permeable in heat-treated (fo) and untreated control (fl)
samples. For cells, fo ranged from 0 to 0.04, and f, was 0.84 in one batch and 0.93 to 0.98
in all other batches. For islets, fo ranged from 0.05 to 0.11, and fl was 0.56 (unusually
low) in one batch of freshly isolated islets and 0.86 and 0.89 in other batches after one
day in culture. In order to compare results from different preparations on the same plot,
each datum point g for a mixture was expressed in terms of the ratio
g* =(g - go)/(g, - go), where go and gi are the values that apply to the preparation from
which the mixture was prepared. The denominator is the maximum difference in the
fraction of cells with impermeable membranes between the untreated control cells and
the damaged heat-treated cells. The numerator is the difference between the values for a
mixture and the damaged heat treated cells. Because g can range between go and gi, the
normalized ratio g* varies between 0 and 1. g* is plotted versus the fraction of untreated
cells in a mixture in Figure 6.2. The data are fit best by a straight line with a slope that is
not significantly different from 1.0, thereby demonstrating that the fraction of cells with
compromised membranes by 7-AAD differential staining was linearly related to the
fraction of heat-treated cells in mixtures. The coefficient of variation of the fraction of
cells with impermeable membranes measured by 7-AAD averaged 6% for combined cell
and islet data.
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Figure 6.2. Normalized fraction of impermeable cells by 7-AAD differential staining
measurement is plotted versus the fraction of untreated cells in mixtures with heat-
treated cells.
The normalized fraction plotted on the ordinate is g* = (g - go)/(go - gi), where g is
the fraction of cells with undamaged, impermeable membranes, and subscripts 0
and 1 refer to samples with all heat-treated cells, and with all untreated cells,
respectively.
The fraction of cells with intact membranes measured by 7-AAD differential
staining was plotted versus the fraction of cells with intact membranes by trypan blue
exclusion in Figure 6.3. The results for the two methods agreed well: the slope of the best
fit straight line through the origin was 1.02 ± 0.01.
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Figure 6.3. Fraction of cells with intact membranes measured by 7-AAD differential
staining versus fraction of cells with intact membranes measured by visual counting
with trypan blue.
Data are for mixtures of heat-killed and undamaged INS-1 (2 batches) and PTC3
(1 batch) cells. The best-fit line through the origin has a slope of 1.02 + 0.01. Error
bars represent standard deviation.
A comparison of the results of 7-AAD differential staining and MTT assay with
the cell mixtures is shown in Figure 6.4. Because the MTT assay did not provide an
absolute measure of viability, each datum point for MTT absorbance per cell was divided
by the value of the untreated control of each particular batch of cells, which ranged from
2.36 to 3.51x10 -7 absorbance units/cell. For consistency, each datum point for fraction of
cells with impermeable cell membrane by 7-AAD was also divided by the value for the
untreated control. These relative fractional values are plotted in Figure 6.4, where the
untreated control has coordinates of 1.0, 1.0. Again, the agreement was excellent, and the
best-fit slope was 1.02 + 0.02.
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Figure 6.4. Relative fraction of cells with intact membranes measured by 7-AAD
differential staining versus relative fraction of viable cells measured by MTT.
Data are for mixtures of heat-killed and undamaged INS-1 (1 batch) and PTC3
(2 batches) cells. The best-fit line through the origin has a slope of 1.02 ± 0.02. The
error bars were calculated by propagation of error analysis and represent the
predicted standard error of each datum point.
6.2.3 Islets
Three batches of rat islets were split, and each portion was treated as described
for cells. Mixtures of heat-treated and untreated controls were analyzed by 7-AAD
differential staining and MTT assay. The MTT absorbance of untreated controls in these
experiments ranged from 3.21 to 4.67x10 -7 absorbance units/ cell. The islet data were
treated in the same way as described for cells in Figure 6.4, and the results for islets are
summarized in Figure 6.5. As with cells, the results of the two methods agreed well, and
the slope of the best-fit straight line through the origin was 0.99 ± 0.03.
In all three sets of comparisons (Figure 6.3, Figure 6.4, and Figure 6.5) the slope
was not significantly different from 1.0.
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Figure 6.5. Relative fraction of cells with intact membranes measured by 7-AAD
differential staining versus relative fraction of viable cells measured by MTT.
Data are for mixtures of heat-killed and undamaged rat islets (3 batches). The best-
fit line through the origin has a slope of 0.99 1 0.03. The error bars were calculated
by propagation of error analysis and represent the predicted standard error of each
datum point.
6.2.4 Comparison of Two Methods to Determine Fraction of Cells with
Impermeable Cell Membranes
We measured the fraction of cells with impermeable membranes with 7-AAD
differential staining of samples for 22 freshly isolated human islet preparations from
Joslin Diabetes Center (assayed 4-6 hr after completion of the isolation process) and 8
human islet preparations received after overnight shipment from other centers.
Measurements of membrane integrity by FDA/PI staining, using procedures
previously described (Chapter 2) were made by islet isolation staff immediately after
completion of the process. For freshly isolated human islet preparations, the fraction of
cells with impermeable cell membranes varied from 0.33 (one preparation) to 0.95 with a
mean of 0.84 L 0.13 by 7-AAD and from 0.70 to 0.95 with a mean of 0.90 ± 0.07 by
FDA/PI. For preparations received after shipment, the fraction of cells with impermeable
cell membranes varied from 0.65 to 0.90 with a mean of 0.83 ± 0.09 for 7-AAD and from
0.75 to 0.97 with a mean of 0.90 ± 0.08 for FDA/PI. Even though the mean values for the
two methods are not significantly different (p<0.05) the FDA/PI measurements
overestimated the fraction of cells with impermeable cell membranes compared to
7-AAD in 18 out of 22 for samples of fresh human islets and 7 out of 8 for samples of
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shipped human islets. For all of these comparisons, measurements with 7-AAD
differential staining were made later than FDA/PI, and the effect of time on the difference
in results is unknown. However, in other experiments with rat and human islets cultured
under anoxia for various periods of time and membrane integrity measurements were
made simultaneously, FDA/PI staining consistently overestimated the fraction of cells
with impermeable cell membranes compared to 7-AAD differential staining, as will be
shown in Chapter 9.
6.3 Discussion
The current method of microscopic visualization for estimating membrane
integrity of cells in islets is subjective and not quantitative, and a better method is
needed. Dissociation of islets with trypsin, followed by dye exclusion measurements
using the liberated cells, is not a suitable option for islets because a substantial fraction of
cells are lost during dissociation (51, 52, 74). Instead, we developed a method based on
differential staining of nuclei with 7-AAD before and after disruption of the cells in
islets. This method built on our experience with enumeration of cells in islets
preparations by nuclei counting (Chapter 5), which demonstrated that nuclei recovery
after cell disruption is quantitative with negligible losses.
We initially tried fluorescent dyes PI and Sytox Orange, but both were
unsatisfactory because they leaked out of nuclei during and after the cell disruption step
much faster than did 7-AAD. Leakage was not observed with 7-AAD if the nuclei were
counted immediately after cell disruption or stored on ice for less than 15 min, indicating
that it bound to cellular DNA with higher affinity than the other dyes. For counting
nuclei, we chose to use the Guava PCA flow cytometer because it rapidly provided an
accurate measurement, the system was convenient, and it had a small bench top footprint.
The normalized fraction of cells that were impermeable by 7-AAD differential
staining was linearly proportional to the fraction of heat-treated cells in mixtures.
Membrane integrity assessed by 7-AAD staining was compared to membrane integrity by
trypan blue staining (cells) and cell viability by MTT (cells and islets). In all cases, there
was no significant difference between results of the three techniques.
Unlike the membrane integrity tests that depend upon visualization, the new
method of measuring islet cell membrane integrity we developed is objective and
operator independent. It does not require a visual assessment and it rapidly provides an
accurate and precise quantitative measurement of the fraction of cells in an islet
preparation that have compromised membranes. The new method shares a characteristic
with the FDA/PI and other membrane integrity assays in that the measured fraction of
cells with compromised membranes reflects the properties of the entire preparation, not
just the islet tissue, in an impure islet preparation. However, we found that FDA/PI
overestimated the fraction of cells with impermeable cell membranes for 18 out of 22
freshly isolated human islet preparations and 7 out of 8 shipped islet preparations in
comparison to 7-AAD differential staining.
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The comparison between 7-AAD membrane integrity measurement and MTT cell
viability assay was carried out with cells and islets that had undergone heat-induce cell
killing, which leads to permeabilization of the cell membrane. In many other situations
where stress is applied to cells or intact islets, loss of cell membrane integrity occurs late
in the cell death process, whereas the MTT assay responds to earlier steps that affect the
redox potential of the cell. In our own hands, we have found that the two assays agree
only after extended periods (24 to 48 hr) of culture under stable conditions (Chapter 9).
Thus, caution must be exercised in interpreting the meaning of membrane integrity
measurements with islets, especially within one day after isolation.
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Chapter 7.
A Stirred Microchamberfor Oxygen
Consumption Rate Measurements with
Pancreatic Islets
Recent improvement in the success of transplanting pancreatic islets of
Langerhans for treatment of type 1 diabetes in humans (4, 9, 10, 98, 132-134) has
prompted interest for more widespread application, which will require standardized islet
quality assessment methods to ensure in vivo efficacy (23, 100), particularly because
islets are compromised during the steps from pancreas procurement to transplantation.
Human organs are procured from brain dead donors (105, 135) and are exposed to
periods of warm and cold ischemia (31, 136). Islets are further damaged by stressful
mechanical and enzymatic procedures during isolation. Currently there are no reliable
quantitative assays that are predictive of transplantation outcome (21, 83, 102), which has
also impeded progress in improving procedures for pancreas procurement, storage, and
transportation, as well as islet isolation, purification, culture, and shipment.
The structure of islets, which are spheroidal aggregates with an average diameter
of about 150 gim containing roughly 1600 cells (Chapter 2), precludes use of most
methods for enumeration, viability, and apoptosis assessment of single cells. Membrane
integrity tests, currently used to assess fractional viability of islet preparations (137, 138),
rarely result in estimates of fractional viability below 80% and do not provide meaningful
information for predicting transplantation outcome unless the preparation is grossly
damaged.
We have proposed the use of oxygen consumption rate (OCR) measurements for
quality assessment of islet preparations prior to transplantation (139). OCR has
previously been applied to assess organ quality in liver, heart, kidney, and skin
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transplantation (140-146), to assess the ability of preservation solutions or supplements,
to maintain pancreas viability following cold storage (147-149), to estimate numbers of
viable cells in continuous bioreactors (150), and to support stress and toxicity studies
with cellular systems (151-153).
Since the first measurements with rodent islets (154, 155), OCR has been used as
a tool to understand glucose-stimulated insulin secretion in islets and [3 cells (16, 154-
163). Because quantities of islets were limited, a very sensitive method using Cartesian-
divers was originally developed and applied (154-156, 159). Subsequent studies to
measure OCR and insulin secretion employed perfusion systems (151, 152, 158, 164),
and continuously stirred chambers (163, 165) together with a Clark-type electrode. These
systems were also recently employed to assess islet quality (166) to a limited extent.
Polarographic microelectrode pO2 sensors suitable for measurements with small sample
sizes consumed oxygen, were unstable, and required frequent calibration. Large
polarographic sensors were more stable (151, 152), but their size precluded
measurements in small liquid volumes required due to the limitation in the number of
islets available. The development of optical fiber sensors that rely on the effect of oxygen
in altering the decay of phosphorescent or fluorescent intensity following irradiation
made possible rapid, continuous, stable measurements of pO2 and have been applied in
perfusion bioreactors (79, 164, 167, 168), static culture devices (169-171), and
continuously stirred chambers (139, 172). A perfusion bioreactor system employing
optical measurements of pO2 (164, 168, 173) enabled continuous measurement of OCR,
insulin secretion, and redox state of cytochromes in islets. Such systems are especially
useful for long-term culture and for following the transient response after changes in
environmental parameters. However, they are more complex and time consuming to use
compared to the stirred chamber. Also they are less efficient when multiple samples or
replicates need to be examined in a short period of time. Static culture devices have also
been recently described, which allow for simple operation and large numbers of
simultaneous measurements (169-171). However these devices at their present state
suffer from issues related to reproducibility and accuracy that are described in detail
elsewhere (172).
In this chapter we describe a stirred chamber device for OCR measurements that
incorporates previous experience with such systems (163, 165). Emphasis was placed on
minimizing chamber volume so that measurements could be made rapidly with a small
number of islets. We report on the characteristics of the device, its use for in vitro OCR
measurements with cells and islets, and its utility for assessing mixtures of live and dead
cells and islets that have been subjected to stressful culture conditions. We show that the
device is capable of making rapid, accurate, and precise OCR measurements for
assessing islet viability.
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7.1 Materials and Methods
7.1.1 Culture of Cell Lines and Islets
Mouse insulinoma 3TC3 cells (117), derived by introducing an SV40 T-antigen
into embryonic cells of transgenic mice, were cultured in tissue culture flasks in DMEM
medium (Mediatech, Herndon, VA) supplemented with 10% (v/v) fetal bovine serum
(FBS, Mediatech), 100 U/ml penicillin (Sigma, St. Louis, MO), 100 jtg/ml streptomycin
(Sigma), and 10 mM HEPES (Mediatech), in a humidified 5% CO2 incubator at 370C.
Rat, porcine, and human islets were provided by the Islet Core at the Joslin
Diabetes Center (Boston, MA). Rat islets were isolated from male Sprague-Dawley rats
by using collagenase digestion/ficoll purification (37, 174). Standard collagenase/
protease digestion methods were used for porcine (40) and human (4, 33) islets. The
islets were cultured in Petri dishes (various sizes, Falcon, Becton Dickinson, Bedford,
MA) with a surface culture density of 20 islet equivalents/cm 2 (or 0.35% surface
coverage) and a medium depth of 1.3 mm (unless specified otherwise) in a 370C
incubator with 5% CO2. The culture medium was RPMI 1640 (Cellgro, Mediatech,
Hemdon, VA), supplemented with 10% fetal bovine serum (heat-inactivated, Cellgro),
100 U/ml penicillin and 100 gig/ml streptomycin (Cellgro, Mediatech), and 10 mM
HEPES buffer (Gibco 09487, Invitrogen, Carlsbad, CA).
7.1.2 Islet Enumeration by Visual Counting
Two aliquots containing 300-500 islets with a diameter larger than 50 gtm were
examined under an inverted microscope equipped with an ocular micrometer. Islets with
a diameter larger than 50 gm were categorized into size groups in 50-jgm increments,
converted to total volume according to the original procedure (48), and reported as the
number of islet equivalents (IE), defined as a spherical islet with a diameter of 150 gm
having volume of 1.77xl06 jlm3 .
7.1.3 Cell and Islet Enumeration by Nuclei Counting
Nuclei were prepared from cells and islets by adding equal 100-jtl volumes of
sample and of a lysis solution containing 0.1 M citric acid (Sigma) and 1% (v/v)
Triton X-100 (Sigma) to a 1.5 ml microtube. The mixture was incubated at room
temperature for 5 min with vortex mixing every 1.5-2 min. The islet mixture was then
placed in a 1-ml syringe and rapidly forced through a 26G3/8 needle (Becton Dickinson,
Franklin Lakes, NJ) 10 consecutive times. Unless otherwise specified, 105 cells and
160 IE (2.5x105 cells) were used for each sample analyzed. Isolated nuclei were diluted
with D-PBS to a concentration no higher than 5x10 5 nuclei/ml, stained with
7-aminoactinomycin D (7-AAD, Molecular Probes, Eugene, OR), and then analyzed
using a flow cytometer (Guava Personal Cell Analysis (PCA) system, Guava
Technologies, Hayward, CA). A detailed description of the protocol is given in Chapter
5. The data were reported as the total number of cells.
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7.1.4 DNA Content
DNA was measured by fluorospectrophotometry (Chapter 5) using the
CyQUANT Cell Proliferation Assay Kit (Molecular Probes, C-7026 Eugene, OR), which
is based on the strong fluorescence enhancement of CyQUANT GR dye when bound to
nucleic acids. The fluorescence intensity was linearly related to the amount of nucleic
acids in the sample. Fluorescence was read at 480 nm excitation and 520 nm emission
wavelengths in a plate reader (FLUOstar/POLARstar Galaxy, BMG Labtechnologies,
Inc., Durham, NC).
7.1.5 Quality Assessment Measurements
a) Membrane Integrity Assays
Several vital staining dyes were used to assess membrane integrity.
(1) Trypan Blue
A volume between 25 pll to 200 pl of cell suspension was diluted with 0.4%
trypan blue solution (Sigma-Aldrich, St. Louis, MO) to a total cell concentration of about
5x1 05 cells/ml. The volume ratio of trypan blue to cell suspension was at least 1 to 1. A
12 p.l sample was loaded onto a hemacytometer slide. Both stained cells and unstained
cells were counted using 40x magnification with a Zeiss photo 3 microscope. The
fraction of cells with compromised membranes was the ratio of the number of cells
stained with trypan blue divided by the total number (stain and unstained) of cells. With
P3TC3 cells heat-killed by incubation at 600C for 1 hr, 97% of cells immediately stained
with trypan blue. With cells exposed to other stresses, such as anoxia, staining increased
slowly with time and reached a steady value within 24 hr (175).
(2) 7-Aminoactinomycin (7-AAD) Differential Staining
The fraction of cells with compromised membranes was also measured using
differential staining before and after cell disruption with the 7-aminoactinomycin D
(7-AAD, Molecular Probes, Eugene, OR) fluorescent dye as previously described in
detail in Chapter 6. Briefly, cell suspensions were stained with 0.05 mg/ml 7-AAD, a
fluorescen dye with very high affinity for cellular nucleic acids, to label all nuclei in cells
with compromised membranes. Unbound 7-AAD was removed by washing. Cells were
disrupted with a lysis solution (0.1 M citric acid and 1% Triton X-100), combined with
vortex mixing for cells or shearing through a needle for islets, and labelled nuclei were
counted using a flow cytometer (Guava PCA). A portion of the nuclei suspension was
further stained with 7-AAD, thereby labelling all the previously unlabelled nuclei, and
the total number of nuclei was counted. The fraction of cells with compromised
membranes was estimated as the ratio of the initially stained nuclei (first measurement) to
the total number of nuclei (second measurement).
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b) Mitochondrial Function Assays
(1) MTT (1-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
Assay
The viability of cells and islets was assessed with MTT, a tetrazolium salt that is
reduced to an insoluble purple formazan as a consequence of the redox state in live cells
(125, 126, 128, 130). One mM MTT working solution in phenol red-free medium was
made fresh before the assay. Islets or cells were centrifuged, the supernatant was
aspirated, and the cells resuspended in D-PBS with 20 mM glucose. A known number of
cells in 100 p. of the suspension were transferred to each well of a 96-well plate, and
20 pl1 of 5 mg/ml MTT reagent (Molecular Probes) added to each well. The plate was
incubated at 370C in a shaker (Jitterbug Model 130000, Boekel Scientific, Feasterville,
PA). After 2 - 4 hr, 100 .1 of lysis solution, which included 9% sodium dodecyl sulfate
(SDS L-6026, Sigma-Aldrich) in 0.01 M HC1, was added to each well, and the plate was
incubated at 370C in a humidified chamber for 18 hr to dissolve the precipitates, after
which optical density was read at 570 nm in a plate reader (FLUOstar/POLARstar
Galaxy, BMG Labtechnologies, Inc., Durham, NC). Extreme care was taken to ensure
that test conditions were identical each time the assay was carried out.
(2) Oxygen Consumption Rate (OCR)
In collaboration with the manufacturer, we designed and tested a variety of stirred
chambers. The final design used for all data presented here is now commercially
available (Micro Oxygen Uptake System, FO/SYSZ-P250, Instech Laboratories,
Plymouth Meeting, PA). The stirred chamber device (Figure 7.1) was water jacketed for
temperature control and was stirred with a glass coated magnetic stirring bar. Titanium
was used for the chamber body and for the oxygen probe jacket because the metal is
oxygen impermeable, inert, has high thermal conductivity, and will not introduce
artifactual drift arising from the surface oxidation. Oxygen partial pressure (pO2) was
measured with a fiber optic oxygen sensor calibrated at 0 and 160 mmHg. The fiber optic
sensors were stable, capable of a long-lasting calibration, insensitive to stirring artifacts,
and had virtually zero oxygen consumption. With the stirring bar in place, the chamber
had a nominal volume of about 200 .1. Exact chamber volume, measured by filling it
with water, then carefully removing and weighing the water, ranged from 184 to 219 Cl
for eight commercial devices. This variation reflected the custom fabrication of device
components, especially the magnetic stirring bar and the sealing plug. The stirrer speed
was controlled by a potentiometer. The stirrer rotational rate (S) was measured with a
stroboscope and was related to the potentiometer setting (P) by S=44.7P-81 rpm. The
potentiometer was normally set at "3" out of "10", corresponding to a rotation rate of
53 rpm that was just enough to suspend the islets off the bottom surface. The oxygen
leakage rate of the sealed chambers was zero but could be as high as
0.2 mmHg/min-mmHg if the sealing plug was chipped. Virtually 100% of the tissue
added could be recovered from the chamber for use with further measurements.
For OCR measurements, islets were centrifuged for 2 min at 173xg, the
supernatant was removed by vaccumming with a Pasteur pipette, and each sample was
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resuspended in 250 il of pre-warmed (370C) DMEM (Mediatech, 10-013-CM) that
contained 4.5 g/l glucose and 0.6 g/l L-glutamine supplemented with 100 U/ml penicillin,
100 jig/ml streptomycin, 10 mM HEPES, and no added serum (so as to minimize bubble
formation). The islet (or cell) suspension was added to the device, the chamber was
sealed, and thermal equilibration at 370C occurred in about 15 sec. After a transient
increase in pO2 resulting from the decreased oxygen solubility at the higher temperature,
pO2 decreased with time. If the tissue viability, as reflected by OCR, did not change
during the course of the experiment, and the minimum pO2 in the islet remained far
above the Michaelis constant for oxygen consumption (<1mm Hg), then the slope
ApO 2/At was constant. A typical measurement took about 20 min.
Beveled s
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Oxvyen sensor in needle -
Magnetic stirring bar J
Figure 7.1. Schematic diagram of device for measuring oxygen consumption.
(A) Exploded view. The device consists of a titanium cup that sits in a water
jacketed enclosure for temperature control. After addition of a glass-coated
magnetic stirring bar (nominal length 5 mm, diameter 2 mm) into the opening in the
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cup, a transparent beveled glass plug is placed into the cup opening (diameter
6.4 mm). The void space remaining in the opening defines the chamber that contains
the cell or tissue suspensions. Oxygen in the chamber is measured by fluorescence
quenching following oxygen binding to a fluorophor in a gel overlain by a silicone
rubber film at the tip of an optical fiber. The fiber is held inside the chamber by a
titanium jacket and elastomeric seal. A magnet attached to a rotating motor is
paced within the enclosure in close proximity to the stirring bar. (B) Cross section
through the titanium cup showing the filling procedure. After the magnetic stirring
bar is added, a volume of the cell or tissue suspension corresponding to the chamber
volume plus 5 to 10 pl excess is placed in the chamber (left figure), the beveled plug
is inserted, and any excess fluid is expelled through the angled side port and
collected in a groone around the cap. When filling is complete, the beveled plug is
rotated (right figure) to block access to the port and seal the chamber. If a bubble is
observed from the top, the plug is removed, cells or islets are allowed to settle,
additional medium is added, and the plug is reinserted as the bubble is washed
through the angled side port.
The OCR was calculated from
Equation 7-1 OCR = Vch a
where Vch is the chamber volume and a is the Bunsen solubility coefficient taken to be
1.27 nmol/cm3mm-Hg at 370 C (176). Data above 60 mmHg in the region yielding the
steepest slope of pO2 versus time was fitted to a straight line using linear regression.
OCR per cell was obtained by dividing both sides of Equation 7-1 by the number of cells
nc in the chamber,
OCR [, AtEquation 7-2 OCR
cell nc
Vch
where the quantity nc/VNh is the cell concentration measured, for example, by nuclei
counting. The quantity OCR/DNA can be calculated from Equation 7-2 if the
denominator is replaced by DNA concentration in the chamber.
7.1.6 Statistics
All measurements were made with three or more replicates. Data is reported as
mean ± standard deviation (SD).
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7.2 Results
7.2.1 Characterization of the OCR Apparatus and Measurements
Data from a typical set of OCR measurements made with three different aliquots
of rat islets originating from the same sample pool is shown in Figure 7.2A. The mean of
the three slopes was 5.02 ± 0.24 mmHg/min, which corresponded to an OCR of
12.8 ± 0.6 nmol/min. The coefficient of variation (COV) was 0.6% or less for the
estimate of the slope of the individual measurements and 4.8% for the triplicate
measurements. The mean value of OCR/cell for these measurements was
3.82 ± 0.45 fmol/min-cell. The standard deviation estimate was obtained from
propagation of error associated with both the slope and nuclei measurements. Curvature
in the data of the third measurement at low pO2 reflected the presence of pO2 gradients
within the islets and the reduction in OCR at low pO2 associated with Michaelis-Menten
kinetics.
The linearity of the pO2 profiles with time in the high pO2 regions of Figure 7.2A
indicated that the OCR and the viability of islets in the chamber was constant for the
duration of the measurement and was not affected by the experimental procedure. Similar
behavior was observed when islets were retained within the chamber for successive
measurements. Figure 7.2B shows data from one experiment in which two consecutive
measurements were made with the same rat islets over a 60-min period. After the first
measurement was ended, the beveled acrylic plug was removed while stirring was
maintained, and the islet suspension in the chamber was allowed to equilibrate with
ambient air, after which the plug was replaced. The second measurement was performed
with the same sample after re-oxygenation. There was essentially no change in the slope
between the first and second measurements and no indication of damage to the islets
during the 60-min period in which the islet suspension was stirred. In other experiments
with rat and human islets, there was no significant change in membrane integrity by
7-AAD differential staining measured before or after 15 min stirring at 53 rpm. At much
higher stirring speeds, a modest increase in the fraction of cells with compromised
membrane integrity was observed with rat but not human islets.
In rare situations, the linearity displayed in Figure 7.2A and Figure 7.2B was not
maintained. Figure 7.2C and Figure 7.2D show an example of data from OCR
measurements with the rat islet samples from the same preparation, each carried out at a
different stirrer speed setting. The profiles of pO2 versus time exhibited curvature,
suggesting that islet cell death occurred within the chamber during measurement. The
slope after 10 min divided by the initial value (at pO2 = 160 mmHg) ranged from 0.61 to
0.72. Consistent behavior was observed with membrane integrity measurements by
7-AAD differential staining. The fraction of cells with impermeable membranes was 60%
when assayed 4 hr after isolation and decreased slowly with time in storage. The fraction
ranged from 30 to 38% for the islets recovered from the chamber after OCR
measurement. These data suggest that this particular preparation was extensively
damaged during isolation and that the samples were further damaged by mechanical
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agitation during OCR measurement. However, neither the extent of curvature nor the
decrease in membrane integrity correlated with the magnitude of the stirring speed.
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Figure 7.2. Actual traces (individual data points) of measured pO2 versus time with
rat islet samples.
(A) OCR measurements, each about 20-50 min with a stirring rotational rate of
53 rpm, were performed with a fresh aliquot obtained from the same islet
preparation. The measured cell concentration of the islets in the chamber was
1.6x106 cells/ml, corresponding to an islet concentration of 1030 IE/ml. Data were
fitted to a straight line in the steepest portion of the trace (indicated by vertical
marks), yielding slopes listed in the figure. Points below a pO2 of 60 mmHg were not
used in any of the slope estimates to ensure that all cells within the islets were
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exposed to a high enough pO2 so that OCR could be assumed constant throughout
the islet. If the experiment is run long enough to allow pO2 to decrease to much
lower values, curvature occurs in the plot of pO2 versus time, as shown in the third
measurement, which reflects the interaction of intra-islet oxygen gradients and the
decrease in OCR as the local pO2 approaches 0 mmHg. (B) Two measurements
performed with the same sample, the second one after re-oxygenation, with a stirrer
rotational rate of 53 rpm and 1.7x10 6 islet cells/ml, corresponding to 1090 IE /ml.
The mean of the slopes was 1.77 mmHg/min, corresponding to an OCR of
4.75 nmol/min and an OCR/cell of 1.33 fmol/min*cell. (C) Sequential OCR
measurements made 4-6 hr after isolation with different samples from the same rat
islet preparation at stirring speed settings of, "9", "3", and "6", corresponding to
rotational rates of 321, 53, and 187 rpm, respectively. (D) Trace of each experiment
shown in (C) with time adjusted so that pO2 = 0 at t=0. (E) pO2 versus adjusted time
from OCR measurements performed with rat islets made within 10 minutes after
isolation was completed at three stirring speed settings. (F) Data from OCR
measurement performed with islets from same preparation as used in (E) but made
4 hr later.
All data with rat islets shown in Figure 7.2A through Figure 7.2D were obtained
4 hr after isolation. A limited number of measurements were made immediately (within
10 min) after isolation. Some of these revealed curvature in profiles of pO2 versus time,
whereas the curvature disappeared when samples were tested 4 hr later. An example is
given in Figure 7.2E, which shows data from OCR measurements with rat islets from two
different preparations carried out within 10 minutes after completion of isolation at three
different stirring speeds. Immediately after isolation, plots of pO2 versus time exhibited
significant curvature that was not affected by stirring speed. These data suggest that the
decline in OCR with time reflected the presence in the chamber of dying cells that were
damaged by the isolation process. OCR measurements performed with islets from the
same preparations 4 hr later produced a straight line with constant slope (Figure 7.2F),
which suggests that, this phenomenon may be restricted to the period shortly after
isolation in most preparations.
The precision of the OCR measurement in Figure 7.2A and Figure 7.2B was
typical throughout this study. The coefficient of variation (COV) from a large number of
experiments is plotted versus the measured OCR (bottom) or the corresponding number
of viable islet equivalents (IE) (top) in Figure 7.3. The COV was calculated as the
standard error of the estimate of the slope divided by the estimate of the slope for a single
measurement and as the standard deviation divided by the mean of the slope for triplicate
measurements conducted with different samples taken from the same islet preparation.
Both sets of data followed the same trend for all three species of islets studied: the COV
increased slowly with decreasing OCR or number of viable IE and then rapidly at very
low OCR or number of islets. The COV was substantially larger for triplicate
measurements as compared to the estimate of the slope for a single measurement; this
behavior reflected sampling errors and possible heterogeneity in the OCR properties of
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the islets. Typically, the COV
IE.
was about 10% with 250 viable IE and 6% with 500 viable
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Figure 7.3. Precision of the OCR measurement.
Coefficient of variation (COV) versus the OCR measured in the experiment
(bottom) or the corresponding estimated number of viable islet equivalents (top) for
measurements conducted with rat, porcine, and human islets in the OCR
measurement apparatus. Data for single and triplicate measurements are shown.
For illustrative purposes, the number of viable islet equivalents was calculated
assuming (OCR/DNA)viable = 500 nmol/min'mg DNA, 6.5 pg DNA/cell, and
1560 cells/IE (Chapter 2).
7.2.2 OCR Correlation with Measures of Viability
Experiments with cells and islets were used to explore the utility of OCR
measurements for assessing the viability of mixtures of live and dead cells and of cells
and islets that have been cultured under stressful conditions. As a first step, mixtures of
healthy and heat killed 13TC3 cells were prepared at predefined ratios. OCR was
measured with healthy and heat-killed cells as well as their mixtures, a common method
for evaluating viability assays (177). The number of viable cells was measured with
trypan blue membrane integrity. Plots of OCR versus viable cell number and OCR/cell
versus fraction viable cells were linear (Figure 7.4A and Figure 7.4B). These data
demonstrate the usefulness of OCR measurements for assessing viability with mixtures of
live and dead cells.
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Figure 7.4. Dependence of OCR on cell viability.
In (A), (B), and (C), viability was assessed by membrane integrity measurements
with trypan blue. (A) OCR as a function of the number of viable cells and
(B) OCR/cell as a function of mixture composition for healthy, heat-treated, and
mixtures of healthy and heat-treated PTC3 cells in ratios of 25/75, 50/50, and 75/25.
Heat-killed cells were incubated at 600C for 1 hr. (C) OCR and viable cell number
from various batches of PTC3 cells cultured for 24 hr with and without imposed
stressful conditions. Aliquots for membrane integrity and corresponding OCR
measurement were taken from the same sample. The solid line is the best fit of a line
through the origin by linear regression (R2= 0.983). The estimate of the slope was
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1.72 ± 0.03 fmol/min-viable cell. (D) Relationship between MTT absorbance and
viable cell number. PTC3 cells from a single batch were cultured for 24 hr under
unstressed (control) or stressed conditions (TNF-a, 500U/ml culture medium).
(E) MTT absorbance versus OCR for porcine islets from a single preparation
cultured under normal and stressful conditions. Islets were cultured for 24 hr in
multi-well plates at 37*C with medium depths of 3 and 10 mm and with fractional
islet surface coverage ranging from 0.4% (control) to 30%. At the end of the
incubation period islets were removed from the corresponding wells for MTT and
OCR measurements. (F) MTT versus OCR for samples of roughly similar islet
volume from 17 different rat islets preparations (R2=0.993). In (A) through (F),
measurements were made in triplicate. Error bars indicate standard deviation and
are contained within domain of symbol if not visible.
The experiments were extended to include exposure of cells to different types and
magnitudes of stresses, including those that islets might be exposed to during isolation,
culture, transportation, and transplantation (139), which can damage cells but do not kill
all of them. The stresses were primarily hypoxia and anoxia, along with hyperoxia,
nutrient depletion, and exposure to TNF-a, all for 24 hr. Surface-attached cells cultured
at 370 C with air and 5% CO2 (used in all experiments) were used as controls.
Representative results for the effect of stressful culture conditions are shown in Figure
7.5. The fraction of cells that were membrane-impermeable after 24 hr ranged from more
than 85% for the control and for pellets cultured at 50 C to less than 10% for pellets
cultured in air at 370C. Surface attached culture (T-flask) under anoxia at 370 C resulted
in a value of 40%; this higher level is consistent with the presence of an active glycolytic
pathway in 1TC3 cells (139, 178). The much lower value in the pellet in air at 370C
indicates that some other stress in addition to severe hypoxia or anoxia, such as nutrient
depletion or toxic waste buildup, must have been operative in the pellet.
Data from a large number of 24 hr culture experiments, such as those illustrated in
Figure 7.5, are summarized in Figure 7.4C. Measured OCR is plotted versus the number
of viable cells in the OCR chamber, which was quantified as the number of cells that
excluded trypan blue. Data from cells cultured under both stressed and unstressed
conditions clustered about a single straight line for the relationship between OCR and the
number of viable cells. The slope of the best straight line through the origin was
1.72 ± 0.03 fmol/min-viable cells. This linear relationship demonstrates that OCR
measurement is suitable for assessing viability of cells subjected to different types and
levels of stress. This finding was further substantiated with a limited number of
experiments using the MTT assay. A linear relationship between MTT absorbance and
viable cell number was also observed in these experiments (Figure 7.4D).
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Figure 7.5. Fraction of pTC3 cells that were membrane impermeable after culture
under normal and a variety of stressful conditions for 24 hr.
Approximately 2x10 7 pTC3 cells were used in each experiment. For surface-
attached cultures, cells were cultured in T-75 flasks in a 370C incubator at a plating
density such that they would not be confluent after 24 hr. Medium depth was 2 mm.
For pelletized culture, cells were placed in 15 ml centrifuge tubes with 15 ml culture
media and let settle by gravity, leading to cell depth of about 3 mm overlain by
11 cm of media. The tubes were sealed and cultured at temperatures of 50C, 240C,
and 370C. For hyperoxic and anoxic culture, flasks and tubes were placed in sealed
chambers within an incubator, and the sealed chambers were continuously flushed
with premixed gases (95% 02 or 95% N2, balance CO2). At the end of the 24-hr
culture, cells in flasks were trypsinized. All cells from each condition were collected
and samples for OCR and trypan blue staining were taken. Fraction of membrane-
impermeable cells was determined as the number of cells that did not take up
trypan blue divided by the total number of cells counted.
Figure 7.6 is the frequency distribution of the values obtained for OCR/viable cell
for all the conditions examined in Figure 7.4C and Figure 7.5. Open bars represent data
obtained with the stressed cells and solid bars those obtained with unstressed cells. The
values obtained with stressed cells covered a 3-fold range, whereas those obtained with
unstressed cells covered a 2-fold range. The mean values of OCR for stressed and
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unstressed cells were not significantly different and the mean value for all measurements
was 1.86 + 0.45 fmol/min-viable cell (n=64).
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Figure 7.6. Frequency distribution of OCR per viable cell for stressed and
unstressed PTC3 cells.
Cell were cultured for 24 hr under stressed and unstressed conditions (Figure 7.4C
and Figure 7.5). OCR per viable cell was estimated by dividing the measured OCR
by the number of viable cells placed in the chamber at the time of the measurement
as determined with a hemocytometer using trypan blue exclusion. Values of
OCR/viable cell ranged between 1.46-2.81 (n=33) for stressed and
0.94-2.99 fmollmin'viable-cell (n=31) for unstressed cells. Mean values were
1.88 ± 0.54 and 1.84 ± 0.34 fmol/min-viable cell (n=31) for stressed and unstressed
cells, respectively. Fractional viability by trypan blue exclusion averaged 0.95, and
the OCR uncorrected for viability was 1.75 ± 0.32 fmol/min-cell. OCR values for
stressed cells covered a wider range, but the mean values of OCR for stressed and
unstressed cells were not significantly different. The mean value for all
measurements was 1.86 ± 0.45 (n=64).
In the experiments shown in Figure 7.4D and Figure 7.5, the fraction of
membrane-impermeable cells varied over a wide range as illustrated in Figure 7.4C. The
equivalence between OCR/viable cell estimates for both stressed and unstressed cells in
Figure 7.6 suggests that membrane integrity measurements provided a valid estimate of
the number of viable cells following 24 hr culture under various conditions.
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7.2.3 OCR Measurements with Islets
Analogous to the studies with 3TC3 cells, experiments were carried out to
examine the use of OCR measurements for assessing the viability of islets that have been
cultured under stressful conditions. Experiments with stresses of the type used with 3TC3
cells (e.g. Figure 7.5) led to much greater loss of viability in the case of both porcine and
rat islets. For example, after 24 hr in a pellet at 240C, rat and porcine islets had oxygen
consumption rates relative to the control of about 15 and 5%, respectively. In contrast,
PTC3 cells retained about 45% fractional viability under same culture conditions
(Figure 7.5). This greater sensitivity of islets to hypoxic stress is consistent with there
being a relatively inactive glycolytic pathway resulting from the low levels of lactate
dehydrogenese in islets (179). Because high-stress experiments of this type resulted in a
very large decrease in viability, necessitating use of several thousand islets to get a
measurable OCR, graded stresses associated with hypoxia in high-density islet culture
were employed. Islets were cultured for 24 hr in multi-well plates at 370 C with medium
depths of 3 and 10 mm and with fractional islet surface coverages ranging from 0.4%
(control) to 30%. Islet viability was measured with the MTT assay, which has been
employed by others for islet viability measurement (126, 127, 129-131, 180, 181).
Fractional viabilities, defined as the MTT absorbance of samples from the test culture
relative to that of the control, in experiments with rat islets ranged from about 20 to 70%.
In a similar series of high-density culture experiments with porcine islets from a single
preparation, both OCR and MTT assays were performed. The data, which is cross-plotted
in Figure 7.4E, demonstrates a linear relationship between OCR and MTT absorbance,
thereby substantiating the usefulness of OCR measurements for evaluating the viability
of islets subjected to differing amounts of stress. OCR measurements were made with a
large number of rat islet preparations, each a mixture of islets from 6 to 20 animals. OCR
and MTT measurements were made with a sample from each of 17 different rat
preparations (Figure 7.4F), and the two parameters displayed excellent linear correlations
of the entire range of measurements.
7.3 Discussion
Improvements in islet transplantation are seriously hindered by the absence of
quantitatively meaningful islet quality assessment methods. Current islet quality
assessment methods are operator dependent, subjective, and not predictive of
transplantation outcome in humans (20, 21, 83, 102). In particular, there is need for
reliable, predictive assays of islet viability and function that will consistently define the
potency of an islet preparation before transplantation (99). Fractional viability is
routinely estimated by membrane integrity tests, typically FDA/PI, even though the data
is operator dependent and unreliable.
In this chapter, we described a novel stirred chamber device for rapidly measuring
OCR of islet preparations, which is a measure of the total amount of viable tissue. Using
the stirred chamber, we demonstrated that OCR measurements with rat islet samples
could be reproducibly conducted in a short period of time (less then an hour for
triplicates) with 500 viable islet equivalents or less with excellent precision (Figure 7.3).
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Measured OCR was in general unaffected by incubation in the OCR chamber with
mechanical stirring (Figure 7.2A and Figure 7.2B). In some cases, in particular with
infrequent highly damaged islet preparations examined 4 hr after isolation and with a few
preparations tested immediately after isolation, islet viability decreased during the
measurement itself, which was demonstrated by a continuous decline in the slope during
the OCR measurement (Figure 7.2C through Figure 7.2F) and by changes in membrane
integrity measurements. The extreme fragility observed with a few preparations is
consistent with observations using a perfusion chamber (164) that islets disintegrated and
recovery from the system was incomplete when the enzymatic digestion during isolation
was deemed to be "less than perfect". The fragility of islets and their death in the OCR
chamber may be an additional and useful indicator of their quality. The observation of
curvature in the pO2 trace immediately after isolation but not when examined 4 hr later
suggests that some of the islets are dying as isolation is completed. This reduction in
viability needs to be studied in much greater detail, and the OCR chamber is especially
useful for this purpose because individual measurements can be made in about 20 min.
Measurements with 3TC3 cells demonstrated that the measured OCR is directly
proportional to the number of viable cells in mixtures of live and dead cells and
correlates linearly with membrane integrity measurements of fractional viability (Figure
7.4A through Figure 7.2C, and Figure 7.5) and MTT viability measurements (Figure
7.4D) made with cells that have been cultured for 24 hr under various stressful
conditions. Estimates of OCR/viable cell obtained from all samples of stressed and
unstressed cells did not produce a single value. Instead, the data yielded frequency
distributions that covered similar ranges with mean values for stressed and unstressed
cells that were not significantly different (Figure 7.6). This finding indicates that when a
sample of cells was subjected to stress for 24 hr, leading to the reduction in fractional
viability for the sample (Figure 7.4C, and Figure 7.5), a fraction of the cells lost all
viability. The remaining viable cells had essentially the same mean value of OCR/viable
cell as the original unstressed sample. There was no evidence for a population of cells
having a partial reduction of OCR/viable cell.
Measurements with islets similarly demonstrated that the measured OCR is
sensitive to damage caused by stress and correlates linearly with membrane integrity
measurements (Figure 7.4E) made with porcine islets that had been cultured for 24 hr
under stressed conditions and with samples from a large number of rat islet preparations
(Figure 7.4F). Together with findings from measurements with 3TC3 cells, the data
indicates that the measured OCR is directly proportional to the number of viable cells in
the sample of islets.
OCR measurements in this study were carried out with highly purified (>95%) rat
and porcine islet preparations. In human islet transplantation, current practice is to use
preparations that have purities as low as 40% in order to maximize the number of islets
transplanted. The presence of exocrine tissue in such impure preparations may limit the
use of OCR measurements (or any other assay of tissue viability) in characterizing islet
quality. Human islet preparations are produced in a high and a low purity fraction, both
of which are subsequently mixed prior to transplantation. We hypothesize that islet
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characterization be conducted on the highly purified fraction, which contains the vast
majority of islets in the preparation, since islet quality in the high purity fraction is
expected to be representative of that in the entire preparation. This notion is supported by
use of the highly purified islet fraction for transplantation in the nude mouse bioassay,
which is considered the best assay in islet quality assessment and the only one that
currently correlates with transplantation outcome in humans (83). Furthermore, this
hypothesis has been tested and validated in diabetic mouse models with rat and human
islets characterized by OCR and OCR/DNA measurements and transplanted under the
kidney capsule (182). Current work is directed towards extending these findings to
transplantation in humans.
Contributions: Preliminary studies were conducted by Dr Klearchos K. Papas
(University of Minnesota) and Haiyan Wu (MIT). Mike Loughnane (Instech
Laboratories, Inc.) helped with the artwork in Figure 7.1 and useful discussions.
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Chapter 8.
Characterization of Islet and Non-Islet
Tissue Prior To and Following Culture
This chapter was written in collaboration with Michael J. Rappel, who developed
an understanding of the changes islet tissue goes through during low density static culture
when no transport limitations are present. My contributions were developing and testing
the tools used here to characterize islet tissue, collection and analysis of the non-islet
tissue data, as well as some of the data after 1 and 2 days in culture.
Transplantation of islets of Langerhans is a promising treatment for patients with
unstable forms of type 1 diabetes (4, 9, 10, 98, 132-134), but several aspects need
improvement to allow widespread application. One need is quantitatively meaningful
islet quality assessment tests that can predict the transplantation outcome (9, 20, 23, 100).
This is especially important because islet isolation and transplantation success rates vary
between centers (183, 184). The most reliable assay, transplantation under the kidney
capsule of nude diabetic mice (47, 185, 186), requires a long time and is useful only
retrospectively. Currently-employed methods for islet characterization include staining
with dithizone (DTZ) for purity assessment and enumeration by visual evaluation under a
microscope (49, 105), and staining with fluorescent diacetate/propidium iodide (FDA/PI)
for assessment of membrane integrity (123). These methods are not quantitative and do
not correlate with transplantation outcome (21, 83, 102).
Recent interest in developing new methods for islet viability assessment has
focused on measurements of mitochondrial function, including mitochondrial membrane
polarization with dispersed islet cells (66), ATP/ADP concentration ratio with intact
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islets (187) and oxygen consumption rate (OCR) (182). The combined use of OCR and
DNA measurements in the latter two studies correlated with transplantation outcome with
high specificity and selectivity. However, there is a paucity of data in the literature on the
OCR of human islet preparations or of any other species.
Islet culture for 36-72 hr prior to transplantation is practiced in most clinical
centers (188) to provide time for tissue recovery from the harsh isolation process,
possible reduction in immunogenicity (189-194), assessment of purity, membrane
integrity, and sterility, recipient matching, patient travel to the islet center, and patient
preparation to reach necessary levels of immunosuppression before transplantation (188,
195, 196). There is need to better understand islet culture and its effect on purity and
viability. Culture conditions, especially temperature, vary between islet centers. Culture
at 370C maintains viability (by membrane integrity) and function better than reduced
temperature (195, 197), but also results in increased necrotic death (197-200), which is
likely the result of oxygen transport limitations. Culture at 22-240 C results in more islet
mantle disintegration and increased apoptosis (201), but also increases the recovery of
islet tissue (194, 195, 197, 202). Currently, only non-adherent tissue is recovered from
culture for analysis and subsequent use.
In this study, we examine OCR properties (Chapter 7) of large numbers of human
islet preparations (freshly isolated, precultured, or shipped from various centers), as well
as rat and porcine islets. Measurements made when received and after 1 or 2 days of
culture included, in addition, total amount of tissue by nuclei counts and DNA content
(Chapter 5), islet volume fraction (Chapter 3) and 13 cell number fraction by light
microscopy, and quantitative membrane integrity (Chapter 6). We also investigated
culture temperatures of 37'C and 24°C and examined both adherent and non-adherent
tissue recovered from culture.
8.1 Methods
8.1.1 Islet Isolation and Culture
Rat islets were isolated from male Sprague-Dawley rats by using collagenase
digestion/ficoll purification (37, 174). Standard collagenase/protease digestion methods
were used for human (4, 33) and porcine (40) isolations. Preparations of rat, and human
islets, human non-islet tissue, and porcine islets were provided fresh (4-6 hr after
isolation was complete) by the Islet Core at the Joslin Diabetes Center (JDC, Boston,
MA). Human islets were also received after culture (1-2 days) from JDC or overnight
shipment (sometimes after up to 1 day culture) from other centers contained in culture
flasks (T-25 and T-75) or centrifuge tubes in Styrofoam boxes. When first observed,
some preparations were in suspension, some in a pellet. Upon receipt, a portion of the
preparation was analyzed and the remainder placed into untreated polystyrene culture
flasks at 370C in a humidified environment (5% CO 2), oxygen partial pressure (pO2) of
142 mmHg, for 34-60 hr during which no medium change occurred. Some cultures were
terminated at 18-24 hr for analysis. To test the effect of temperature, some islets were
cultured at 240C, then warmed for 1 hr at 370 C before OCR measurements.
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Islets were cultured in supplemented RPMI (11.1 mM D-glucose, 100 U/ml
penicillin, 100 [tg/ml streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate (all from
Mediatech Inc., Herdon, VA), and 50 pM [3-mercaptoethanol (Sigma Aldrich, St. Louis,
MO) with 10% fetal bovine serum (FBS, Mediatech Inc.), at low densities
(< 8x104 cells/cm2 or about 50 islet equivalents (IE)/cm 2, where IE is the volume of a
sphere with a diameter of 50 pm) in 1.3 mm of medium in tissue culture flasks. After
culture the free, non-adherent tissue (which is the only tissue used in current practice)
was collected. In selected experiments, human tissue attached to the culture vessel
(adherent) was incubated for 5 min at 370 C in 0.05% trypsin EDTA (Mediatech Inc.),
dislodged with fresh medium, and collected. Rat islets and human tissue at 240 C did not
adhere significantly. Tissue suspensions were centrifuged for 3 min at 300xg, supernatant
removed and the tissue suspended in fresh medium.
Human and porcine islets were also isolated and analyzed at the University of
Minnesota (MN) using standard methods (203). Islets were cultured in CMRL 1066
formulated for islet culture (Mediatech), further supplemented with 10% FBS and
heparin (10 U/ml). Islets were cultured at 200 IE/cm in 30 ml of medium in tissue
culture flasks in an incubator with 5% CO 2 for 18 to 24 hr at 370C and then 18 to 24 hr at
24 0C.
8.1.2 DNA Content
At MIT, DNA was measured by fluorospectrophotometry (Chapter 5) using the
CyQUANT Cell Proliferation Assay Kit (Molecular Probes, C-7026 Eugene, OR), and a
X DNA standard (Invitrogen) and 50-250 IE/sample. Fluorescence was read at 480 nm
excitation and 520 nm emission wavelengths in a plate reader (Spectra MAX Gemini
microplate spectrophotometer, Molecular Devices, Sunnyvale CA). At UMN (porcine
and human islets), PicoGreen dye was used (Quant-iT PicoGreen dsDNA kit, Molecular
Probes, Eugene, OR) (182). Fluorescence was read at 520 nm excitation and 585 nm
emission wavelengths.
8.1.3 Islet Enumeration by Nuclei Counting
Nuclei were prepared by adding equal 100-gtl volumes of sample containing 160
or more IE and of lysis solution (0.1 M citric acid (Sigma) and 1% (v/v) Triton X-100
(Sigma)) to a 1.5 ml microtube (Chapter 5). The mixture was incubated at room
temperature for 5 min with vortex mixing every 1.5 min, and nuclei were liberated by
shearing through a needle. Isolated nuclei were diluted with Dulbecco's Phosphate
Buffered Saline (D-PBS, Invitrogen, Carlsbad, CA) to a concentration no higher than
5x10 5 nuclei/ml, stained with 7-aminoactinomycin D (7-AAD, Molecular Probes,
Eugene, OR), and analyzed using a flow cytometer (Guava Personal Cell Analysis (PCA)
system, Guava Technologies, Hayward, CA) to determine the total number of cells with
intact nuclei in the sample.
8.1.4 Oxygen Consumption Rate (OCR)
OCR was measured as previously described in Chapter 7. Briefly, suspensions
containing about 2500 IE/ml in DMEM containing 4.5 g/1 glucose and 0.6 g/l
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L-glutamine supplemented with 100 U/ml penicillin, 100 jig/ml streptomycin, 10 mM
HEPES, and no added serum were sealed in a 200-il stirred titanium chamber (Micro
Oxygen Uptake System, FO/SYSZ- P250, Instech Laboratories, Plymouth Meeting, PA)
maintained at 370C. The time dependent pO2 within the chamber was recorded with a
fluorescence-based oxygen sensor (Ocean Optics, Dunedin, FL), and data at high pO2
were fit to a straight line. The maximal OCR was evaluated from OCR=VCha(ApO 2/At),
where Vch, where Veh is the chamber volume and a = 1.27 nmol/mmHg-ml is the Bunsen
solubility coefficient for oxygen in medium (176). OCR measurements were normalized
by the measured number of cells (nuclei counting) or DNA content of the sample
examined.
8.1.5 Membrane Integrity
a) 7-Aminoactinomycin (7-AAD) Differential Staining
Cell membrane integrity was assessed by differential staining with 7-AAD
(Molecular Probes, Eugene, OR) (Chapter 6). An aliquot of about 300 islets was
resuspended in 100 jil of D-PBS, and 5 pl of 1 mg/ml 7-AAD and incubated for 20 min at
40C protected from light. After two washes with 1 ml of D-PBS, cells were disrupted by
adding equal volume of lysis solution in D-PBS to the islet suspension and sheared as
described for islet enumeration. Labeled nuclei were counted immediately in the flow
cytometer or stored on ice for less than 15 min before counting. A portion of the islet
suspension was further stained with 7-AAD, thereby labeling all of the previously
unlabelled nuclei, and the total number of nuclei was counted. The fraction of cells with
compromised membranes was estimated as the ratio of the initially stained nuclei (first
measurement) to the total number of nuclei (second measurement).
b) Fluorescein Diacetate (FDA)/Propidium Iodide (PI)
Immediately after human islet isolation was completed, a 250 pl aliquot was taken
from the preparation, resuspended in 5 ml of PBS solution in a 60 mm Petri dish, and
10 tl of 24 mM fluoroscein diacetate (FDA) and 750 pM propidium iodide (PI) was
added (137). The tissue was examined in a light microscope by focusing through the
tissue to visually estimate the volume fraction of cells containing nuclei stained red
because of loss of membrane integrity.
8.1.6 Islet Volume Fraction by Morphological Analysis
A 0.5 ml aliquot of human islet preparation was processed to produce 1-pCm
sections stained with toluidine blue and examined by light microscopy (Chapter 3). Islet
tissue was distinguished from non-islet tissue as previously described (Chapter 3).
Sections were analyzed at 420x by stereological point counting (84) with a 90-point grid
covering adjacent, non-overlapping fields. At point intercepts of the grid with tissue, the
nature of the tissue was determined, and the volume fraction of islet tissue, denoted 0 1,
was calculated as previously described (Chapter 3).
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8.1.7 P Cell Identification by Immunocytochemical Insulin Staining
Tissue samples were washed twice with 1 ml D-PBS, fixed for I hr in 10%
formalin (Sigma Aldrich), washed twice with 1 ml of D-PBS, and centrifuged at 300xg
for 5 min. To the pellet, 500 jil of warm 2% (w/v) agarose was added. The solution was
mixed using a vortex mixer for 1 sec, immediately centrifuged at 18000xg for 10 sec,
allowed to cool for 2 min, and then 500 jl of 10% formalin was added. After 1-hr
incubation at room temperature, formalin was removed, samples were stored in D-PBS
until embedded in paraffin, and 5-1tm sections were cut. Sections were stained by the
unlabeled antibody peroxidase-antiperoxidase (PAP) method (204) using guinea pig anti-
bovine insulin (Linco, St. Charles, MO) as primary antibody and goat anti-guinea pig IgG
(Cappel, Irvine, CA), as secondary antibody, to link primary antibody to rabbit PAP
complex (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Use of a
heterologous antibody gave specific staining with little background (205). After applying
PAP, slides were stained in 50 ml of a 2 mM 3,3'-diaminobenzidine tetrahydrochloride
(DAB, Sigma Aldrich) solution activated with 25 .l of 30% (v/v) hydrogen peroxide
(EMD Chemicals Inc., Gibbstown, NJ) for 30-120 sec, then viewed under a microscope.
Reaction between hydrogen peroxide, DAB, and PAP formed a dark brown insoluble
precipitate (206). Slides were counterstained with hematoxylin (Sigma Aldrich). P cell
volume fraction exclusive of vascular space, denoted Opxv, was quantified using
stereological point counting, as described for morphological analysis, with 200 points or
more counted.
This procedure was used with samples after 2 days culture because trypsinization
of adherent tissue degraded the structure and produced single cells, which, in turn, made
it harder to morphologically differentiate between cell types and evaluate vascular
volume fraction, whereas it was more accurate to distinguish insulin staining. Methods
for calculating ODpxv (day 2) and comparing it with (II (day 0) are described in Appendix
B.
8.1.8 Statistics
Measurements were made with three or more replicates and reported as
mean ± SD (standard deviation). Statistical significance was determined using a Student
t-test for unpaired data for comparing population means, and for paired data when
appropriate.
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8.2 Results
Nuclei counts, DNA content, membrane integrity by 7-AAD, and OCR were
measured with fresh rat, fresh human, and cultured/shipped (data combined) human
islets, and fresh human non-islet pancreatic tissue at MIT; islet and 0 cell volume fraction
were measured with human fresh and cultured/shipped islets. DNA content and OCR
were measured with porcine islets at MIT and UMN and with human islets at UMN.
Measurements with fresh tissue were performed 4-6 hr after isolation. At MIT, all islet
preparations were analyzed on day 0 (day of isolation for all fresh tissue or the day of
receipt for cultured/shipped human islets), and a subset on day 1 and 2 of culture. Tissue
analyzed in this study was often used for other purposes, and there was usually
insufficient tissue for all tests, so that population means did not come from identical
preparations. In a series of paired studies, measurements on day 0 and day 2 were made
with non-adherent, adherent, and combined (total) tissue samples, enabling measurement
of the recovery of the total amount of tissue (DNA and nuclei), the total OCR, and the
number of p cells relative to that originally placed in culture. In experiments in which
there was insufficient adherent tissue to carry out individual assays, adherent was
nonetheless combined with non-adherent tissue for assay of the total
8.2.1 DNA/cell
Frequency distributions of DNA/cell for day 0 and for non-adherent tissue on day
1 and 2 in culture are shown in Figure 8.1. DNA/content (pg DNA/cell) of rat (6.4 ± 1.6),
fresh human islets (6.4 ± 1.1), and human non-islet tissue (5.7 ± 2.3) was similar while
that of human cultured/shipped islets (7.9 + 1.8) was significantly higher (p<0.01),
thereby suggesting that significant cell death occurred during pre-culture and shipment
and that DNA had been released from dead cells but had not yet degraded. The DNA
content of cultured rat islets did not change with time, whereas on day 1 it increased
substantially with non-adherent fresh islets (p<0.01) and non-islet tissue (p<0.20) and
decreased with cultured/shipped islets; on day 2, all returned partially towards the day 0
value. Rat islets produced a normal frequency distribution with a coefficient of variation
(COV) of 0.25. The COV was 0.14 for fresh human islets and usually about 0.25 for
other conditions, all of which were skewed to the right, reflecting the presence of very
high DNA/cell in some cultured preparations.
Additional data for the effect of 2-day culture on DNA/cell is tabulated in
Table 8.1. At 370C, day 2, DNA/cell for rat tissue was significantly lower than that of
human non-adherent cultured/shipped (p<0.02) tissue but not for fresh human tissue.
Changes from day 0 to day 2 were not significant for any of the non-adherent islets but
was significant for non-adherent human non-islet tissue. At 240C, DNA/cell of the non-
adherent rat islets was substantially higher than at 370 C. The same trend with
cultured/shipped human islets was not significant for paired data. The opposite trend was
observed for non-adherent fresh human-islets, though only three paired measurements
were made, and the mean at 370C (10.6 + 1.9) was substantially higher than that for a
larger number of preparations (7.2 + 2.8)
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8.2.2 DNA and Nuclei Recovery
The fraction of tissue recovered on day 2, as nuclei or DNA, relative to day 0 is
summarized in Table 8.1. At 370C, the fraction recovered for all tissue groups and for the
combined subsets within each group, was substantially less than 1.0 based on either
nuclei counts (p<0.01) or DNA measurements (p<0.01 to 0.15). The fractional recovery
of nuclei was 0.63 ± 0.14, 0.34 ± 0.15, 0.50 ± 0.17, and 0.40 ± 0.24 respectively, for rat,
human fresh, and cultured shipped islets, and non-islet tissue, 0.22 ± 0.10 and 0.30 ± 0.17
for human fresh and cultured/shipped adherent tissue, respectively, and 0.63 ± 0.14,
0.63 ± 0.17, and 0.81 ± 0.20 for rat and human fresh and cultured/shipped total tissue,
respectively. When based on DNA, these fractions were slightly lower for rat and
cultured/shipped human islets and slightly higher for human fresh islets and non-islet
tissue.
Fractional recovery of nuclei was higher for rat than non-adherent human fresh
(p<0.01) and cultured/shipped (p<0.10) islets, but total nuclei recovery was not
significantly different. The same trends were true with DNA recovery but with higher p
values. Human fresh islets had lower recovery than cultured/shipped islets for non-
adherent (p<0.09) and total (p<0.02) tissue. Recoveries of adherent tissue were similar.
Significant differences in recoveries of human fresh and cultured/shipped islets were not
observed in terms of fraction of original DNA. At 240C, fractional cell recoveries for rat
and non-adherent human fresh and cultured/shipped islets were 0.74 ± 0.16, 0.83 ± 0.04,
and 0.77 ± 0.19, respectively, all significantly less than 1.0 but higher than at 370 C.
Similar data were obtained with fractional DNA recovery.
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Figure 8.1. Frequency distributions of DNA content.
Data are for day 0 and for non-adherent tissue on day 1 and 2 in culture for (A) rat,
(B) human fresh, and (C) human cultured/shipped islets, and (D) human non-islet
tissue. n is the total number of islet preparations for which measurements were
made.
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Table 8.1. DNA/cell and the fraction of original tissue (quantified by nuclei and
DNA) recovered after 2 days culture .
Tissue collected after 2 days culture
Temp
Day ("C) Type
Rat
Fresh islets
0 - -
2 37 NA
2 24 NA
Human
Fresh islets
0
DNA/cell
n (pg DNA/cell)
30 6.4 ± 1.6
7 5.7 1.5
5 6.0± 1.6 -|
C
5 7.3±1.7 -_
B
20 6.4 ± 1.1 -1
2 37 NA 12 7.2 ± 2.8
3 10.6 3 1.9 -
2 37 A 2 6.6
z of I T I O.O Z.O
2 24 NA 5 7.4 ± 0.2
3 7.0 0.7
Cultured/shipped
n
islets
24A 7 .L 1 8
3 8.7 2.5
2 37 NA 17 7.7 ± 1.8
B
2 37 A 3 7.2 1.9 1
2 37 T 5 7.3 ± 1.3
2 24 NA 8 8.8 ± 2.6
Fraction of
n original nuclei
1.0 -.
A
11 0.63± 0.14 -
C
11 0.74 0.16 .-
Fraction of
n original DNA
1.0 "
A B
5 0.59 ± 0.23 ~
5 0.72 ± 0.21
A
AA A5 0 34 + 1.5 .
3 0.41 ± 0.20 - A
4 0.32 ± 0.17 "
C
4 0.22 ± 0.10 - A
4A r• .l7 n 47
B -
5 0.83 ± 0.04
3 0.81 ± 0.01
"I , -
A A
14 0.50 0.17 J
8 0.54 ± 0.20 -
8 0.54 ± 0.15 A
B8 0.30 ± 0.17 - -f
11 0.81 ± 0.20
A
8 0.77 0.19 -J
I.U -11-
A B4 0.41 ± 0.14 -
2 0.25
11 0.64 ± 0.18 1
3 0.77 ± 0.14
-1 =I-1 -
A A
10 0.45 0.25 C
6 0.58 0.26 -
3 0.38 ± 0.12- B
3 0.27 ± 0.13 I -
3 0.65 ± 0.23 -
6 0.76 0.19 1 -
IC
Fresh non-islet
0 - - 6 5.7 2.3
4 4.9 ± 1.3
2 37 NA 4 6.9 ± 0.9
A
5 0.40 ± 0.24 -
B
5 0.54 ± 0.35 -
a Data are tabulated for day 0 and day 2 non-adherent (NA), adherent (A), and the
combined total (T, adherent + non-adherent) tissue within each group and includes
overall population means for comparison between groups (e.g. fresh rat versus fresh
human) and paired data for comparisons of subsets within each group. Data are reported
as mean ± SD for measurements with n different islet preparations. The p values of
paired (bold face) and unpaired (not bold face) comparisons (denoted by brackets) are
given for p < 0.15 according to the following notation: A: p 5 0.01, B: 0.01 < p < 0.10,
and C: 0.10 < p < 0.15. Fractional recoveries for NA and A add up to T only for paired
samples.
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8.2.3 OCR/cell and OCR/DNA
Frequency distributions of OCR/cell and OCR/DNA for day 0 and for non-
adherent tissue on day 1 and 2 in culture are shown in Figure 8.2 and Figure 8.3,
respectively. OCR/cell for rat islets, human fresh and cultured/shipped islets, and human
non-islet tissue was 2.7 ± 1.1, 1.5 ± 0.5, 1.6 ± 1.1, and 1.6 ± 0.7 fmol/min-cell on day 0,
respectively, and 2.6 ± 0.4, 2.6 ± 1.1, 2.3 ± 0.7, and 2.2 + 0.7 fmol/min-cell on day 2. On
day 0, none of the distributions were normal. The COV was 0.41 for rat, 0.33 for human
fresh, and 0.70 for cultured/shipped islets, and 0.44 for non-islet tissue, all larger than the
comparable value of DNA/cell. Furthermore, the ratio of maximum to minimum
measured value ranged from about 2.0 to 3.1 for DNA/cell and about 3.5 to 6.4 for
OCR/cell. Because the precision in measuring DNA content and OCR was comparable,
the wider range of the OCR/cell distributions indicates differences in the viability
characteristics of the different preparations. For the frequency distributions of OCR/DNA
(Figure 8.3), trends of the population means between species and days in culture were
similar to those shown by the OCR/cell distributions, except that there were larger
differences between some mean values and smaller differences between others because of
the differences in the DNA/cell between the various types of tissue preparations. Notably,
the increase in OCR/DNA from day 0 to day 2 for human fresh non-adherent and total
tissue was not significant, whereas it was significant for OCR/cell measurements.
The effect of 2-day culture on OCR/cell and OCR/DNA is tabulated in Table 8.2
The increased OCR/cell with time observed in Figure 8.2 for non-adherent human tissue
was significant in paired t-tests. OCR/cell for all adherent human islets tissue was lower
than that of the corresponding non-adherent tissue and was not significantly different
than day 0 values. OCR/DNA followed similar trends, but significance in differences did
not follow a precise correspondence because of variation in DNA/cell and occasional
large COVs. After 2 day 240C culture, OCR/cell and OCR/DNA of rat non-adherent and
human islets were substantially lower than after 370C culture. In addition, after 240C
culture OCR/cell of non-adherent tissue was lower for fresh human islets than that of rat
and human cultured/shipped islets.
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Figure 8.2. Frequency distributions of OCR/cell.
Data are for day 0 and for non-adherent tissue on day 1 and 2 in culture for (A) rat,
(B) human fresh, (C) human cultured/shipped islets, and (D) human non-islet tissue.
n is the total number of islet preparations for which measurements were made.
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Figure 8.3. Frequency distributions of OCR/DNA.
Data are for day 0 and for non-adherent tissue on day 1 and 2 in culture for (A) rat,
(B) human fresh, (C) human cultured/shipped islets, and (D) human non-islet tissue.
n is the total number of islet preparations for which measurements were made.
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Table 8.2. OCR/cell, OCR/DNA, and fraction of original OCR recovered after
2 days culture a.
Temp OCR/cell
Day ("C) Type n (fmol/min cell)
Fresh islets
Huma.
F
0 - - 37 2.7 ± 1.1 -
7 2.8 ± 0.7
2 37 NA 9 2.6 ± 0.2
8 2.8 ± 0.5- B
B
2 24 NA 8 2.2 ± 0.5-1
7 2.1 0.4 J
OCR/DNA
n (nmollmin mg DNA)
30 41 n. 4,12
1
1 AlA
resh islets
0 - - 21 1.5±0.4
8 1.5 0.5
9 1.4±0.7- B
A
2 37 NA 12 2.6 ±1.1
8 2.9±1.0J
3 2.6±0.7
2 37 A 2 1.8 B
2 37 T 11 2.2±0.5
9 2.1±0.5
3 2.7±0.4-1 C
B
2 24 NA 5 1.5±0.4
3 1.4±0.4
3 1.6 ±0.5
Culturedlshipped islets
0 - - 26 1.6 ± 0.6
18 1.6 ± 0.61
A
2 37 KIA In 2. .3 n7 I
18 2.3 ±0.7-1 C
3 3.0 ± 0.8
8 2.6 ± 0.8
2 37 A 3 1.7 ± 0.4-1
B
2 37 T 6 2.2 ± 0.4
3 2.4 ± 0.5-1
2 24 NA 8 1.9 ±0.5 1 -
3 1.7 ± 0.31
Fresh non-islet
0 - -
2 37 NA
6 1.6±0.7
4 1.4±0.6-
B
4 2.2±0.8-
4 360 ± 110
3 340 ± 60
5 420 ± 130 i/
4 450 ± 130 B
4 430 ± 120 -,
B
4 270 ± 40 -_
3 260 ± 40 1
23 230 ± 60
A
IA
9 280 ± 110
1 307
9 280 ± 110
3 420 ± 120 1
B
5 210 ± 70
3 240 ± 90
24 230 ± 120
16 210±110-
5 230 ± 140 '
17 290 ± 90 B
16 290 ± 90 -8 290 ± 100
3 250 ± 80
5 310 ± 60 -
3 300 ± 80 ,
8 220 ± 50
3 220 ± 40
6 290 ± 160
4 340 ± 160
Fraction of
n original OCR
1 n
8
1 -I
I I
B
B
_j
0.65 0.20
A
0.63 0.20 -1
1 1
B
3 0.63 ± 0.06-
A
2 0.31
11 0.75±0.23 -
3 0.95 ± 0.10-, I
I A
5 0.65±0.14 A
3 0.63 ± 0.06J
B
-Il
A
11 0.70±0.27-
3 0.69 ± 0.04 A
A
3 0.33 ± 0.06-1
5 0.98 ± 0.07
6 0.87 ± 0.21
1 A
A
5 0.46 ± 0.27-
a Format is identical to that in Table 8.1.
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8.2.4 OCR Recovery
The fractional recovery of OCR from 2-day, 370C culture was significantly less
than 1.0 for almost all categories (Table 8.2). Fractional recovery of total tissue was
0.65 ± 0.20, 0.75 ± 0.23, and 0.98 ± 0.07 for rat and human fresh and cultured/shipped
islets, respectively; that for non-adherent tissue was 0.63 ± 0.06, 0.70 ± 0.27, and
0.46 ± 0.27 for human fresh and cultured/shipped islets and non-islet tissue. Fractional
recovery of the adherent component was smallest, about 0.33 for both groups of human
islets, but the number of measurements was small, and the data for fresh islets may not be
representative. At 240 C, fractional OCR recoveries for non-adherent rat and human fresh
islets were 0.63 ± 0.20, and 0.65 ± 0.14, respectively, which are lower than that for non-
adherent cultured/shipped islets, 0.83 ± 0.28. All are significantly less than 1.0 but not
significantly different from their values at 370C.
Comparisons Between Centers
distributions of the OCR/DNA for
different centers are shown in Figure 8.4. Fresh human
lower OCR/DNA values (130 ± 30 nmol/min-mg DNA)
analyzed at MIT on day 0 (p<0.01). These values did not
in culture, and the difference between dates obtained
greater at day 2.
islets isolated and analyzed at
islets at UMN had significantly
than those isolated at JDC and
increase significantly with time
at the two locations was even
0 100 200 300
OCR/DNA
0
Center DayMN 0-2
MIT 2
400 0 100 200
(nmol/min-mg DNA)
n B. Porcine:
50 195 ± 50
8 190 ± 80
300 400
Figure 8.4. Frequency distributions of the OCR/DNA for different centers (MIT,
MN).
Data are for (A) human, and (B) porcine islets. Islets were analyzed right after
isolation and after 2-day culture at the respective centers. The data for day 0 and 2
are combined. n is the total number of islet preparations for which measurements
were made.
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8.2.6 Membrane Integrity by 7-AAD
Frequency distributions of the fraction of cells with impermeable cell membranes
by 7-AAD for day 0 and for non-adherent tissue on day 1 and 2 in culture are shown in
Figure 8.5. On day 0, the fraction of cells with impermeable cell membranes averaged
0.85-0.87 for all human tissue and 0.77 for rat islets, and only rat islets had a substantial
fraction of preparations below 0.8. The fraction increased with time in culture for rat
islets, and did not change for human islets. It also did not change for non-islet tissue
(paired t-test with p = 0.2, and 0.3 for day 1 and 2 respectively), even though the trends
of the means in Figure 8.5 are misleading.
20 . 8. . . . . .
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Figure 8.5. Frequency distributions of the fraction of cells with impermeable cell
membranes by 7-AAD.
Data are for day 0 and for non-adherent tissue on day 1 and 2 in culture for (A) rat,
(B) human fresh, (C) human cultured/shipped islets, and (D) human non-islet tissue.
n is the total number of islet preparations for which measurements were made.
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8.2.7 OCR/cell with Impermeable Cell Membranes by 7-AAD
The value of OCR/cell of each preparation was divided by the fraction of cells
with impermeable cell membranes by 7-AAD for that preparation. The frequency
distributions of this quantity, denoted as OCR/(cell)MI, for day 0 and for non-adherent
tissue on day 1 and 2 in culture are shown in Figure 8.6. Conversion of OCR/cell data to
OCR/(cell)MI had only a small and inconsistent effect on COV for the distribution, and
introduced divergences into the value after 2 days in culture.
To further explore the relationships between OCR and membrane integrity
measurements, OCR/DNA measurements are plotted versus the fraction of cells with
impermeable cell membranes by FDA/PI staining and 7-AAD in Figure 8.7. Whereas
OCR/DNA measurements varied from about 150 to 700 nmol/min-mg DNA for rat islets,
100 to 350 nmol/min-mg DNA for human islets, and 100 to 500 nmol/min-mg DNA for
porcine islets, values of membrane integrity from FDA/PI staining and 7-AAD sequential
staining were always in excess of 70%, except for a few lower values for rat islets.
8.2.8 Purity
The mean islet volume fractions (0Ij) were 0.64 ± 0.12 (range 0.43 to 0.79) and
0.67 ± 0.09 (range 0.58 to 0.82) for fresh and cultured/shipped human islet preparations
on day 0, respectively (Table 8.3). These values fall within the range reported for typical
clinical preparations. Dr for non-adherent tissue increased on day 2 compared to day 0;
the effect was significant only for fresh tissue. The P cell volume fraction exclusive of
vascular space ((Ipxv) was higher for cultured/shipped islets (0.41 1 0.03) than for fresh
islets (0.33 + 0.03) on day 0. On day 2, (Dpxv increased for non-adherent tissue and
decreased for adherent tissue. The differences were larger for fresh islets. The number
fraction 0 cells (fp), which was calculated from 0I1 and Dpxv as outlined in Appendix B,
follows a similar trend. Combining fp and nuclei recovery measurements (Appendix B)
revealed that the fraction of original P cells recovered from culture (Fp) was significantly
higher for non-adherent tissue than adherent tissue, but was less than 1.0 even when the
fractions were combined. A loss of about 30% P cells was observed for cultured/shipped
tissue while a much larger loss, about 65% was observed for fresh tissue though only two
data points were available.
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Figure 8.6. Frequency distributions of OCR/membrane-impermeable cell.
Data are for day 0 and for non-adherent tissue on day 1 and 2 in culture for (A) rat,
(B) human fresh, (C) human cultured/shipped islets, and (D) human non-islet tissue.
n is the total number of islet preparations for which measurements were made.
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Figure 8.7. OCR/DNA versus fraction of cells with impermeable cell membranes by
FDA/PI staining and 7-AAD for (A) rat islets, (B) human fresh islets from UMN and
JDC, and (C) porcine islets from UMN.
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8.3 Discussion
In this study, we used previously-developed quantitative methods (Chapters 3, 5,
6, and 7) to measure quantity (nuclei counts, DNA content), purity (volume fraction islets
and 0 cells), viability (OCR), and membrane integrity for islet and non-islet preparations
of different species (rat, human, and porcine) from different islet isolation centers before
and after culture at different temperatures (240C and 370C). Measured values were
expressed on a per cell basis when appropriate. We also estimated the recovery of total
tissue, viable tissue, and P cells after 2-day culture for non-adherent and adherent tissue.
This is the first study to report this comprehensive set of quantitative parameters with a
large number islet preparations before and after culture.
On day 0, fresh islet tissue had DNA values close to 6.5 pg DNA/cell
(Figure 8.1 and Table 8.1), which is the value expected for rat (74) and human (75) cells.
The higher value for cultured/shipped human islets likely reflects residual, undegraded
DNA. With time in culture, DNA/cell did not change for rat islets but increased for fresh
human islet and non-islet tissue and decreased for cultured/shipped islets. This behavior
is consistent with the notion that the cell death process had proceeded to a greater extent
when the cultured/shipped samples were received and that subsequent behavior in culture
reflected greater cell death in fresh human islets as a result of stresses imposed during the
isolation process.
Losses of tissue during culture, as measured by nuclei counts, were substantial.
After culture for 2 days, the non-adherent tissue collected accounted for about 2/3, 1/3,
and 1/2 of the rat, human fresh, and human cultured/shipped islet preparation,
respectively, placed into culture at day 0. Recovery of non-adherent non-islet tissue was
about 40%. The non-adherent fraction of human islet tissue is the part currently used for
both research purposes and clinical transplantation. When the adherent tissue (20-30% of
the original tissue) is included, the fraction of the original tissue that was actually lost
was about 1/3 for rat and fresh human islets and 1/5 for cultured/shipped islets. At 240 C,
a substantially larger fraction of the original tissue was recovered as the non-adherent
fraction especially for fresh human islets (0.83), consistent with previous reports for
human (207) and porcine islets (208). Thus, from the same original preparation, the
amount of tissue recovered after 2 days at 240C was more than double that at 370 C.
Culture at 240 C did not result in significant adherence and thus could explain the higher
tissue recovery. In addition, since the combined tissue recovery was also lower at 370 C
than non-adherent tissue recovery at 240C, it is likely that there are slower rates of DNA
and nuclei degradation at reduced temperature.
Trends with DNA measurements were similar but not as sharp and often with
lower p values. Nonetheless, measurements with both methods are desirable because
DNA/cell estimates provide a measure of the extent of recent cell death.
OCR/cell and OCR/DNA of human tissue (islet and non-islet) was lower than that
of rat on day 0 likely because of the harsher isolation procedure. After 2-day culture at
MIT in 370 C rat and human OCR/cell values of non-adherent islet and non-islet tissue
were similar indicating that tissue respiration in stable, undamaged tissue is similar for
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different cell types and for rat and human tissue. However, porcine islets, both from MIT
and MN, had a lower OCR/DNA than rat and human islets (MIT), suggesting there could
be intrinsic differences in respiration between certain species. The OCR/cell values we
obtained are within the range of values reported in the literature for intact islets of
different species measured by different methods, 2 - 3.5 fmnol/min-cell (data converted to
similar units for comparison purposes) (79, 155, 171, 173, 209-211). One study reports
lower values (0.3-0.5 fmnol/min-cell) but the measurements were made with a system of
unreliable accuracy (172).
Human islets from MN had a lower OCR/DNA than those analyzed at MIT that
could be explained by differences in the isolation and/or culture procedure for which
temperature and density can have large effects. The effect of temperature is supported by
the lower OCR/cell and OCR/DNA measurements obtained on day 2 at 240C compared
to 370 C for rat, human fresh, and cultured/shipped islets. Decreases in membrane
integrity and cellular function (stimulation index) have been observed following reduced
temperature culture (207, 208). The lower OCR/cell following 240 C culture could also be
an indication that the respiration of the tissue has not acclimated to 370 C or that the
reduced culture temperature has permanently changed cellular machinery resulting in
cells that require less oxygen as previously suggested (212) bringing up questions about
changes in cellular function. Brandhorst et al concluded that 370 C culture of porcine
islets resulted in superior insulin content, secretion, and dynamic response to glucose as
compared to culture at 220C (208), which is consistent with results for human islets (207)
suggesting that 370C culture maintains islet function better than reduced culture
temperatures.
OCR recovery of non-adherent human non-islet tissue was lower than that of non-
adherent fresh human islets. When accounting for both non-adherent and adherent tissue
the total OCR recovery of cultured/shipped tissue was about 1 indicating no loss in viable
tissue, while fresh tissue resulted in an average 25% decrease in viable tissue during
culture, probably because tissue had not completed the cell death process initiated during
isolation. OCR recovery for rat islets was less than 1 either because of loss of viable
tissue during culture for similar reasons as fresh human islet tissue or because adherent
tissue was not analyzed, though based on visual observations very little tissue adhered.
The fraction of cells with impermeable cell membranes by 7-AAD for fresh rat
islets was lower than that for human tissue. A possible explanation could be that human
non-islet cells are less susceptible to damage on their membrane integrity than islet cells.
The fraction of cells with intact membranes spans a narrower range than respective
OCR/DNA measurements for rat, human, and porcine islets (Figure 8.7). This behavior is
consistent with our findings that OCR, a mitochondrial function assay, is an earlier
indicator of cell death than membrane integrity tests (Chapter 9).
If the fraction of membrane-impermeable cells in islets 4 hr after isolation or
receipt actually represented the fraction of viable cells, the OCR/viable cell or
OCR/DNA for viable cells can be calculated. Because the spread of the distributions
(Figure 8.6) was wider than those of the OCR/cell and the fraction of cells with
impermeable cell membranes by 7-AAD, it is suggested that the normalization of OCR
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with 7-AAD does not result in a unique value for OCR of viable cell. If islet and non-islet
tissue 4 hr after isolation are still recovering from damage incurred during the isolation
process, then the fraction of cells that are viable (as assessed, for example, by a
mitochondrial function assay such as OCR) is likely to be much smaller than that inferred
from membrane integrity measurements, as will be observed in Chapter 9, because
permeabilization of the cell membrane occurs relatively late in cell death processes (213).
The islet volume fraction of the non-adherent fresh human islets increased in
culture because non-islet tissue preferentially adhered to the flask, consistent with a
lower 1 cell volume fraction exclusive of vascular space. In cultured/shipped tissue about
30% of the original P cells were lost in culture though they were likely dead prior to
culture since the OCR recovery was almost 1. This could also be attributed to P cell
dedifferentiation that would cause loss of insulin expression (214).
This chapter provides the basis for a complete understanding of islet and non-islet
tissue behavior in culture, at different temperatures, in terms of purity, quantity, viability,
and p cell fraction. Other methods on islet characterization have intrinsic shortcomings
that render them inappropriate and unreliable for islet assessment prior to transplantation.
In order to obtain the 0 cell viability index that Ichii et al. (66) introduced, islets needed
to be dissociated, which has been shown to result in samples not representative of the
original islet (52). The study of ATP/ADP ratio by Goto et al. (187) is hindered by the
extreme sensitivity of the assay to changes in environmental conditions (temperature,
pO2, pH, etc) and therefore it can be quite difficult to use the assay to get an accurate
prediction, especially with islets that are large aggregates, and cells in the outer and inner
regions may experience very different microenvironments depending on the assay
conditions (16, 215). Finally, even though Guarino et al. (171, 216) used oxygen
consumption rate measurements as an islet assessment method, the system they chose to
use, BD OBS, is offset by difficulties in obtaining accurate and meaningful OCR
estimates. Reported OCR values measured with the OBS do not agree with measurements
made with other methods and therefore render the assay questionable.
Contributions: The data from the University of Minnesota were provided by Dr.
Klearchos K. Papas and Phillip Rozak.
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Chapter 9.
Dynamics of Cell Death Evaluated by
Mitochondrial Function, Apoptosis, and
Membrane Integrity Assays
Cell viability is a fundamental property, measured in biological research, medical
diagnosis, and treatment of disease. The methods available assess different properties of
living cells. When cells are under stress, these properties may display different temporal
behavior, and it is important to understand how the data from different measurements
relate to each other.
This issue is important in transplantation of primary tissue obtained from
cadavers, especially for transplantation of islets of Langerhans, which is considered a
promising treatment for type 1 diabetes (4, 9, 10, 98, 132-134). Islets are exposed to
stress in the body after brain death and from the retrieval and storage of the organ, warm
and cold ischemia, mechanical and enzymatic stress during isolation, and oxygen and
nutrient starvation during culture and shipping. The current method for islet viability
assessment is membrane integrity staining with fluorescein diacetate (FDA) and
propidium iodide (PI) (123), which usually results in estimates of fractional viability
above 80% and does not predict transplantation outcome (21, 83, 102).
The need to characterize the viability of primary islet tissue that has been exposed
to lethal stress motivated us to examine the dynamics of cell death by different assays.
We hypothesized that assays that measure properties at different stages of cell death
would provide different assessments of viability. To test this hypothesis, we examined
the temporal response of two cell lines and of rat and human pancreatic islets that were
undergoing exposure to stress using three different types of assays, mitochondrial
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function, apoptosis events, and membrane integrity, and we examined different methods
for each type of assay.
We used four methods to examine mitochondrial function: (1) Oxygen
consumption rate (OCR) was measured in a stirred microchamber that we developed for
use with islets (Chapter 7). OCR is a direct measure of the rate of oxidative
phosphorylation and is directly proportional to the number of viable cells in a sample.
(2) A viable cell has a pool of ATP available for cellular energy-requiring processes,
whereas a dead cell does not, and measurement of ATP content was exploited for assay
of cell viability (217). (3) Reduction of the tetrazolium salts MTT and MTS to form a dye
molecule with an absorbance spectrum different from the parent dye was used to
distinguish viable from non-viable cells (125). This technique has been applied to the
viability assessment of islets (127). Two methods were used to detect apoptotic events,
annexin V and multicaspase activation. Annexin V, a protein that binds with a high
affinity to phosphatidylserine PS was used together with PI to detect translocation of (PS)
from the inner to the outer side of the cell membrane, which occurs during the early
stages of apoptosis (54). The amount of activated caspases was measured as another
marker of early apoptosis (218). Lastly, we studied a combination of four different dyes
or dye combination to measure membrane integrity, trypan blue staining, LDS 751/Sytox
Orange, fluorescein diacetate/propidium iodide (FDA/PI), and 7-aminoactinomycin D (7-
AAD).
9.1 Materials and Methods
9.1.1 Culture of Cell Lines and Islets
Rat insulinoma INS-1 cells (118), with passage numbers 20-30, were cultured in
tissue culture flasks in RPMI medium with 11.1 mM D-glucose (Mediatech, Herndon,
VA, USA) supplemented with 10% (v/v) fetal bovine serum (FBS, Mediatech), 100 U/ml
penicillin (P3539, Sigma-Aldrich, St. Louis, MO, USA), 100 jtg/ml streptomycin
(Sigma), 10 mM HEPES (Mediatech), 2 mM L-glutamine (Mediatech), 1 mM sodium
pyruvate (Mediatech), and 50 pM P-mercaptoethanol (Sigma). Human T-lymphocyte
Jurkat cells were cultured in tissue culture flasks in the same supplemented RPMI
medium used for INS-1 cells. Jurkat cells grew in suspension unlike INS-1 cells that
grew attached to the surface of the flasks.
Rat and human islets were provided by the Islet Core at the Joslin Diabetes Center
(Boston, MA). Rat islets were isolated from male Sprague-Dawley rats by collagenase
digestion/ficoll purification (37, 174). Standard collagenase/protease digestion was used
for human (4, 33) islets. Islets were cultured in untreated tissue culture flasks with a
surface culture density of 20 islet equivalents (IE)/cm2 (or 0.35% surface coverage) and a
medium depth of 1.3 mm in a 370 C incubator with 5% CO2. The supplemented RPMI
medium used for INS-1 and Jurkat cells was also used for islets.
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9.1.2 Cell Suspension Preparation
INS-I cell suspensions were prepared as previously described in Chapter 5, with
slight modifications to make sure all cells were collected. Briefly, the medium was
removed from the tissue culture flasks, and 0.05 ml/cm2 of 0.05% (w/v) trypsin in
0.53 mM EDTA solution (Mediatech) were added and incubated at 370C for 3 min.
Culture medium (0.13 ml/cm 2) was added in order to deactivate the trypsin and cells were
detached by gently tapping the flask, collected in a tube, centrifuged at 300xg for 3 min
(AllegraTM 21R Centrifuge, Beckman Coulter), and resuspended in fresh medium. By not
removing the trypsin before adding culture medium, we made sure all cells were
collected. Jurkat cell suspensions were removed from the tissue culture flask, centrifuged
at 300xg (AllegraTM 21R Centrifuge, Beckman Coulter) for 5 min, and resuspended in
fresh medium. The resulting cell suspensions were stored on ice until used.
9.1.3 Cell and Islet Enumeration by Nuclei Counting
Nuclei were prepared from cells and islets, as previously described in Chapter 5,
by adding equal 100-tl volumes of sample and of a lysis solution containing 0.1 M citric
acid (Sigma) and 1% (v/v) Triton X-100 (Sigma) to a 1.5 ml microtube. The mixture was
incubated at room temperature for 5 min with vortex mixing every 1.5 - 2 min. The islet
mixture was then placed in a 1-ml syringe and rapidly forced through a 26G3/8 needle
(Becton Dickinson, Franklin Lakes, NJ) 10 consecutive times. For each sample analyzed,
105 cells and 160 IE (2.5x105 cells) were used. Isolated nuclei were diluted with
Dulbecco's Phosphate Buffered Saline (D-PBS, Invitrogen, Carlsbad, CA) to a
concentration no higher than 5x10 5 nuclei/ml, stained with 7-aminoactinomycin D
(7-AAD, Molecular Probes, Eugene, OR), and then analyzed using a flow cytometer
(Guava Personal Cell Analysis (PCA) system, Guava Technologies, Hayward, CA). The
data were reported as the total number of cells in the sample. A conversion factor of
1560 cells/IE (Chapter 2) was used to calculate number of IE from nuclei counting data.
9.1.4 Stresses and Mechanisms
Cells or islets were cultured under stressful conditions for specified time periods,
after which they were immediately analyzed by different assays. Stress was applied to
staggered parallel cell cultures initiated at different times; the end of stress exposure
coincided for all samples, which were analyzed simultaneously. All islet experiments
were initiated about 4 hr after isolation was completed. In experiments with cells,
samples to be used as controls were cultured under normal conditions without application
of stress and were analyzed at the end of the full time course when samples from all of
the different time points were analyzed. In experiments with islets, the unstressed control
samples were analyzed at the beginning of the experiment when stress exposure was
initiated. These stresses provided different mechanisms through which cell damage
occur. Islets were stressed by exposure to anoxia, which is encountered during pancreas
storage, islet isolation, high-density culture, and shipping. Anoxic conditions were
achieved in an incubator purged with 5% CO2 and 95% N2. Because the cell lines were
resistant to anoxia (175), alternative stresses were used. Cell death was induced in INS-1
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cells with 5 mM streptozotocin (STZ, Calbiochem, LA Jolla, CA) (219, 220), and with
1 pM camptothecin (MP Biomedicals, Aurora, OH) in Jurkat cells (221).
Anoxia causes oxygen starvation that shuts down oxidative phosphorylation,
depletes ATP, and leads to apoptosis and necrosis. STZ induces apoptosis at low
concentrations (<20 mM) and necrosis at high concentrations (>20 mM) (219, 220) in P
cells, similar to its concentration-dependent effects in vivo (222, 223), by causing DNA
strand breaks (222) by mechanisms that are not well understood. A p53-dependent
pathway, similar to the mechanism of other cytotoxic drugs (224), has been suggested.
Camptothecin induces apoptosis in Jurkat cells by causing single strand DNA breaks that
are covalently linked to DNA topoisomerase I and inhibiting the catalytic activity of
DNA topoisomerase I (225).
9.1.5 Assessment Methods
Mitochondrial function was evaluated with measurements of oxygen consumption
rate (OCR), ATP content, and MTT and MTS reduction. Apoptosis events were
evaluated using caspase activity and annexin-V binding assays for cell suspensions.
Membrane integrity was evaluated through staining with fluorescein diacetate/propidium
iodide (FDA/PI), trypan blue, SYTOX Orange/LDS 751, and 7-aminoactinomycin D
(7-AAD). At least one assay of each of the three types was performed in all cell
experiments, apoptosis events were not assayed with islets.
a) Mitochondrial Function Assays
(1) Oxygen Consumption Rate (OCR)
Oxygen consumption rates were measured as previously described in Chapter 7.
Briefly, cells or islets were resuspended in DMEM (Mediatech, Herndon, VA, USA)
containing 4.5 g/l glucose and 0.6 g/l L-glutamine without serum supplemented with
100 U/ml penicillin (Sigma-Aldrich), 100 jtg/ml streptomycin (Sigma), and 10 mM
HEPES (Mediatech), then placed and sealed in a 200-til stirred titanium chamber (Micro
Oxygen Uptake System, FO/SYSZ- P250, Instech Laboratories, Plymouth Meeting, PA)
maintained at 370C. The time dependent oxygen partial pressure (pO2) within the
chamber was recorded with a fluorescence-based oxygen sensor (Ocean Optics, Dunedin,
FL), and the data at high pO2 were fit to a straight line. The maximal OCR was evaluated
from OCR = Veh a (ApO 2/At), where Vch is the chamber volume and
a = 1.27 nmol/mmHg-ml is the Bunsen solubility coefficient for oxygen in medium
(176).
(2) MTT and MTS
Viability of cells or islets was measured with two water soluble tetrazolium
compounds, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) using
the Vybrant® MTT Cell Proliferation Assay Kit (Molecular Probes), and 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetraolium,
inner salt (MTS) using the CellTiter 96® Aqueous Non-Radoactive Cell Proliferation
Assay kit (Promega G5421). After centrifugation of the sample and aspiration of
supernatant, a known number of cells or islets (between 10 - 25x104 cells/well or
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65-160 IE/well) was resuspended in 100 tl of D-PBS containing 20 mM glucose (MTT)
or 100 [l culture medium (MTS) and transferred to the wells of a 96 well plate. For
MTT, 20 tl of 5 mg/ml MTT reagent (Molecular Probes) was added to each well, and the
plate was incubated at 370C for 4 hr in a humidified chamber. A 100 tl volume of a lysis
solution (9% (w/v) sodium dodecyl sulfate in 0.01 M HC1) was added to each well and
incubated at 370 C for about 18 hr in a humidified chamber to dissolve the precipitates.
The absorbance was measured at 570 nm in a plate reader (FLUOstar/POLARstar
Galaxy, BMG Labtechnologies Durham, NC). The MTT absorbance was directly
proportional to the number of viable cells. For MTS, 20 tl of the combined electron
coupling reagent phenazine methosulfate (PMS) and MTS solution (MTS/PMS) was
added to each well. The absorbance was measured at 490 nm at 10 min intervals for
90 min in an ELISA plate reader (FLUOstar/POLARstar Galaxy, BMG Labtechnologies,
Durham, NC). The slope (rate of increase of absorbance with time), determined by linear
least squares regression, was proportional to the number of viable cells.
(3) ATP Concentration
Adenosine triphosphate (ATP) was measured with a luminescence assay
(CellTiter-GloTM Luminescent Cell Viability Assay, Promega). A known number of cells
or islets was resuspended in 100 gil of medium and transferred to wells of an opaque-
walled 96 well plate (cell density < x10 4 cells/well or 30 IE/well). Background
luminescence was measured with control wells contained only medium. Cells were
equilibrated at room temperature for 20 min, 100 jtl of CellTiter-GloTMI reagent (Promega
G7510) was added to each well, and the plate was agitated for 1 hr to lyse all cells and
stabilize the luminescence signal, which was read at 250C using a plate reader
(FLUOstar/POLARstar Galaxy, BMG Labtechnologies, Durham, NC). With islets,
readings were recorded every 2 hr to ensure all cells were lysed and the luminescence
signal was stable. Steady state was usually reached within the first 2 hr.
In the experiments with both cell lines, the number of cells in the cultures under
stress decreased with time to about 60% of their initial value. To permit comparison
between results of different experiments with the mitochondrial function assays, the
parameter measured was normalized by the total number of cells used in the
measurements (determined by nuclei counting) to give the parameter value per cell.
b) Apoptosis Events Assays
(1) Annexin V
Apoptosis was assayed with the Guava Nexin Kit (Guava Technologies,
Hayward, CA) based on the binding of annexin V-PE, a fluorescently labeled cell-
impermeable molecule, that binds to phosphatidylserine after translocation from the
internal to the external cell membrane surface early during apoptosis. To 40 p.l of cell
suspension in Nexin buffer was added 5 p.l of annexin V-PE and 5 ptl of 7-AAD, a
fluorescent dye that binds with high affinity to nucleic acids. Samples were incubated for
20 min on ice and analyzed by flow cytometry (Guava PCA) to determine the fraction of
cells undergoing early (7-AAD-/annexin +) and late (7-AAD+/annexin ÷) apoptosis.
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(2) Multi-caspase Activation
Apoptosis was also assayed with the Guava MultiCaspase Kit (Guava
Technologies) using sulforhodamine-valyl-alanyl-aspartyl-fluoromethylketone (SR-
VAD-FMK), a fluorochrome-conjugated inhibitor of caspases that penetrated all cells but
bound only to active caspases and was washed away from non-apoptotic cells. To 100 pl
of cell suspension in Apoptosis Wash Buffer was added 5 pl SR-VAD-FMK. After
incubation for 1 hr at 370C, cells were washed three times, 5 •l of 7-AAD was added, and
each sample was incubated for 10 min at room temperature. Samples were analyzed by
flow cytometry (Guava PCA) to determine the fraction of cells undergoing early
(7-AAD-/ SR-VAD-FMK ÷) and late (7-AAD+/ SR-VAD-FMK ÷) apoptosis.
c) Membrane Integrity Assays
Different vital dyes were used to assess membrane integrity (Table 9.1).
(1) Trypan Blue
Cell suspensions were stained with 0.4% (v/v) solution of trypan blue (Sigma)
and diluted with D-PBS to a concentration between 5 and 15x10 5 cells/ml. A 12 •l
sample was placed on a hemacytometer slide; stained and unstained cells were counted
using 40x magnification with a Zeiss Photo 3 microscope. The fraction of cells with
compromised membranes was calculated as the number of cells stained divided by the
total (stained and unstained) number of cells.
(2) Sytox Orange/LDS 751
Cell suspensions were stained with a solution (in D-PBS) containing 0.8 gM LDS
751 (Molecular Probes), a membrane permeable dye and 0.2 pM Sytox Orange
(Molecular Probes), a membrane impermeable dye. LDS 751 was dissolved in dimethyl
sulfoxide (DMSO). Samples with a cell concentration no higher than 5x10 5 cells/ml were
incubated for 5 min at room temperature and analyzed in a flow cytometer (Guava PCA)
using the Guava Viacount software. The fraction of cells with compromised membranes
was the ratio of the number of cells stained with Sytox Orange over the number of cells
stained with LDS 751.
(3) 7-AAD Differential Staining
Differential staining before and after cell disruption was used with 7-AAD
fluorescent dye as described in Chapter 6. Briefly, cell suspensions were stained with
0.05 mg/ml 7-AAD to label all nuclei in cells with compromised membranes. Unbound
7-AAD was removed by washing. Cells were disrupted with a lysis solution (0.1M citric
acid and 1% Triton X-100), combined with vortex mixing for cells or shearing through a
needle for islets, and the number of labelled nuclei was counted (N 1) using a flow
cytometer (Guava PCA). A portion of the nuclei suspension was further stained with
7-AAD, thereby labelling all the previously unlabelled nuclei, and the total number of
nuclei was counted (N2). The fraction of cells with compromised membranes was
estimated as the ratio of the initially stained nuclei (NI) to the total number of nuclei
(N2).
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(4) Fluorescein Diacetate (FDA)/Propidium Iodide (PI)
Cell suspensions were stained with a final concentration of 50 gg/ml fluorescein
diacetate (FDA, F7378, Sigma), first dissolved in DMSO, and 50 gg/ml propidium iodide
(PI, P4864, Sigma) in D-PBS (Invitrogen) prepared the day of use. Tissue was incubated
for 30 min before examination under a fluorescent microscope. Cells stained bright red
with PI or cells stained bright green with FDA were separately counted on a
hemacytometer slide using a Zeiss Photo3 microscope. The total number of cells was
counted using visible light. The fraction of cells with intact membranes was the number
of cells stained with FDA divided by the total number of cells. The fraction of cells with
compromised membranes was the number of cells stained with PI divided by the total
number of cells. In some instances, some cells displayed a weak fluorescent signal. Only
cells that were brightly stained were counted. For islet preparations, the same staining
procedure was followed and the volume fraction of cells containing nuclei stained red
(PI) was visually estimated.
9.1.6 Statistics
All data are reported as mean values of triplicate measurements, unless otherwise
indicated. Error bars in figures with averaged data represent + standard deviation
(STDEV) and are smaller than data points if not shown.
9.2 Results
The results of individual experiments for the Jurkat cells, INS-i cells, and islets
are plotted in Figure 9.1, Figure 9.2, and Figure 9.3 respectively, versus the time of stress
exposure. In each panel, ordinate is the fraction of apoptotic cells, the relative fraction of
viable cells from mitochondrial function, or the relative fraction of cells with intact
membranes. To obtain the relative fraction quantities, mitochondrial function and
membrane integrity data were normalized by the value of the control in each experiment
in order to facilitate comparison between data from different preparations of cells and
islets. Data from experiments started with the same preparation of cells are represented
by a single symbols shape (circle, square, triangle, upside down triangle). Filled and half-
filled symbols are used when more than one assay of a certain type is performed.
The fraction of cells that displayed apoptotic events increased with time following
initiation of stress. Apoptosis assessed by annexin V binding increased more rapidly than
multi-caspase activation for Jurkat cells (Figure 9.1A), while the opposite was true for
INS-1 cells (Figure 9.2A), but the differences were small. The relative fraction of viable
cells measured by mitochondrial function decreased with time. The data from all the
mitochondrial function assays used with both cell lines (Figure 9.1B and Figure 9.2B)
and islets (Figure 9.3A) clustered together. Because the stress exposure time required to
achieve substantial cell death was much longer for the Jurkat/camptothecin combination
than for the INS-1/streptozotocin combination, and the rate at which cells died was
slower, an experiment of 18 hr duration was carried out to investigate the early time
behavior of the former in greater detail. With Jurkat cells the fractions of apoptotic and
viable cells did not change significantly until about 4 hr, followed by a rapid increase in
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apoptotic fraction (Figure 9.1A) and decrease in fractional viability (Figure 9.1B). A less
pronounced time lag of the same magnitude was observed before apoptosis increased
with INS-i cells (Figure 9.2A), but no time lag was observed with mitochondrial function
assays with either INS-1 cells (Figure 9.2B) or islets (Figure 9.3A).
In contrast to the behavior of apoptosis and mitochondrial function, the relative
fraction of cells with intact membranes changed slowly, sometimes preceded by a period
of little or no change (up to 15 hr for Jurkat cells (Figure 9.1C) or 2 hr for INS-1 cells
(Figure 9.2C). Data from all methods clustered together except for FDA (Figure 9.2C),
which was about 20% lower than for PI after 4 hr with INS-1 cells. After 12 hr, the
fraction of cells with intact membranes was about 0.2, which is comparable to the highest
value of fractional viability measured by mitochondrial function at the same time. In
these experiments, FDA and PI were stained simultaneously, and the sum of the fractions
of intact (bright green) and compromised (bright red) membranes ranged from 75 to 90%
of the total number of cells counted with visible light. The remaining cells were in a
population that stained faintly green. A possible explanation for this behavior is that, as
damage progressed, some of the FDA leaked out of the cells before PI reached the
nucleus and stained DNA. For islets, the fraction of cells with compromised membranes
was estimated visually as the volume fraction stained with PI, and FDA was ignored, as
is common in clinical practice.
Data from assays of same type from Figure 9.1, Figure 9.2, and Figure 9.3 were
averaged at similar time points and plotted in Figure 9.4. The average relative fraction of
viable cells (closed circles symbols), the average relative fraction of cells with intact
membranes (closed triangles), and the average fraction of apoptotic cells (closed squares)
for all assays of the same type for all experiments are plotted against the time of stress
exposure for (A-B) Jurkat cells stressed with 1 p.M camptothecin, (C-D) INS-1 cells
stressed with 5 mM streptozotocin, and (D) rat and human islets cultured under anoxia.
Error bars represent the standard deviation of all data points from the different
experiments. The mean OCR/cell for the control samples was 4.2 ± 0.3,
2.7 ± 0.4 fmol/min-cell for Jurkat and INS-1 cells respectively and 4.2 ± 0.9,
1.7 ± 0.1 fmol/min-cell for rat and human islets respectively.
The average fraction of apoptotic cells averaged about 0.9 at the end of the
experiments with cells and about 0.1 for Jurkat cells and 0.3 for INS-1 cells at the
beginning. The higher initial fraction of apoptotic cells for the INS-1 cell line may have
been caused by the prior step of trypsinization, a harsh enzymatic process that can lead to
some extent of cell death (226), a step not required for Jurkat cells. At the end of the
experiment, the relative fractional viability by mitochondrial function averaged about 0.1
for both cells lines and 0.2 for islets, whereas the relative fraction of cells with intact
membranes averaged about 0.6 for Jurkat cells and 0.4 for INS-1 cells and islets. For both
cells and islets, there was an initial period during which fractional viability by
mitochondrial function decreased relatively rapidly while there was little change in
membrane integrity, leading to very large differences in assessment of the response to
lethal stress. For example, for both Jurkat cells and islets, after about 12 hr of exposure,
the relative fraction by membrane integrity was about 0.95 whereas that by mitochondrial
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function was less than 0.5. The data suggest that the relative fraction of cells with intact
membranes would have eventually attained a low, steady value comparable to fractional
viability measured by mitochondrial function after a time period that depended on the
nature of the cells and the type of stress. Preliminary studies with INS-1 cells cultured
under anoxia suggested that membrane integrity measurements stabilized within 24 hr
(175).
The Relative fraction of viable cells by mitochondrial function and the fraction of
cells that are not apoptotic from Figure 9.4 versus time of stress exposure are plotted
together in Figure 9.5, which demonstrates the striking correlation between the
progression of apoptosis and the loss of mitochondrial function in the two cell line-stress
combinations investigated
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Figure 9.1. Data from Jurkat cells plotted versus time of exposure to 1 pM
camptothecin.
(A) Fraction of apoptotic cells, (B) relative fraction of viable cells by mitochondrial
function, (C) relative fraction of cells with intact membranes.
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Figure 9.2. Data from INS-1 cells plotted versus time of exposure to 5 mM
streptozotocin.
(A) Fraction of apoptotic cells, (B) relative fraction of viable cells by mitochondrial
function, (C) relative fraction of cells with intact membranes.
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Figure 9.3. Data from islets plotted versus time of exposure to anoxia.
(A) Relative fraction of viable cells by mitochondrial function, (B) relative fraction
of cells with intact membranes.
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Figure 9.5. Data from mitochondrial function and apoptotic events assays averaged
at similar time points and plotted versus time of stress exposure.
The average relative fraction of viable cells by mitochondrial function (open circles)
and the average fraction of non-apoptotic cells (filled triangles) from Figure 9.4 are
plotted versus the time of stress exposure for (A) Jurkat cells stressed with 1 PM
camptothecin, and (B) INS-1 cells stressed with 5 mM streptozotocin. The fraction
of non-apoptotic cells = 1 - fraction of apoptotic cells.
9.3 Discussion
In this chapter, we hypothesized that viability assays of different types, which
detect the cell death process at different stages, would provide different temporal
assessments of viability if cells or tissue that had veeb exposed to lethal stress. To test
this hypothesis, we examined the temporal behavior of cells and islets that were stressed
and detected cell death by assays that measure apoptotic events, mitochondrial function,
and membrane integrity. We investigated two different cell lines, one anchorage
dependent (INS-1), and one anchorage independent (Jurkat), as well as rat and human
islets. We applied a different lethal stress to each cell line and to the islets.
In each set of experiments (INS-1, Jurkat cells, and islets), the results of different
mitochondrial function assays (OCR, ATP, MTT, and MTS) were closely clustered and
followed the same trend (Figure 9.1B, Figure 9.2B, Figure 9.3A) as did the results for
membrane integrity assays (Figure 9.1C, Figure 9.2C, Figure 9.3B), but the behavior of
the two assay types diverged sharply. After a very short lag period, fractional viability by
mitochondrial function decreased continuously and relatively rapidly, whereas the
fraction of cells with intact membrane integrity varied slowly at first and began to
decrease rapidly only at longer times (Figure 9.1 C and Figure 9.2C). The time scale over
169
4 r)
which the cells or islets underwent the cell death process varied with the combination of
cell type and stress. However, in all three cases, there was always a range of time over
which fractional viability by mitochondrial function was much lower than the fraction of
cells with intact membranes. Early apoptosis events displayed a longer initial lag and
then followed the time course of mitochondrial disfunction.
The striking correlation between relative fractional viability and fraction of
apoptotic cells (Figure 9.5), and the disparity relative to membrane integrity, is consistent
with the notion that early apoptosis and mitochondrial disfunction are closely connected,
whereas compromise of cell membranes occurs later in the cell death process (213). As a
consequence, assays of mitochondrial function identify cells that are committed to the
cell death process, even though they remain intact and are identified as alive by
membrane integrity tests. It is conceivable that the damage caused by the stress in our
experiments might be reversed by removal of the stress at an early time, but this
possibility has not yet been explored.
These findings have important implications for assessing the viability of tissue
that is, or has recently been, subject to lethal stress. A prime example is human islet
tissue for transplantation. The isolation process is a harsh mechanical and enzymatic
procedure that lasts about 8-12 hr prior to which the pancreas is removed from the
cadaver, and then stored in chilled preservation solution. During this period, which likely
totals at least 10-15 hr or more, islet tissue is exposed to periods of deep hypoxia,
probably also anoxia. The data in Figure 9.5 suggests that 50% or more of the tissue may
have suffered mitochondrial disfunction by the time the isolation process is complete, and
the effects of stress exposure would persist substantially longer. This scenario is
consistent with our findings that (1) OCR/cell for islet tissue measured 4-6 hr after
isolation is complete covers a wide range, whereas measurements of membrane integrity
immediately after isolation indicate 80 - 95% islets with intact membranes, and
(2) freshly isolated islets undergo a substantial loss of tissue in subsequent culture, as
shown in Chapter 8.
The relevance of mitochondrial function measurements to islet viability
assessment is reflected in recent studies examining the utility of mitochondrial membrane
potential (66), ADP/ATP ratio (187), and OCR (182) measurements for correlating the
results of transplantation experiments. Studies of this type are likely to lead to
improvements in islet isolation procedures and our ability to predict transplantation
outcome.
Contributions: Some of the experiments with INS-1 cells presented are a contribution of
a team of undergraduate students at the Chemical Engineering Department at MIT that
worked on the study as part of one of their classes (Hana Oh, Rachel Livingston, Kristin
Smith, and Luis Abrishamian-Garcia). The Jurkat cells were a gift from Dr. Jeff Harvey,
Guava Technologies, Hayward, CA.
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Chapter 10.
Stimulation with Exogenous Substrates
During Oxygen Consumption Rate
Measurements
Islet transplantation is emerging as a promising potential for treatment of type 1
diabetic patients. Despite the major advances in the field that followed the early success
of the Edmonton Protocol (4), there are no islet quality tests that can predict the
transplantation outcome (3, 5, 9). Among the most important qualities of islet tissue that
need to be known prior transplantation are purity, quantity, viability, and function. In the
previous chapters we focused on the first three quantities (Chapters 2, 3, 5, 6 and 7). In
this study, we will focus on the fourth property, function, and the correlation of function
with oxygen consumption. It has been suggested that information on islet function (such
as the change in OCR with glucose stimulation, AOCR) may be useful for predicting
transplantation outcome (211). Islet function can be assessed through glucose stimulated
insulin secretion, which plays a crucial role in maintaining glucose homeostasis.
Increases in the oxygen consumption rate upon glucose stimulation in single islets (227,
228) suggest an accelerated rate of f3 cell metabolism accompanying increases in insulin
secretion (229). The link between metabolism and insulin secretion can be studied by
measuring oxygen consumption rate as a function of the conditions that affect insulin
secretion, and glucose concentration is the most obvious one. Similar studies have been
undertaken by a number of other researchers (46, 103, 171, 173) but there is no profound
agreement between their results, partially because of the differences in the systems used
to measure oxygen consumption rate and different conditions during these measurements.
In this chapter, we examined stimulation with glucose as the exogenous substrate
during oxygen consumption rate measurements. An increase in the glucose concentration
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will increase the metabolic activity of islets in glucose free medium (e.g Phosphate-
Buffered Saline, PBS) and thus their oxygen consumption rate. We applied this
hypothesis to both pure (rat, porcine islets) and impure preparations (human islets). We
investigated the maximum change in the OCR after stimulation with the exogenous
substrates as well as the effect of incremental step changes in the glucose concentration
on the OCR. We also examined the effect of stimulation with glucose in media that
differed in their nutrient concentration (DMEM, CMRL, and PBS).
10.1 Materials and Methods
10.1.1 Islet Isolation and Culture
Rat islets were provided by the Islet Core at the Joslin Diabetes Center (Boston,
MA), porcine islets by the University of Minnesota, and human islets by Joslin Diabetes
Center received fresh or other center received after shipment. Rat islets were isolated
from male Sprague-Dawley rats by using collagenase digestion/ficoll purification (37,
174). Standard collagenase/protease digestion methods were used for porcine (40) and
human (4, 33) islets. Islets were cultured in tissue culture flasks in RPMI medium with
11.1 mM D-glucose (Mediatech, Herndon, VA, USA) supplemented with 10% (v/v) fetal
bovine serum (FBS, Mediatech), 100 U/ml penicillin (P3539, Sigma-Aldrich, St. Louis,
MO, USA), 100 [tg/ml streptomycin (Sigma), 10 mM HEPES (Mediatech), 2 mM
L-glutamine (Mediatech), 1 mM sodium pyruvate (Mediatech), and 50 PiM
2-mercaptoethanol (M-7522, Sigma). The islets were cultured in untreated tissue culture
flasks with a surface culture density of 20 islet equivalents/cm2 (or 0.35% surface
coverage) and a medium depth of 1.3 mm in a 370 C incubator with 5% CO 2.
Measurements with rat, porcine, and human islets received from Joslin Diabetes
Center were performed on a fraction of the final preparation transferred in a 50-ml tube
or a T75 flask 4-6 hr after isolation. Measurements with human islets received from other
centers were performed upon receipt after shipment. Some islets were placed in culture
and stimulation measurements were performed after certain days of culture. Cultured
islets were collected and resuspended in Dulbecco's Modified Eagle Medium (DMEM,
Mediatech) with 4.5 g/l (25 mM) glucose, 0.6 g/l L-glutamine and without serum
supplemented with 100 U/ml penicillin (Sigma-Aldrich, St. Louis, MO, USA), 100 pg/ml
streptomycin (Sigma), and 10 mM HEPES (Mediatech), which was the medium used for
basal OCR measurements (Chapter 7), until further analyzed.
10.1.2 Morphological Analysis by Light Microscopy (LM)
Samples for morphological analysis by LM were processed for the measurements
obtained with human islets as described in Chapter 3. Aliquots were taken from the
suspension that was used for the OCR measurements. A 0.5 ml aliquot was fixed in 2.5%
glutaraldehyde 0.1 M phosphate buffer, pH 7.4, divided into two samples, dehydrated,
cleared, embedded in plastic (Araldite), and cured. Blocks were trimmed, and 1-jim
sections were cut, stained with toluidine blue, and examined by LM. Islet tissue was
distinguished from non-islet tissue (exocrine or ganglia) by its cordlike pattern of cells
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often around vascular spaces, lack of visible granulation, and occasional visible small
lipid droplets, whereas the exocrine tissue was in the form of either large sheets of simple
columnar ductal epithelia or clumps of duct and acinar tissue. The acinar tissue in freshly
isolated tissue was granulated with large stained granules. The 1-pLm sections were
analyzed at 420x by stereological point counting (84) with a 90-point grid covering
adjacent, non-overlapping fields. At point intercepts of the grid with tissue, the nature of
the tissue was determined, and the volume fraction of islet tissue was calculated as
previously described in Chapter 3.
10.1.3 Oxygen Consumption Rate (OCR)
Oxygen consumption rates were measured as previously described in Chapter 7.
Briefly, cell or islet suspensions were sealed in DMEM with 4.5 g/1 glucose and 0.6 g/1
L-glutamine without serum (Cellgro), unless otherwise specified, with basal glucose
concentration on 25 mM in a 200-dl stirred titanium chamber (Micro Oxygen Uptake
System, FO/SYSZ- P250, Instech Laboratories, Plymouth Meeting, PA) maintained at
370C. The time dependent pO2 within the chamber was recorded with a fluorescence-
based oxygen sensor (Ocean Optics, Dunedin, FL), and the data at high pO2 were fit to a
straight line. The maximal OCR was evaluated from OCR=Vcha(ApO 2/At), where VCh is
the chamber volume and a is the Bunsen solubility coefficient for oxygen in medium.
The value of a = 1.27 nmol/mmHg-ml was used based on previous measurements (176).
OCR measurements were normalized by the number of cells used in the measurement
(determined by nuclei counting) to give OCR per cell.
10.1.4 Stimulation with Exogenous Substrates During OCR Measurements
Stimulation was studied in different media that varied in their nutrient
concentration. The media studied were Dulbecco's Phosphate Buffered Saline (D-PBS,
Invitrogen, Carlsbad, CA, USA) without any nutrients, DMEM (Mediatech) with
L-glutamine but no glucose or sodium pyruvate (11966-025, Invitrogen) supplemented
with 100 U/ml penicillin (Sigma-Aldrich), 100 p.g/ml streptomycin (Sigma), and 10 mM
HEPES (Mediatech), and CMRL 1066 Supplemented with 5.5.mM glucose (96-603-CV,
Cellgro), the medium used by a lot of islet centers for culture and shipment. Islets were
placed in DMEM (4.5 g/l or 25 mM glucose) without serum upon receipt (day 0) or after
collection from culture and an aliquot of the suspension was washed twice in the medium
the stimulation was going to be performed by centrifuging at 300xg for 3 min (AllegraTM
21R Centrifuge, Beckman Coulter).right before the OCR measurement. This procedure
was chosen in order to minimize storage time in media with no nutrients that would result
in a decrease in the viability of the tissue. The process time for the washes was 10-15 min
for each fresh sample to be used. The storage time on ice before OCR measurements
varied between 0 to 1 hr depending on how many OCR measurements were performed.
To perform stimulation experiments, custom-made sealing plugs that had an opening on
the top (small whole) (Instech Laboratories, Plymouth Meeting, PA) to allow the needle
of an HPLC syringe to fit in were used. Addition of the glucose (D-glucose, 450g/l,
Sigma) was achieved through an HPLC 5 p1l syringe (Hamilton Company, Nevada). A
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small volume of known glucose concentration (made up from the stock solution) was
injected through the syringe in the chamber during the OCR measurements. The injected
volume was small (- 0.5 gl) to prevent overflow from the chamber. The concentration of
the substrate in the syringe was adjusted so that the final concentration in the chamber
was the desired one. Stimulation usually took place at a pO2 of about 100 mmHg so that
there was enough time before and after the injection of substrate to obtain a straight slope
and ensure ApO 2/At was constant (Chapter 7). Data were reported as stimulation index,
which was the ratio of stimulated OCR after the glucose addition over the basal OCR.
The reported glucose concentration was the final concentration in the medium in the
chamber after its addition.
10.1.5 Statistics
Data are expressed as means ± standard deviation (SD). Significance was
determined with a two-tail Student t-test for a= 0.05.
10.2 Results
10.2.1 Maximum Stimulation Index in Nutrient-Free Media
Preliminary experiments showed that maximum stimulation index with glucose in
nutrient-free media was observed when the final glucose concentration was 20 mM (230).
Higher concentrations resulted in the same stimulation index obtained with 20 mM
glucose. Therefore, 20 mM was the concentration chosen for studying the maximum
stimulation index experiments. The effect of glucose stimulation in nutrient free media of
different groups of rat, human, and porcine islets was studied. The medium used in this
study was D-PBS (Invitrogen) because it had no nutrients that could interfere with the
islet metabolism. The rat islet data presented were from highly purified rat islet isolations
(n=7 for day 0 or n=1 I for day 0-3 after isolation) while the human islet data were from
preparations either received fresh (from Joslin Diabetes Center) or after shipment (from
other centers). The human islet data were from experiments run the day of isolation for
the fresh islets or the day of receipt for the shipped islets and for preparations that had an
islet volume fraction estimated by LM, (CI))LM, higher than 0.5. The islet volume fraction
ranged between 0.53-0.86 for fresh islets and between 0.64-0.79 for shipped islets. The
porcine data were from two preparations, one of which was studied three consecutive
days after isolation. OCR measurements used for the analysis of the stimulation index
were performed in D-PBS while measurements used for the estimate of OCR/cell were
performed in the standard medium used for OCR analysis (DMEM with 25 mM glucose
but no serum). The results from these experiments for maximum stimulation from 0 to
20 mM glucose stimulation are presented in Table 10.1.
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Table 10.1. Stimulation index (0-20 mM glucose) in nutrient-free medium (D-PBS).
Islet VolumeStimulatio OCR/cellIslet Tissue n Fraction by LM,
n Index (fmol/min-cell)
(I)LM
Rat- day 0 5 1.57 ± 0.10
Rat- day 0-3 11 1.60 ± 0.21 2.9 ± 0.4*
Human-Fresh 5 1.38 ± 0.26 1.8 ± 0.9 0.67 ± 0.13
Human- 6 1.01 + 0.36 1.7 ± 1.2 0.69 ± 0.09*
Shipped
Porcine 4 1.50 ± 0.27 3.0 ± 1.3
* Data are available for only 3 preparations
The maximum stimulation indices among species were pretty consistent with
exception of those obtained from shipped human islets. For highly purified rat islet
preparations the maximum stimulation index was 1.57 ± 0.10 for measurements obtained
on the day of the isolation and 1.60 + 0.21 for measurements obtained between the day of
and 3 days in culture after the isolation. The data obtained after 1 day in culture were
more variable but they were not significantly different (p=0.68) compared to those
obtained the day of the isolation. The maximum stimulation index was slightly lower and
more variable for fresh human and porcine islets but not significantly different (p=0.13
and p=0.66 respectively) compared to that of rat islets. The lower values of stimulation
index observed in the fresh human islets could be attributed to the presence of non-islet
tissue, shown by the lower islet volume fraction. The stimulation index for shipped
human islets was not significantly different than 1 (p=0.97), showing there was no
stimulation. The islet volume fraction by LM and the OCR/cell for shipped human islets
were not different than that for fresh islets and similar to values we have previously
reported in Chapter 8. Therefore, another parameter of the islet preparations or the
shipment process has affected the outcome of the stimulation. Possible parameters that
could affect the outcome are days after isolation when shipment took place, shipping
conditions, glucose concentration of the medium the islets were stored in or a
combination of these. We do not have data to show any correlations that will prove this
hypothesis but a more detailed study should take place to investigate the effect of these
parameters.
10.2.2 Stimulation Index in Different Media (PBS, CMRL, DMEM).
The effect of stimulation of different glucose concentrations on different media
was also examined. The initial glucose concentration was 0 mM (unless otherwise stated)
and incremental step changes resulted in glucose concentrations of 3, 5, and 20 mM. The
stimulation index for all step changes was measured, where the basal conditions were the
glucose concentration just before the glucose addition, in each medium. Other parameters
like OCR/cell measured in DMEM with 25 mM glucose, day after isolation, and islet
volume fraction by LM were recorded to examine any correlation with stimulation index.
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The media studied were D-PBS, DMEM, both of which had a basal glucose of 0 mM,
and CMRL Supplemented with a basal glucose concentration of 5.5 mM.
Three experiments with rat islets were performed but only the data of two are
presented because one of them ended up showing contamination after 2 days in culture
(Table 10.2). The data shown were obtained the day of the isolation (4-6 hr post
isolation). In these experiments, two different media were studied, D-PBS with no
nutrients and DMEM with no glucose but other nutrients, like amino acids (a complete
formulation of the media can be found at (231). The changes in the glucose concentration
occurred as step changes, 0-3, 3-5, and 5-20 mM. For every step change, fresh islets that
had been stored in DMEM with 25 mM glucose and washed twice in the respective
medium with the appropriate glucose concentration before placed in the OCR chamber
were used. OCR measurements used for the estimate of OCR/cell were performed in the
standard medium used for OCR analysis (DMEM with 25 mM glucose but no serum).
Stimulation indices were normalized over the basal OCR at 0 mM glucose.
Table 10.2. Stimulation index over basal OCR at 0 mM glucose for two sets of
measurements obtained with rat islets in PBS and DMEM.
OCR/cell
(fmol/min-cell)
Glucose PBS DMEM PBS DMEMConcentration (mM)
0 1.00 1.00 1.00 1.00
3 0.99 0.85 0.91 0.99
5 1.21 0.97 1.03 0.80
20 1.76 1.23 1.69 1.03
The results between the two experiments were consistent with each other. The
quality of the two preparations, as measured by OCR/cell, was different. The first
preparation had an OCR/cell of 2.9 fmol/min-cell, which is considered a high quality
preparation, based on our findings in Chapter 8. The second preparation had an OCR/cell
of 1.5 fmol/min-cell, which is considered a medium quality preparation for rat islets. The
islet volume fraction by LM for these preparations was not available but rat islet
isolations result in highly pure tissue. Therefore, these preparations may be considered as
really high purity ones. The effect of glucose stimulation was most prominent between
5 and 20 mM glucose in the nutrient-free medium (D-PBS) while it was observed at a
much lower value in the amino acid rich medium (DMEM). The maximum stimulation at
20 mM glucose was consistent with the findings obtained for maximum stimulation
indices in D-PBS, shown in Table 10.1. Stimulation indices smaller than one show that
the OCR after stimulation was smaller than that before stimulation. This was probably an
artifact from the injection of glucose (for example small amounts of islet tissue may have
leaked out of the chamber) and not a real decrease. Stimulation index at different
concentrations for these two experiments are shown in Figure 10.1.
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Figure 10.1. Effect of glucose concentration on the oxygen consumption rate (OCR)
studied on two preparations of rat islets in PBS and DMEM.
Different shapes of symbols represent the two experiments that were performed.
Open symbols refer to data obtained in PBS and filled symbols refer to those in
DMEM.
Similar experiments were performed with human islets, shown in Table 10.3. The
difficulty with human islets was obtaining high purity and high quality preparations.
Three experiments with shipped human islets from the same isolation after different days
in culture were performed. Unfortunately, the quality of the preparation, as expressed by
normalized OCR, was poor (0.61 and 0.98 fmol/min-cell) for the first two days the
stimulation was studied and higher (1.15 finol/min-cell) for the third day but still below
that of an average human islet preparation (Chapter 8). The islet volume fraction by LM
of this preparation upon receipt (data on first two columns) was 0.64, which was among
the higher values of human islet preparations received after shipment we have studied.
The islet volume fraction was not available for the other two sets of experiments, but in
our experience islet volume fraction increases as a function of time because non-islet
tissue tends to stick to the culture flask and not be recovered, as discussed in Chapter 8.
These findings were not consistent with the results from the experiments with rat
islets. There seems to be no significant stimulation observed any of the days for any of the
step changes in the glucose concentration in any medium. The largest stimulation indices
observed were for 5 mM glucose in DMEM (1 st run) or PBS (2 nd run). These results were
consistent neither with each other nor with the data from the rat islet studies. The islets
were medium purity and particularly low quality when the experiment was initiated. Even
though the quality and purity increased with culture (even though purity values are not
available) no stimulation was observed. Stimulation index at different concentrations for
these two experiments are shown in Figure 10.2.
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Table 10.3. Stimulation index over basal OCR at 0 mM glucose for three sets of
measurements obtained with shipped human islets in PBS and DMEM.
OCR/cell
(fmol/min-cell)
Islet Volume
Fraction by LM
Glucose
Concentration (mM)
0
3
5
20
0.61
0.64
0.98 1.15
n/an/a
PBS DMEM PBS DMEM PBS DMEM
1.00 1.00 1.00 1.00 1.00 1.00
0.77 0.96 0.72 0.65 0.90 1.07
0.86 1.52 1.30 1.15 0.61 0.88
0.72 1.11 0.86 0.98 0.87 1.07
1.5
1
0.5
5 10 15 20
Glucose Concentration (mM)
Figure 10.2. Effect of glucose concentration on the OCR studied on three
preparations of shipped human islets in PBS and DMEM.
Different shapes of symbols represent the three experiments that were performed.
Open symbols refer to data obtained in PBS and filled symbols refer to those in
DMEM.
The effect of glucose concentration on the stimulation index for shipped human
islets was not consistent with that observed in rat islets. This discrepancy was consistent
with the different results obtained when studying the maximum stimulation index at
20 mM glucose in rat and shipped human islets (Table 10.1). The effect of incremental
changes of glucose concentration needs to be studied with fresh islets, where the
maximum stimulation index at 20 mM glucose is similar to that of rat islets.
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Six experiments with human islets examining the effect of incremental increase of
glucose concentration in three different media, D-PBS and DMEM, as previously
described, and CMRL Supplemented were performed. The step changes studied were
0-3, 3-5, 5-10, and 5-20 mM glucose for D-PBS and DMEM and 5.5-10 and 5.5-20 mM
glucose for CMRL (basal glucose concentration is 5.5 mM). The results of these
experiments were not consistent with the results of those with rat islets or with the human
islets presented in Table 10.2 and Figure 10.1. In most measurements, there was no
stimulation observed even though properties like OCR/cell and islet volume fraction
estimates had similar values as for other studies performed. The islet volume fraction by
LM varied between 0.45-0.82 and the normalized OCR between 0.71-2.08 fmol/min-cell.
Three of the preparations had an OCR/cell less than one, showing poor islet quality that
could affect the stimulation outcome. No significant correlations between the properties
of the preparations and the absence of the stimulation upon glucose injection were
observed. Human islets do not provide a good model for basic preliminary studies of the
effect of glucose concentration on OCR because of the many parameters that affect the
outcome. More studies need to be performed with rat islets.
10.2.3 Comparison of OCR/cell Between Different Media
From the measurements obtained when comparing the stimulation index in
different media and for different glucose concentrations, values of OCR/cell in different
media were compared.
For rat islets, the ratio of OCR/cell measured in DMEM over that in D-PBS for all
glucose concentrations tested was 2.00 + 0.46 (n=8, two experiments with four
concentrations each) showing that rat islets consume oxygen twice as fast in a medium
with nutrients compared to a medium with no nutrients. Similar findings have been
reported by other investigators (230) For human islets this ratio was 1.37 ± 0.31 (n=12,
three experiments with four concentrations each) showing that human islets consume
oxygen nearly 1.5 times as fast in a medium with nutrients compared to a medium with
no nutrients. This average was slightly lower and more variable than that for rat islets.
Individual averages for each glucose concentration for rat and human islets are shown in
Table 10.4.
Table 10.4. Ratio of OCR/cell in DMEM over that in PBS for rat and human islets
in different glucose concentrations.
Ratio OCR/cell in
DMEM over PBS
Glucose Rat Islets Human
Concentration (mM) (n=2) Islets (n=3)
0 2.36 1.16
3 2.23 1.29
5 1.84 1.50
20 1.56 1.53
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10.3 Discussion
In this study, we examined the effect of glucose during OCR measurements of rat,
porcine and human islet preparations. Correlations between glucose-stimulated OCR and
glucose-stimulated insulin secretion (GSIS) have been previously published in the
literature for islets from a variety of species, and they are widely accepted (154, 155, 158,
162, 165, 232-234). It has been suggested that information on islet function (such as the
change in OCR with glucose stimulation, AOCR) may be useful for predicting
transplantation outcome (211).
Our findings suggested that stimulation with 20 mM glucose during OCR
measurements increased the OCR of islets by a factor of 1.4 - 1.6, for fresh human,
porcine, and rat islets. Rat and porcine islets were highly pure preparations while the
human islets used for these studies had an islet volume fraction estimated by LM of about
0.7. This could explain the slightly lower stimulation index obtained for fresh human
islets. Measurements with human islets that have a higher islet volume fraction (higher
purity) will show whether stimulation indices depend on the purity of the islet
preparations as well. We have not been able to obtain similar stimulation indices with
human islets that were received upon shipment, even though the OCR/cell and islet
volume fractions of the preparations studied were comparable to those of fresh human
islets studied. We believe another parameter, like day after isolation the shipment took
place or shipping conditions or a combination of these parameters could affect the
function of islet tissue and therefore the outcome of the stimulation during OCR
measurements.
We also examined the effect of stimulation with different concentrations of
glucose during OCR measurements for two media; DMEM, a glucose-free medium that
was rich in other nutrients (like amino-acids), and D-PBS, a nutrient-free medium. For
rat islets, the effect of glucose stimulation is most prominent between 5 and 20 mM
glucose in the nutrient-free medium (D-PBS) but barely observed in the amino acid rich
medium (DMEM). The maximum stimulation index at 20 mM glucose was consistent
with the findings obtained for maximum stimulation indices in D-PBS. For one
preparation of human islets tested after shipment for multiple days in culture, the
stimulation indices obtained were not consistent with our previous findings for rat islets
and the studies did not provide any meaningful results. More detailed studies with high
purity fresh human islets need to be undertaken to examine the effect of glucose
concentration on OCR measurements in different media.
Finally, we compared the normalized oxygen consumption rate, OCR/cell, of rat
and human islets in different media. Rat islets consumed oxygen twice as fast in a
nutrient-rich medium compared to a nutrient-free medium while this value was 1.5 for
human islets, comparable to the value for rat islets.
Similar studies on the effect of glucose concentration on oxygen consumption rate
of islet preparations have been recently reported (171, 211). In one study (211), the
authors used a flow culture system (173), which is an elegant tool for studies involving
long-term culture, simultaneous OCR and insulin secretion measurements, or studies
involving multiple changes in environmental parameters where the transient dynamics of
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the response are to be followed (172). The authors used Kreb's Ringer Bicorbonate that
contained no glucose and studied stimulation between 3 and 20 mM glucose. They
handpicked islets for the measurements and the stimulation index they reported was the
difference of the OCR/IE at high glucose minus that at low glucose. The human islet data
are more variable than the rat ones. The mean values of OCR/cell for rat and human islets
are 1.6 and 1.9 fmol/min-cell and 3.5 and 2.6 fmol/min-cell at 3 and 20 mM glucose
respectively, which are similar to the values we have reported for OCR/cell of rat and
human islets (Chapter 8). When the AOCR is converted to a ratio of OCR/cell at high
glucose over that at low glucose, the stimulation indices are of 1.41 and 2.16 for human
and rat islets respectively. These stimulation indices are similar to the mean value of
stimulation index for rat islets in PBS between 3 and 20 mM glucose that is 1.8 (average
value of two runs reported in Table 10.2). However, we found the larger stimulation
index is observed between 5 and 20 mM glucose and not between 3 and
20 mM, as Sweet et al. report. Our data on human islets did not agree with these findings
since we did not observe any significant stimulation in the three experiments run.
Handpicking islets is impractical and most importantly introduces limitations for the
assessment of the whole islet preparation because the islets chosen are usually the larger,
more intact and more robust ones, and may not be a representative sample of the islet
preparation.
In the second study (171), the authors used a novel oxygen biosensor system by
Becton Dickinson, BD OBS, (169) to measure oxygen consumption rates and the effect
of glucose concentration. The OBS is easier to use than the stirred microchamber
chamber we used for these measurements, and is therefore attractive for islet quality
assessment. Unfortunately, the ease of use of the OBS is offset by difficulties in
obtaining accurate and meaningful OCR estimates, described in detail in (172). The
published data and our own experience suggest that obtaining accurate results is difficult
or impossible in the system as it is currently constructed and used. The authors examined
the effect of glucose concentration on oxygen consumption rate at short (120 min) and
long (168 hr) incubation times and report significant stimulation indices at high glucose
concentrations (16.7 and 33.3 mM) in CMRL, a medium with basal 5.5 mM glucose and
other nutrients. These findings are different that what we discovered where there was no
stimulation in media with nutrients. The values of OCR/cell for human islets reported by
Wang et al. (171) are 0.51 fmol/min-cell at 24 hr and 0.29 fmol/min-cell at 168 hr of
incubation in the plate. These values are extremely low and do not agree with estimates
of OCR/cell for human islets we report.
There are large inconsistencies in the studies examining the effect of glucose on
OCR reported in the literature. There are methodological differences that include OCR
measurements systems, media, glucose concentrations, islet tissue (handpicked or not).
Studies need to be undertaken in a systematic way to examine the effect of different
media in one system in more details. These studies should also examine possible
correlations of more parameters that may affect the changes in the OCR after glucose
stimulation is required. We also suggest investigating the possibility that measures of
islet function (basal and stimulated insulin secretion rate and change in OCR with
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glucose stimulation, AOCR) enhance the ability of OCR and OCR/DNA to predict
transplantation outcome.
Contributions: Preliminary studies were conducted by Dr. Klearhcos K. Papas
(University of Minnesota). Samantha Polak, an undergraduate student, helped with the
experiments in this study.
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Chapter 11.
Conclusions and Outlook
The objective of this thesis was to develop, test, and validate quantitative methods
for quality assessment of islets of Langerhans to be used in islet transplantation to cure
Type 1 diabetes. The lack of reliable, meaningful, and accurate tools has impeded the
field. Because insufficient viable islet volume or excessive damaged tissue may lead to
failure, tools for reproducible quantitative evaluation of meaningful properties in islet
preparations are prerequisites for consistent success of islet transplants, for improvements
in islet isolation, for conduct of islet transplantation research, and for the advancement of
the islet field. The development of such tools is needed because currently used methods
are inadequate and not predictive of clinical outcome.
We have combined a quantitative bioengineering approach with biological insight
to develop assays that are meaningful, accurate, and precise We have developed novel,
improved methods in areas pertinent to islet characterization; cell composition and purity,
quantity, and viability. For islet purity we have made use of morphological measurements
with electron and light microscopy. For islet quantity, we have developed a nuclei
counting protocol suitable for use with islets. For viability determination, we have
focused on oxygen consumption rate (OCR) measurement in stirred chambers and
designed a system that is now commercially available. With our collaborators we have
employed the methods we developed as a potency test and have shown that a
combination of OCR and normalized OCR on a basis of tissue quantity, can predict
transplantation outcome.
183
Future studies in these areas can further improve these methods and explore new
techniques that offer potential advantage in simplicity and convenience.
11.1 Quantitative Methods for Islet Quality Assessment
We have developed and validated methods to estimate purity and cell composition
by electron or light microscopy analysis, quantify total amount of tissue by nuclei
counting or packed cell volume measurements, and measure oxygen consumption rate
(OCR) of islet preparations in a stirred chamber.
11.1.1 Purity
We have emphasized morphological analysis and developed a framework for
interconverting cell composition number fraction data from electron microscopy (EM)
with volume fraction data from light microscopy stereological point counting. We were
able to show that light microscopy (LM), which is easier, faster, and more convenient to
carry out, provides measurements of islet volume fraction with the same accuracy as EM.
LM also offers the prospect of use of frozen sections for real time measurements, whose
feasibility we have shown in our preliminary studies, even though the test requires further
validation. Our measurements showed that the conventional assay using dithizone (DTZ)
staining substantially overestimates purity and correlates poorly with morphological data.
We also discovered that the P cell volume fraction of islets is virtually constant in all
preparations. This important finding means that P cell volume (or number) is proportional
to islet volume, and one value can be estimated from the other.
11.1.2 Quantity
We developed a protocol to use nuclei counting, a standard method for cell
enumeration, with islets and demonstrated its accuracy and precision. When combined
with LM morphological data, using our mathematical analysis, it gives an accurate
estimate of islet volume in terms of the cells that have an intact nucleus. Measurements
with 12 research human preparations received fresh demonstrated that the conventional
DTZ staining/visual counting method grossly overestimates the number of islet
equivalents by nearly a factor of two. This finding helps explain why single pancreas
transplants do so poorly and it is consistent with our hypothesis that the islet damage
incurred during islet isolation, which is not picked up by the conventional membrane
integrity assay, is far more extensive than generally appreciated. We also investigated
packed cell volume as a measure of total amount of tissue, but its accuracy requires
further improvement.
11.1.3 Viability
Membrane integrity measurement by visual assessment following staining with
fluorescein diacetate and propidium iodide (FDA/PI) is the currently-employed method
to assess fractional viability of islet preparations. This assay usually gives erroneously
high values that are not predictive of the transplantation outcome because it differentiates
only between dead (membrane permeable) and non-dead (membrane impermeable) cells
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but fails to distinguish healthy cells from cells that have entered the cell death process but
have not reached the membrane permeabilization step. It is currently practiced with
microscopic visual estimation, making it non quantitative. In order to make a quantitative
membrane integrity estimate, we developed and validated a new method using nuclei
counting with differential staining (before and after cell disruption) with a dye that binds
tightly to nuclear DNA.
We selected oxygen consumption rate (OCR) as a measure of the amount of
viable tissue, since it represents the rate of mitochondrial oxidative phosphorylation
occurring in the entire preparation. We designed, developed, and validated a stirred
microchamber that has since been commercialized by Instech Laboratories. We have
trained staff from five institutions on its use. We have used it for extensive measurements
to characterize a large number of rat, porcine, and human islet preparations. We
compared our findings with those from different centers. This study provides a complete
understanding of the behavior of islet and non-islet tissue in culture, the change in their
properties, and the similarities and differences between species. One of the interesting
findings was that the mean OCR/cell measured with human islet preparations and pure
exocrine tissue was the same, which has important implications for potency testing.
11.1.4 Dynamics of Cell Death
We hypothesized that mitochondrial function tests, such as OCR, provide the
earliest indication of damage to cells that eventually leads to cell death. We verified this
hypothesis by studying the transient response of rat and human islets and Jurkat and
INS-1 cells to stresses causing extensive cell death with a number of assays of different
type (mitochondrial function, apoptosis events, and membrane integrity). The data
suggested that the results of different mitochondrial function assays (OCR, ATP, MTT,
and MTS) correlated closely and followed a similar trend, as did the membrane integrity
assays, but the behavior of the two assay types diverged sharply. The data demonstrated
that mitochondrial function assays provide the most meaningful measurement of
fractional viability and a more accurate assessment of the health of an islet preparation
because they are able to identify cells that are damaged but do not yet have compromised.
In some cases, the damage may be reversible, and removal of the stress might be
sufficient to rescue some of the cells. This has not been explored and warrants further
study. These findings are of particular importance to the field in view of the current use
of FDA/PI that would show high islet viability prior to transplantation even though the
fraction of viable tissue, estimated by a mitochondrial function assay, would be much
smaller.
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11.2 Predictive Capability
11.2.1 Potency
In collaboration with our collaborators at the University of Minnesota, we tested
the predictive capability of the tests we developed by performing transplantations or rat
or high-purity human islets in immunosuppressed and immunodeficient mice (182, 235,
236), respectively. The results showed definitively that combined use of two parameters,
OCR and OCR/cell, is predictive of transplantation outcome with high sensitivity and
specificity. Because we employed the high purity fraction that was enriched in islet for
the transplants (for the human islets), and because OCR/cell (or OCR/DNA) of islet and
non-islet tissue is virtually the same, the population average of OCR/DNA for islet and
non-islet tissue was the same. The data from the rat islet transplants mostly segregated
into two regions representing all cured or all not cured, separated by a third small region
of mixed results. This pattern allowed prediction of transplantation outcome in the
immunodeficient mouse for a rat islet preparation having any arbitrary combination of
OCR and OCR/DNA values. The results with human islets were not as definitive as with
the pure rat islets but had a pattern similar to that with rat islets in that data segregated
into regions of most or all cure, most or all fail, separated by a region of mixed results.
These findings show that prospective OCR and OCR/DNA measurements could
effectively replace the retrospective nude mouse bioassay in assessing human islet
quality prior to transplantation.
11.3 Future Work
This thesis provides the basis for the development of improved islet assessment
methods. The methods we developed can be improved, or even supplanted by new
techniques, to allow further advantages in terms of simplicity, convenience, and
predictive capability.
In particular, staining protocols for the use of frozen sections for measurement of
islet purity by morphological analysis with light microscopy need to be developed and
validated. This approach will allow quantitative accurate measurement of purity in a few
hours, thereby allowing real time measurement. Immunofluorescence for insulin staining
on frozen sections in order to estimate volume fraction 03 cells in the preparation by
morphological analysis needs to be studied.
The use of packed cell volume (PCV) measurements can be improved by
determining the void volume fraction of packed cell pellets of impure human islet
preparations. Packed cell volume measurements are extremely attractive for determining
the total volume of tissue because they are simple and rapid. However, they require an
accurate knowledge of the pellet void volume fraction that, in principle, could vary over a
wide range, depending on the purity and composition of the tissue.
Large particle flow cytometry for islet quality assessment can be explored. Large
particle flow cytometry together with staining by dyes (TMRE, JC-1) sensitive to
mitochondrial membrane potential (MMP) can provide a quantitative measure of viability
of whole islets. Flow cytometry with TMRE staining has been used to assess viability of
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single cell suspensions derived from islet preparations (66). Use of whole islets with
large particle flow cytometry will eliminate problems of loss of some cells and damage to
remaining cells during the dissociation process. Because both MMP and OCR
measurements reflect mitochondrial function, they should correlate with each other. If
such a correlation is achieved, large particle flow cytometry can be further explored as a
method to provide purity and number of IE measurements equivalent with the
quantitative methods we developed. The prospect of a single instrument capable of
measuring islet purity, quantity, and viability is very attractive.
Islet damage immediately after isolation changes through culture and needs to be
assessed. The effect of the islet isolation process on islet tissue is variable over a wide
range but that the extent of damage is often more extensive than currently appreciated.
The cell death process initiated during processing causes continued decrease of overall
mitochondrial function immediately after isolation and for some period thereafter.
Therefore, assessment of islet tissue right after isolation and through the early times in
culture will provide information on how much damage is incurred, how much tissue dies
or is rendered non viable during this period, or whether all or part of the damage is
reversible.
Measurements based on OCR for their ability to predict transplantation outcome
can be further evaluated and refined. Furthermore, the possibility that measures of islet
function (basal and stimulated insulin secretion rate and change in OCR with glucose
stimulation, AOCR) enhance the ability of OCR and OCR/DNA to predict transplantation
outcome needs to be examined. Different systems for OCR measurements using static
culture methods, like the Oxygen Biosensor System from Beckton Dickinson (BD OBS)
can be investigated and used as long as they are validated against the microchamber with
developed. Preliminary work in this area has been undertaken in our laboratory (237).
Finally, the assessment tools we developed can be used to improve pancreas
preservation and isolation by investigating perfusion of pancreata with a perfluorocarbon
emulsion during preservation to provide improved oxygenation and viability compared to
the current two-layer method. The can also be used to advance current techniques of
shipping by developing a practical shipping container that minimizes loss of viable islet
tissue by controlling temperature and supplying sufficient oxygen to maintain islet
viability and function. At last but not least, these assessment tools can also be applied
towards the advancement of culture of islets by improving high density culture by
determining factors that limit or could enhance.
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Chapter 12.
Appendix A. Supplemental Material
for Chapter 2
12.1 Appendix A. Supplemental Material for Chapter 2
12.1.1 Number Fraction and Volume Fraction Relationships in Islet Preparations
Our objective is to develop a framework of equations and parameters for
conversion between number fraction and volume fraction measurements with human
pancreatic islet preparations. We begin with development of the basic number-volume
relationships for cells. We then examine volume definitions and relationships applicable
to tissues, in which extracellular volume is included. The third section provides estimates
of parameter values used in these relationships. We conclude with use of packed cell
volume measurements for estimating the total islet volume in a preparation.
12.1.2 Cells
Cell composition measurements from EM provide data on the number ni of each
type of cell in the sample, where i represents the cell type. The islet cells (IC) include P
cells and non-0 cells (NP). The non-islet cells (NIC) include acinar (A), duct (D), and
other (0) cells. The individual cell counts are summed to give the number of islet,
non-islet, and total cells (TC),
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Equation A- 1
Equation A- 2
Equation A- 3
nic = n1 + nN3
nNIC = nA +nD +n o
nTC = nIC +nNIC
from which the islet and non-islet cell number fraction is calculated as the number of
cells of each type divided by the total number of cells in the sample
Equation A- 4
Equation A- 5
nic
fIc -
nTC
nNIC
fNIC - = 1 -fIC
nTC
In general, the number fraction fi of any cell type i in the islet preparations is determined
from
Equation A- 6
ni
fi = nTC
Recognizing that the volume of each cell type Vi is the product of the number of cells ni
and the volume per cell vi of that type, analogous equations can be written for the
volumes of islet, non-islet, and total cells in the preparation,
Equation A- 7
Equation A- 8
Equation A- 9
VIC = Vp + VN = np vp + nNP VN
VNIC =VA +VD +Vo =nAVA +nDVD +0 VO
VTC = VIC + VNIC
The fractions f of total cell volume occupied by islet and non-islet cells is defined by
Equation A- 10
Equation A- 11
Vic
VTc
VNIC
lNIC = 1-CIC
VTC
and the volume fraction of any cell type i is given by
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V.
Equation A- 12 i VT
VTC
In order to relate cell number fractions to cell volume fractions, we make use of the
average volume per cell for different combinations of cells. For example, the average
volume per cell for islet cells vIc is the volume of islet cells divided by the number of
islet cells in the preparation. Using this definition, together with Equation A- 4,
Equation A- 6, and Equation A- 7, yields
Equation A- 13
VIC  np vp +nNO VNp nTC np vp +nNP VNp 1
TC . n-n-T= (fpvj +fN vN )
nic nic nic nTC fIC
The sequential substitutions and manipulations show how the final result is expressed
entirely in terms of cell number fractions and individual cell volumes. Similar
expressions are obtained for non-islet and total cell average volumes
VNIC 1
Equation A- 14 N NI - (fAVA +fDVD +foV )
nNIC fIC
VTrc
Equation A- 15 VTC -p =fv' +fNp VNp +fAVA +fDVD +foVO
nTC
The volume of islet cells is the product of the number of islet cells and the average
volume of islet cells, vic
Equation A- 16 VIC = nic Vic
Similarly, for the total cells
Equation A- 17 VTC = nTC VTC
The volume fraction islet cells Iic can be related to the number fraction islet cells fIc by
combining Equation A- 10, Equation A- 16, and Equation A- 17, to yield
VIC nc IC Ic VIC
Equation A- 18 V - n c  = fIC
VTC nTC VTC VTC
Equation A- 18 is the key equation for converting between islet cell number fraction fic
and islet cell volume fraction 0Ic. If the ratio of islet cell to total cell average volumes
VIC /VTC is unity, meaning all islet cells have the same average volume as all non-islet
cells, then 4ic=fic.
Also of interest are the 3-cell number fraction fpic, i.e. the fraction of islet cells that are p
cells,
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Equation A- 19 np nTC np fp
nic nic nTC fIC
and the P-cell volume fraction, i.e. the fraction of the islet cell volume comprised of
0 cells,
Vp nA vp fp vp
c = VIC nic vIC fIc vIC
To this point, all volume fractions denoted by lower case are based upon the volume of
the cells without other tissue spaces.
Table A. 1. Estimated volume (pm3) of pancreatic cells.
Native Pancreas Freshly Isolated
Islet
Beta
Non-beta (mainly a )
Non-Islet
Acinar
Duct
Other
12.1.3 Tissues
1000
400
1550
200
200
950
400
1200
200
200
Next we develop expressions for volume fractions based upon the total tissue
volumes, V1 and VNI, the components of which are shown schematically in Figure A- 1.
Non Islet Islet
I I
Extracellular
Cellular
Figure A- 1. Volume definitions and relationships in islet preparations.
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Symbol
VNIEc
VNI VNIC
Equation A- 20
VNP
Equation A- 21
Equation A- 22
VNI = VNIEC + VNIC
VI = VvI + VIxv = VIEC + VIC
We denote by capital (D the volume fractions that are based upon the total volumes,
which include both the cell and the extracellular volume in each tissue. The volume
fraction of extracellular space in islet tissue is defined as
Equation A- 23 VIECIIEC vVI
and the volume fraction islet cells is given by
Equation A- 24 VICIC = 1-IEC 
- V,
Analogous expressions for the volume fractions of extracellular space and cells of
non-islet tissue are given by
Equation A- 25
Equation A- 26
VNIEC
( NIEC = VN
VNI
Components of the extracellular space, i.e., the interstitial and vascular spaces, are shown
separately for islets in Figure A- 1 because the vascular void volume fraction
Equation A- 27 VVID V, VI
constitutes a significant fraction of the total. However, the calculations in this chapter
make use only of the total islet extracellular volume fractions.
The volume fraction islets based upon the total tissue volume (II, which is
equivalent to the purity of an islet preparation, is defined as
Equation A- 28 V,
V, +VNI
Substituting for VI and VNI from Equation A- 23 and Equation A- 25, respectively, yields
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VIC
1- C IEC
Equation A- 29 D I "=
VIC VNIC
+
1 - IEC - NIEC
Division of numerator and denominator by the total cell volume VTC, followed by
substitution of Equation A- 10 and Equation A- 11 for the quantities VIC/VTc and
VNIC/VTc leads to
lIc
1- IEC
Equation A- 30 I = 1 -( lC
+
1-(DIEC 1 - (D NIEC
This key equation shows how the volume fraction of islets in the preparation CDI may be
calculated from the volume fraction of islet cells 4Ic and the volume fractions of
extracellular space in the islet (cIIEC) and non-islet (CINIEc) tissues. The quantity ýIc, in
turn, is calculated from the islet cell number fraction fic (from EM cell composition data)
using Equation A- 18.
Other quantities of interest related to the entire islet volume can be calculated
from expressions developed to this point. The islet volume fraction, IDp, i.e., the volume
fraction of the entire islet occupied by P cells, is defined by
Equation A- 31 (i - Vi
substituting Equation A- 20 and Equation A- 24 into Equation A- 31 leads to
Equation A- 32 (pI = fpIC (1- (IEC )
An islet equivalent (IE), a sphere of diameter 150 gim, has a volume VIE = 1.77x10 6 jtm3.
The total number of cells in an IE is given by the volume of cells (the product of (1-CIEC)
and VIE) divided by the average volume per islet cell,
(1-CIIEC) VIE
Equation A- 33 nlE =
VIC
and the number of 0 cells in an IE is
Equation A- 34 npIE =f nIE
12.1.4 Parameters
Estimates of the cell volumes and tissue extracellular volumes are needed to carry
out the calculations described here. The cell volume estimates used in carrying out
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calculations are summarized in Table A. 1. Values for P and non-P cells (assumed to have
properties of a cells) are taken from measurements with freshly isolated and purified rat
islets (50, 67). The 0-cell volume for freshly isolated islets reflects an estimated 5% loss
from the commonly accepted value of about 1000 pMn3 for the native pancreas (238, 239),
which is consistent with a partial degranulation during isolation and dispersion. Acinar
volume in the mature pancreas on average is within the 1300 to 1800 pm3 range reported
for the adult rat (68, 70, 240) and it is assumed that about 20 to 25% of the volume in
freshly isolated preparations is lost from degranulation. Estimates for duct and other cells
are from our observations (241). After several days in culture, surviving p-cells partially
regranulate. Acinar cells are more prone to death when cultured and are not as well
studied.
Available data for estimating the extracellular volume fractions 1IEC and NIEC
are limited. In one study (232), the extracellular spaces in islet and non-islet tissue of the
mouse in vivo were determined by sorbitol distribution experiments to be 39 and 26% of
tissue water, respectively, based on an estimated tissue water content of 75%, which
corresponds to DIEc = 0.29 and ONIEC = 0.19 when based on total tissue volume. We
reanalyzed the original data (232) and obtained IIEC = 0.288 ± 0.062 (mean ± SD, n=3).
In a study using stereological point counting with electron micrographs of rat islets (85),
the extracellular volume fraction averaged 0.203 ± 0.088 (n=3). These estimates are not
significantly different (p < 0.05), and the larger value (232) was used in the calculations.
We have estimated the vascular volume fraction (Dvj of human islets to be about 0.14
using stereological point counting with light microscopy (Chapter 3). After 24 hr in
culture, the vascular volume of isolated islets collapses, completely for rodent islets and
incompletely for human islets, leading to a substantial reduction in islet volume (86).
12.1.5 Packed Cell Volume
Volume components of a packed cell pellet are shown schematically is
Figure A- 2. The measured total packed cell pellet volume is Vpc, and the volume of
microscopic voids between the tissue components is Vvpc.
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Packed Cell Pellet
Void Non-islet Islet[ • I I I
VPC NI I v
VT
VPC
Figure A- 2. Volume and number definitions and relationships in a packed-cell
pellet.
The volume fraction of voids is defined by
VVPC
Equation A- 35 cIVPC - VP
VPC
The total tissue volume VT in the pellet is therefore
Equation A- 36 VT =(1- DvPC ) VPC
and the total islet volume VI in the preparation is given by
Equation A- 37 V, = ID, VT
from which the total number of islet equivalents is calculated using
VI
Equation A- 38 NIE VIE
VIE
Rearrangement of Equation A- 24 and Equation A- 20, respectively, gives expressions
for islet cell volume
Equation A- 39 VIC = (1- IEC ) VI
and f3-cell volume
Equation A- 40 Vp = •p•c VIC
These volume quantities, in turn, can be used to calculate the number of islet cells and 13
cells in an islet preparation
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Equation A- 41
Equation A- 42
VIC
ni = " = fplc nic
By combining Equation A- 31 and Equation A- 32, one obtains
Equation A- 43
(DIEC is a constant. If fpic, the volume fraction of p cells among all islet cells is constant,
then the volume (and number) of p cells is directly proportional to the islet volume (or
number of islet equivalents) in an islet preparation.
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VP = PIC (1G- IE C ) V I
Table A. 2. Data from EM and LM morphological analysis and DTZ staining of 27
human islet preparations.
Number Fraction Cells by EM
Islet Non-islet
Volume Fraction by LM DTZ
Islet Tissue Volume
w/o Vascular Vascular Whole Fraction
Sample Beta
f_3
1 2
1-16 0.220
2-06 0.186
2-08 0.322
2-17 0.291
2-19 0.308
2-20 0.490
2-21 0.176
2-22 0.529
2-24 0.267
2-25 0.398
3-06 0.287
3-10 0.354
3-13 0.330
3-16 0.525
3-19 0.343
3-21 0.507
3-23 0.637
3-25 0.532
3-28 0.162
4-01 0.362
4-06 0.378
4-07 0.489
4-10 0.323
4-11 0.452
4-15 0.358
4-23 0.131
4-24 0.303
Mean
SD
COV
SEM
Count
0.358
0.129
0.36
0.025
27
Non-Beta
3fN3
0.126
0.036
0.131
0.136
0.060
0.160
0.154
0.179
0.120
0.114
0.149
0.092
0.102
0.128
0.077
0.056
0.216
0.162
0.088
0.149
0.079
0.191
0.170
0.163
0.269
0.036
0.058
0.126
0.056
0.44
0.011
27
Total Acinar Duct Other
fic
4
0.346
0.222
0.453
0.427
0.368
0.650
0.330
0.708
0.387
0.512
0.436
0.446
0.432
0.653
0.420
0.563
0.853
0.694
0.250
0.511
0.457
0.680
0.493
0.615
0.627
0.167
0.361
0.484
0.163
0.34
0.031
27
fA fD fo
5 6 7
0.338 0.307 0.009
0.416 0.330 0.032
0.301 0.228 0.018
0.288 0.270 0.015
0.387 0.201 0.044
0.194 0.129 0.027
0.355 0.285 0.030
0.161 0.092 0.039
0.305 0.300 0.008
0.200 0.284 0.004
0.281 0.242 0.041
0.130 0.383 0.041
0.326 0.231 0.011
0.157 0.185 0.005
0.224 0.321 0.035
0.287 0.109 0.041
0.054 0.016 0.077
0.115 0.150 0.041
0.414 0.303 0.033
0.191 0.262 0.036
0.340 0.172 0.031
0.099 0.149 0.072
0.199 0.190 0.118
0.170 0.179 0.036
0.089 0.243 0.041
0.407 0.384 0.042
0.349 0.247 0.043
0.251 0.229 0.036
0.108 0.089 0.024
0.43 0.39 0.67
0.021 0.017 0.005
27 27 27
Void
(IxV)LM
8
0.332
0.087
0.469
0.435
0.356
0.653
0.285
0.690
0.432
0.535
0.467
0.540
0.407
0.692
0.441
0.624
0.857
0.716
0.179
0.546
0.456
0.702
0.509
0.674
0.695
0.105
0.385
0.491
0.192
0.39
0.037
27
Void Islet Islet
(vI ((l)LM ((I)DTZ
9 10 11
0.142 0.367 0.58
0.045 0.091 0.30
0.146 0.508 0.55
0.147 0.474 0.70
0.139 0.391 0.60
0.117 0.681 0.80
0.131 0.314 0.50
0.115 0.716 0.75
0.137 0.468 0.35
0.162 0.579 0.50
0.178 0.516 0.75
0.059 0.555 0.80
0.197 0.461 0.70
0.077 0.709 0.70
0.125 0.474 0.70
0.140 0.659 0.85
0.203 0.883 0.90
0.177 0.754 0.95
0.135 0.201 0.30
0.162 0.589 0.75
0.083 0.478 0.60
0.173 0.740 0.80
0.096 0.534 0.90
0.114 0.700 0.90
0.214 0.744 0.90
0.170 0.124 0.37
0.148 0.424 0.77
0.138 0.523
0.042 0.195
0.30 0.37
0.008 0.038
27 27
0.68
0.19
0.28
0.04
27
198
Table A. 3. Calculated quantities from EM and LM morphological analysis of 27
human islet preparations.
Average Cell Volume (pm3) p Cells in Islets Volume Fraction by EM Islet Equivalent
Cell Islet
Size Number Volume Volume Number of cells
Sample Islet Non-islet Total Ratio Fraction Fraction Fraction Islet Cells Whole Islet Total 0
vic VNIC VTC VC/VcTC fpic 4 1C D1pl (cI)EM (0I)EM nIE nplE
1 12 13 14 15 16 17 18 19 20 21 22
1-16 750 717 728 1.03 0.636 0.806 0.570 0.356 0.386 1670 1062
2-06 861 735 763 1.13 0.838 0.925 0.654 0.251 0.276 1455 1219
2-08 791 750 769 1.03 0.711 0.854 0.604 0.466 0.498 1583 1125
2-17 775 703 733 1.06 0.681 0.836 0.591 0.451 0.483 1616 1101
2-19 860 812 830 1.04 0.837 0.924 0.654 0.381 0.412 1456 1218
2-20 815 754 794 1.03 0.754 0.879 0.622 0.667 0.695 1537 1159
2-21 693 730 718 0.97 0.533 0.731 0.517 0.319 0.347 1806 963
2-22 811 751 794 1.02 0.747 0.875 0.619 0.724 0.749 1544 1154
2-24 779 698 729 1.07 0.690 0.841 0.595 0.414 0.445 1607 1108
2-25 828 610 721 1.15 0.777 0.892 0.631 0.587 0.618 1513 1176
3-06 762 698 726 1.05 0.658 0.821 0.581 0.458 0.490 1643 1082
3-10 837 435 614 1.36 0.794 0.901 0.638 0.608 0.638 1497 1188
3-13 820 774 794 1.03 0.764 0.885 0.626 0.446 0.478 1527 1166
3-16 842 652 776 1.08 0.804 0.907 0.642 0.708 0.734 1487 1195
3-19 849 586 697 1.22 0.817 0.914 0.646 0.512 0.544 1475 1204
3-21 895 857 878 1.02 0.901 0.956 0.676 0.574 0.605 1399 1260
3-23 811 567 775 1.05 0.747 0.875 0.619 0.892 0.904 1545 1153
3-25 822 576 746 1.10 0.767 0.886 0.627 0.764 0.786 1524 1168
3-28 756 752 753 1.00 0.648 0.814 0.576 0.251 0.276 1656 1073
4-01 790 591 692 1.14 0.708 0.852 0.603 0.583 0.614 1586 1123
4-06 855 826 839 1.02 0.827 0.919 0.650 0.466 0.498 1465 1212
4-07 796 509 704 1.13 0.719 0.859 0.608 0.768 0.791 1574 1132
4-10 760 593 675 1.13 0.655 0.819 0.579 0.555 0.587 1647 1079
4-11 804 642 742 1.08 0.735 0.868 0.614 0.667 0.695 1557 1144
4-15 714 439 611 1.17 0.571 0.760 0.537 0.732 0.757 1754 1001
4-23 831 689 712 1.17 0.784 0.896 0.634 0.195 0.216 1506 1181
4-24 862 746 788 1.09 0.839 0.925 0.655 0.395 0.426 1453 1220
Mean 806 674 745 1.09 0.739 0.867 0.614 0.526 0.554 1559 1143
SD 47 110 61 0.08 0.086 0.052 0.037 0.179 0.177 95 69
COV 0.06 0.1.6 0.08 0.08 0.12 0.06 0.06 0.34 0.32 0.06 0.06
SEM 9 21 12 0.02 0.017 0.010 0.007 0.034 0.034 18 13
Count 27 27 27 27 27 27 27 27 27 27 27
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Table A. 4. Data and calculated quantities from packed cell volume measurements
combined with LM analysis for 27 preparations".
Packed
Sample Cell Pellet
VPc
1 2
1-16 3.50
2-06 5.00
2-08 3.50
2-17 1.70
2-19 2.20
2-20 1.20
2-21 2.00
2-22 2.00
2-24 4.00
2-25 1.50
3-06 1.10
3-10 0.80
3-13 1.35
3-16 0.70
3-19 1.70
3-21 0.90
3-23 1.20
3-25 1.20
3-28 3.70
4-01 1.00
4-06 1.20
4-07 0.80
4-10 0.60
4-11 1.20
4-15 1.50
4-23 2.80
4-24 2.20
Mean
SD
COV
SEM
Count
1.87
1.15
0.62
0.22
27
a. Quantities calculated
Equation A- 37 with
as follows: Column 2 from Equation A- 36; Column 3 from
DI from
Equation A- 40 with )p3IC from Equr
LM data; Column 4 from Equation A- 39 and
ition A- 31 and with fo and fic from EM data; Column
5 from Equation A- 38; Column 7 from Equation A- 20 with fplc from Equation A- 19
and nic from Equation A- 1 with parameters from EM data.
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Volume
Islets
VI
3
Beta
Cells
VO
4
0.90
0.32
1.25
0.56
0.60
0.57
0.44
1.00
1.31
0.61
0.40
0.31
0.44
0.35
0.56
0.41
0.74
0.63
0.52
0.41
0.40
0.41
0.22
0.59
0.78
0.24
0.65
0.58
0.27
0.47
0.05
27
IE by
PCV/LM
(NIE)PCV/LM
5
0.51
0.21
0.75
0.33
0.39
0.36
0.23
0.62
0.78
0.38
0.23
0.20
0.27
0.22
0.36
0.28
0.46
0.40
0.30
0.25
0.26
0.25
0.13
0.36
0.42
0.15
0.43
0.35
0.16
0.46
0.03
27
Number
IE by DTZ
Staining
(NIE)DTZ
6
507707
179405
703739
318948
340193
323012
248720
565938
741056
343228
224453
175614
246039
196224
318765
234443
418871
357782
294576
233074
226640
234174
126754
332211
441077
137137
368514
327344
155184
0.47
29865
27
Beta Cells by
PCV/LM
na (x 106)
7
543500
399600
450600
460400
370100
381700
326400
498500
523601
265800
341100
298200
269000
454623
468903
289000
318738
599845
814343
243440
515653
531505
289833
496829
447398
386955
570308
427995
128999
0.30
24826
27
539
219
792
351
414
374
240
653
821
404
243
209
287
235
384
295
483
418
316
262
275
265
137
380
442
162
450
372
172
0.46
33
27
Table A. 5. Data and calculated quantities from packed cell volume measurements
combined with EM analysis for 33 preparations. Similar format to Table A. 4.
Mean
SD
COV
SEM
Count
1.81
1.07
0.59
0.19
33
Volume
7
Packed
Sample Cell Pellet
VPc
1 12
1-16 3.50
2-06 5.00
2-08 3.50
2-17 1.50
2-19 1.50
2-20 2.00
2-21 1.00
2-17 1.70
2-119 2.20
2-20 1.20
2-21 2.00
2-2:2 2.00
2-24 4.00
2-2:5 1.50
3-06 1.10
3-10 0.80
3-13 1.35
3-16 0.70
3-19 1.70
3-20 2.20
3-21 0.90
3-23 1.20
3-25 1.20
3-28 3.70
4-01 1.00
4-06 1.20
4-07 0.80
4-110 0.60
4-111 1.20
4-1.5 1.50
4-23 2.80
4-24 2.20
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Islets
VI
13
0.95
0.96
1.22
0.59
0.48
0.72
0.47
0.58
0.63
0.58
0.49
1.05
1.25
0.65
0.38
0.36
0.45
0.36
0.65
0.76
0.38
0.76
0.66
0.72
0.43
0.42
0.44
0.25
0.58
0.79
0.42
0.66
0.62
0.25
0.40
0.04
33
I I
Beta
Cells
VP
14
0.54
0.63
0.74
0.37
0.30
0.32
0.30
0.34
0.42
0.36
0.25
0.65
0.74
0.41
0.22
0.23
0.28
0.23
0.42
0.50
0.26
0.47
0.41
0.41
0.26
0.27
0.27
0.14
0.36
0.43
0.27
0.43
0.38
0.15
0.39
0.03
33
IE by
PCV/EM
(NIE)PCV/EM
16
534772
544915
689787
333595
269321
407690
266283
324872
358757
329980
274794
592104
704376
366794
213072
201874
255395
203285
365816
428901
215349
429096
373216
404074
242768
236210
250140
139227
329817
449013
239130
370676
350500
139165
0.40
24226
33
Number
IE by DTZ
Staining
(NIE)DTZ
17
543500
399600
450600
451800
385500
431200
410100
460400
370100
381700
326400
498500
523601
265800
341100
298200
269000
454623
468903
343995
289000
318738
599845
814343
243440
515653
531505
289833
496829
447398
386955
570308
423303
117672
0.28
20484
33
Beta Cells by
PCV/EM
np (x 106)
18
568
664
776
384
315
334
312
358
437
382
265
683
781
431
230
240
298
243
441
529
271
495
436
433
273
286
283
150
377
450
283
452
398
157
0.39
27
33
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12.2 Appendix B. Supplemental Material for Chapter 8
Purity measurements on day 2 were performed using immunoperoxidase staining
for insulin in conjunction with stereological point counting while day 0 measurements
were made using morphological analysis. The reason a second method was used to
determine purity following culture was because several samples contained single cells
following culture that resulted from trypsinization of the adherent tissue. Morphology
differences in single cells would be hard to differentiate whereas differences in color
based on insulin staining are easier to distinguish resulting in a more accurate reflection
of tissue composition. For insulin staining quantification by stereological point counting
vascular space was excluded because vascular space in non-adherent tissue will be
different than in adherent tissue. These measurements resulted in the beta cell volume
fraction exclusive of vascular spaces (Dpxv), which is defined as
PP _ V-+VPNT
Equation B- 1 pryxv = V, + V-NI
PI + PNI V I + VNI- VvI
where Pp is the points counted as insulin positive, PI is a point counted as islet tissue, PNI
is a point counted as non-islet tissue, Vp is the volume of insulin positive cells, VpINT is
the volume of the interstitial space of insulin positive cells, VI is the volume of islet
tissue, VNI is the volume of non-islet tissue, and Vvi is the volume of the vascular void
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space. If Pp is only counted if insulin staining is present, which should only occur in cells
and not interstitial space (i.e. VPINT = 0), then the following is true.
Equation B- 2 Oprxv = Vy
V + VNI - VVI
In order to compare the morphological measurements made on day 0 for the
volume fraction islets (QDI) with ODxv from day 2 samples we needed to perform some
data conversions, which are summarized in Figure B- 1. We showed in Chapter 3 that DI
can be converted to the islet volume fraction exclusive of vascular spaces (Qixv)
assuming the vascular void fraction ((ivi) in the islet tissue is known (Equation 3-4). Dixv
can be converted to Ipxv using
VINT
VI _pl [IIxVEquation B- 3 1 +
VI
where Vic is the volume if islet cells, VINT is the volume of interstitial space in islet cells,
and 1plc is the 3-cell cell volume fraction. This equation can be obtained by combining
Equation B- 2 and the definition of Dixv, which is
P1  - Vtc+VITEquation B- 4 IxV P -VI + V
P1+ I V i + VNI- Vi
From previous analysis we know that fresh tissue has an average pjic = 0.867,
=•T - 0.15 (Chapter 3), and VIc - 0.71 (Table 2.3) thereby allowing us to estimate
VI VI
ODpxv of fresh tissue from measurements of ~I.
Islet volume 13 cell volume
Islet volume fraction exclusive fraction exclusive
Fraction Equation 3.4 of vascular space Equation B. of vascular space
01 OvI = 0.138 DIXV <pic = 0.867 (Oxv
VNT = 0. 1 5 , VI = 0.7 1V, VI
Figure B- 1. Conversion from islet volume measurements of fresh tissue to the beta
cell volume fraction exclusive of vascular spaces.
In order to combine nuclei measurements with purity measurement Ipxv and Di
need to be converted from volume fractions to number fractions. In particular we will
convert each volume fraction to the number fraction beta cells (fp). Day 0 measurements
of (II were converted to fp as outlined in Figure B- 2. 1i was converted to the volume
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fraction islets (tIc) which was converted to the number fraction islet cells (fic) which was
converted to fp using previously defined relationships and assuming the volume fraction
of islet extracellular space ((IIEc), the volume fraction of non-islet extracellular space
(IOIEC), the average cell volume for islet cells (Vic),the average cell volume of all cells
(VTrc), the P1-cell volume (vp), and ýpic are the same as previously reported (Chapter 2).
Volume fraction Number fraction
Islet volume Equation 2.3 islet cells Equation 2.1 islet cells
Fraction >- fl c
1 IEC = 0.29 VIC = 806 Equation 2.2
TC = 745  pc = 0.867
VIC = 806
vp = 950
Number fraction
3 cells
fo
Figure B- 2. Conversion from islet volume measurements of fresh tissue to the
number fraction beta cells using previously defined relationships.
Day 2 measurements of Opxv were converted to fp using the procedure outlined in
Figure B- 2. Opxv is converted to Dixv using Equation B- 3 and Equation 2-2. Values for
T, , vp, flIc (f/fic), and Vic are estimated as indicated in Table B. 1. ~Ixv is
v, " vi
converted to 01 which is then converted to ýIc using previously defined relationships and
assuming values for (DIEC, •NIEc, and 'Dvi. ýic is converted to fic using using Equation
2-1. fp is calculated from fic by assuming f/fic = 0.739 (fpic does not change in culture).
Though we have a value for fo we need to make sure all variables are consistent.
We assume that the number fraction of other cells (fo) is the same as fresh tissue thereby
suggesting that the change in fp and fic (which allows determination of the number
fraction non-P3 islet cells, fNp) is offset by a change in exocrine tissue, specifically the
number fraction of acinar cells (fA) and duct cells (fD) such that fNp + fD + fo + fo + fA =1
(242). This change in exocrine tissue is assumed to be equally distributed between acinar
and duct cells such that fA/fD is constant. Using the number fraction of each cell type and
the assumed cell volumes of each, Vic and VTC can be calculated as previously indicated
(Chapter 2). These calculated values are compared to those originally assumed in the
calculation. If unequal, the new values replace the old ones and the calculation is
performed again. The loop continues until the calculated Vic and VTC matches those
assumed.
205
0 * * 0
SW C *-
u > =
CO
c._
a)
E w
-- c:> -
cujCD
-4-
z
C-L-
I>
c 0
0 a,
I> C
C)
SCu
cla
C• c
,, 0 u
d
I I
0
co4-
.E
0 oCU =
a )
CU
4--
o cE
Cu
a, T-
co
C>
L-
o
Cr
r'-
II
II
0 ()>
CU
O
or
x aO~,c/
)
II
4m,
o ++ 
II I
+
+
:3
II
II
II
N
Cu)I I
U
0c (
.u
u"
Co0
WC)7-
t- L.C\i
c0CCUcU >
W I
OC>>• X
cu c
a)0>>cna,
0Co- a)
m'=
II IIy-<
10
z
>
0,
Ta,
206
0
oo
I-ik
eI.
0
09
0
,
0orn
aoc6
a
v,
o
rn
o•
Q;
,. ,
0
0I
o Q;
E
°• •,
'3
1
The parameters used in the above calculations for fresh tissue and tissue
following 2 day culture, both non-adherent and adherent, are shown in Table B. 1. The
values of the parameters for fresh tissue (day 0) were determined previously (Chapter 2).
During culture these parameters are likely to change. Since the degree of change is
unknown, we will consider two different scenarios, one that we feel is realistic and one
that has more extreme changes in parameter values allowing us to see how sensitive the
analysis is to the assumptions.
For non-adherent tissue in scenario 1 we assume that the vascular void space is
cut in half during culture for both islet and non-islet tissue, but that the volume fraction
of the interstitial space in an islet does not change. In scenario 2 we assume that all the
vascular void space is gone and that VT decreases from 0.15 to 0.1. These assumptions
VV
allow us to calculate IC-, (IEC, IVI, and (NIEC. In scenario 1 and 2 we assume that theV,
v, increases to 975 and 1000 pmn3 , respectively based on observations from our
collaborators that show a slight increase in size of 0 cells during culture (242). For
adherent tissue on day 2 we assume that all vascular void space is gone since
VIT
trypsinization is conducted. We also assume that VI  decreases to 0.1 and 0.05 for
VVI
scenarios 1 and 2 allowing -ic IlEC, IVI, and DNIEC to be calculated, v. is the same as
that for non-adherent tissue (975 and 1000 gm3 for scenario 1 and 2). The results
presented were determined using scenario 1. When performing the calculations with the
two scenarios there was at most a 7% change in fp (absolute change of 0.027).
VI
capillary space, which is normally considered interstitial space. In the original study the
pericapillary space was counted as vascular space. This brings into question the use of its
value in our data conversions. Despite this the value of Vr T for fresh tissue (0.15) is
VI
inline with previous estimates (Chapter 2) and the error associated with it is likely small.
Once fp was determined the fraction of original P cells collected from culture (Fp) could
be calculated using
Equation B- 5 Fp (nTcf) 2
(nTCfp )
where nTc is the total number of cells either placed in culture (day 0) or collected from
culture (day 2).
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Table B. 1. Parameter values used to estimate fp from c(pxv.
Fresh Value
0.15
0.71
0.138
0.19
0.29
0.484
950
Day 2 non-adherent
Case 1 Case 2
0.15 0.1
0.78 0.9
0.07 0
0.17 0.1
0.22
0.562
975
0.1
0.639
1000
Parameter
VINT/VI
Vc/VcnI
(Dvi
INIEC
(DIEC
fic
vp
VNP3
VA
VD
Vo
fo
fA/fD
Calculated Averages
806
745
0.251
0.229
823
763
0.20
0.18
841
767
0.40
0.37
Values of VNP, VA, VD, VO, fo, fA/fD, and flIc were assumed to not change with culture.
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400
1200
200
200
0.036
1.1
0.736
Day
Case 1
0.1
0.9
0
0.1
0.1
0.194
975
2 adherent
Case 2
0.05
0.95
0
0.05
0.05
0.097
1000
Vic
VTC
fA
fD
823
724
0.40
0.37
841
726
0.41
0.37
Appendix C. Data for Rat, Human Fresh,
Human Cultured/Shipped Islets and
Human Non-Islet Tissue
12.3 Appendix C. Data for Rat, Human Fresh, Human Cultured/Shipped
Islets and Human Non-Islet Tissue
The following tables contain the raw data of all the measurements and analysis
performed on the preparations received for rat, human fresh, human cultured/shipped
islets and human non-islet tissue. The values in bold represent points that were
determined to be outliers by three statistical tests and therefore were not included in the
data analysis.
209
Table C. 1. Data for Rat Islets
DNA/cell (pg DNA/cell) of rat islets
DNA Content Ratio over Day 0(pg DNA/cell)
Date Day after
isolation
3/13/2003 0
3/20/2003 0
3/27/2003 0
4/10/2003 0
4/17/2003 0
5/8/2003 0
5/22/2003 0
5/29/2003 0
6/5/2003 0
6/12/2003 0
6/26/2003 0
7/31/2003 0
8/7/2003 0
8/14/2003 0
9/4/2003 0
9/15/2003 0
10/2/2003 0
10/16/2003 0
10/30/2003 0
11/6/2003 0
12/7/2003 1
12/11/2003 0
1/29/2004 0
3/4/2004 0
3/11/2004 0
3/19/2004 0
4/2/2004 0
4/7/2004 0
4/14/2004 0
4/16/2004 2
5/5/2004 0
5/16/2004
Day 0
5.5
1.8
5.2
7.9
6.9
3.7
5.6
6.7
7.7
4.1
7.1
Day 1 Day 2 Day 1 Day 2-NA
6/23/2004
7/7/2004
7/14/2004
10/1/2004
12/14/2004
1/14/2005
1/24/2005
4/25/2005
6/21/2005
7/11/2005
7/18/2005
8/22/2005
3/1/2006
Without outliers
Average
STDEV
COV
COUNT
1.03
0.44
0.42
8
6.4
1.6
0.24
30
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OCR/cell (fmol/min'cell) of rat islets
Date DayO
3/13/2003 2.9
3/20/2003 0.9
3/27/2003 1.7
4/10/2003 2.1
4/17/2003 1.4
5/8/2003 1.2
5/22/2003 3.3
5/29/2003 1.9
6/5/2003 6.3
6/12/2003 1.5
6/26/2003 2.5
7/31/2003 4.1
8/7/2003 2.7
8/14/2003 3.9
9/4/2003 2.6
9/15/2003 5.0
10/2/2003 2.0
10/16/2003 3.5
10/30/2003 5.9
11/6/2003 4.6
12/7/2003
12/11/2003
1/29/2004 3.2
3/4/2004
3/11/2004 2.5
3/19/2004
4/2/2004 2.0
4/7/2004 1.6
4/14/2004 2.2
4/16/2004
Ratio over Day 0
Day 1 Day 2 Day 1 Day 2-NA
0.54
0.90
0.60
3.0
2.7
2.7
2.3
2.5
2.2
5/5/2004
5/16/2004
6/23/2004
0.93
1.06
1.00
1.20
0.79
7/7/2004
7/14/2004
10/1/2004
12/14/2004
1/14/2005
1/24/2005
4/25/2005
6/21/2005
7/11/2005
7/18/2005
8/22/2005
3/1/2006
0.96
Without outliers
Average
STDEV
COV
COUNT
2.7
1.1
0.42
37
2.1
0.8
0.39
7
2.6
0.4
0.15
9
0.81
0.26
0.33
5
0.99
0.05
0.05
4
OCR/cell (fmol/min cell)
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OCR/DNA (nmol/min-mg DNA) of rat islets
OCR/DNA Ratio over Day 0(nmol/min mg DNA)
Date Day 0 Day 1 Day 2 Day 1 Day 2-NA
3/13/2003 523
3/20/2003 510
3/27/2003 328 301 0.92
4/10/2003 260
4/17/2003 199 211 1.06
5/8/2003 333
5/22/2003 580
5/29/2003 284
6/5/2003 821
6/12/2003 351
6/26/2003 352
7/31/2003 175 317 1.81
8/7/2003 459
8/14/2003
9/4/2003 385
9/15/2003 368
10/2/2003 494
10/16/2003 393
10/30/2003 408
11/6/2003 317
12/7/2003 467
12/11/2003
1/29/2004 490
3/4/2004
3/11/2004
3/19/2004
4/2/2004 484 545 1.13
4/7/2004 308 304 0.99
4/14/2004
4/16/2004
5/5/2004
5/16/2004
6/23/2004 263 291 1.11
361 379 1.05
7/7/2004 247 363 1.47
7/14/2004 413 573
10/1/2004 437
12/14/2004 496
1/14/2005 584
1/24/2005 578
4/25/2005 591
6/21/2005
7/11/2005 680
7/18/2005
8/22/2005
3/1/2006 318
Without outliers
Average 405 352 421 1.19 1.19
STDEV 127 102 129 0.35 0.25
COV 0.31 0.29 0.31 0.30 0.21
COUNT 30 7 5 5 3
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Fraction of cells with impermeable cell membranes by 7-AAD of rat islets
Membrane Integrity by Ratio over Day 07-AAD (%)
Date Day 0 Dayl Day 2 Day 1 Day 2-NA
3/13/2003 91
3/20/2003 93
3/27/2003 87 89 1.02
4/10/2003 88
4/17/2003 72 69 0.95
5/8/2003 82 90
5/22/2003 78
5/29/2003 54
6/5/2003 41 45
6/12/2003 58 62
6/26/2003 61
7/31/2003 69
8/7/2003 67
8/14/2003 78
9/4/2003 84
9/15/2003 70
10/2/2003 79
10/16/2003 73
10/30/2003 73
11/6/2003 76 90 1.19
12/7/2003 78
12/11/2003 70 79 1.14
1/29/2004 83 85
3/4/2004 79
3/11/2004 54
3/19/2004 86
4/2/2004 74 83
4/7/2004 78 80
4/14/2004
4/16/2004 75 90
5/5/2004
5/16/2004 86
6/23/2004 75 68 0.90
77 80 1.04
7/7/2004 75 96
7/14/2004 87 92
10/1/2004 92
12/14/2004 87
1/14/2005 84
1/24/2005 86
4/25/2005 68
6/21/2005
7/11/2005 78
7/18/2005
8/22/2005
3/1/2006 90
Without outliers
Average 77 73 88 1.01 1.19
STDEV 11 14 6 0.09
COV 0.15 0.19 0.06 0.09
COUNT 40 9 7 5
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OCR/cell with impermeable cell membranes (fmol/min-cell) of rat islets
OCR/viable cell
(fmol/min cell)
Dayl Day 2
Ratio over Day 0
Day 1 Day 2-NA
0.53
0.94
Date
3/13/2003
3/20/2003
3/27/2003
4/10/2003
4/17/2003
5/8/2003
5/22/2003
5/29/2003
6/5/2003
6/12/2003
6/26/2003
7/31/2003
8/7/2003
8/14/2003
9/4/2003
9/15/2003
10/2/2003
10/16/2003
10/30/2003
11/6/2003
12/7/2003
12/11/2003
1/29/2004
3/4/2004
3/11/2004
3/19/2004
4/2/2004
4/7/2004
4/14/2004
4/16/2004
5/5/2004
5/16/2004
6/23/2004
7/7/2004
7/14/2004
10/1/2004
12/14/2004
1/14/2005
1/24/2005
4/25/2005
6/21/2005
7/11/2005
7/18/2005
8/22/2005
3/1/2006
Without outliers
3.0
0.5
0.18
5
0.89
0.34
0.38
4
Day 0
3.2
1.0
2.0
2.3
1.9
1.5
4.1
3.5
15.5
2.5
4.1
5.9
4.0
5.1
3.1
7.1
2.5
4.8
8.0
6.0
1.33
0.76
Average
STDEV
COV
COUNT
3.7
1.6
0.45
33
2.4
1.0
0.43
5
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OCR/DNA of cell with impermeable cell membranes (nmol/min.mg DNA) of rat
islets
oc
(nm
Date Day 0
3/13/2003 576
3/20/2003 549
3/27/2003 377
4/10/2003 294
4/17/2003 276
5/8/2003 404
5/22/2003 740
5/29/2003 526
6/5/2003 2006
6/12/2003 600
6/26/2003 579
7/31/2003 254
8/7/2003 685
8/14/2003
9/4/2003 456
9/15/2003 524
10/2/2003 629
10/16/2003 539
10/30/2003 557
11/6/2003 417
12/7/2003
12/11/2003
1/29/2004 590
3/4/2004
3/11/2004
3/19/2004
4/2/2004 654
4/7/2004 395
4/14/2004
4/16/2004
5/5/2004
5/16/2004
6/23/2004
7/7/2004
7/14/2004
10/1/2004
12/14/2004
1/14/2005
1/24/2005
4/25/2005
6/21/2005
7/11/2005
7/18/2005
8/22/2005
3/1/2006
Without outliers
Average
STDEV
COV
COUNT
R/viable DNA
l/min mg DNA) Ratio over Day 0
Daymin g DNA)
Dayl Day 2 Day 1 Day 2-NA
0.90
1.22
1.01
527
159
0.30
30
429
116
0.27
5
509
151
0.30
4
1.06
0.14
0.13
4
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Fraction of original OCR, nuclei, and DNA recovered after 2 days in culture for rat
islets
Date
3/13/2003
3/20/2003
3/27/2003
4/10/2003
4/17/2003
5/8/2003
5/22/2003
5/29/2003
6/5/2003
6/12/2003
6/26/2003
7/31/2003
8/7/2003
8/14/2003
9/4/2003
9/15/2003
10/2/2003
10/16/2003
10/30/2003
11/6/2003
12/7/2003
12/11/2003
1/29/2004
3/4/2004
3/11/2004
3/19/2004
4/2/2004
4/7/2004
4/14/2004
4/16/2004
5/5/2004
5/16/2004
6/23/2004
7/7/2004
7/14/2004
10/1/2004
12/14/2004
1/14/2005
1/24/2005
4/25/2005
6/21/2005
7/11/2005
7/18/2005
8/22/2005
3/1/2006
Fraction of original quantity after
day 2 in culture
OCR DNA Nuclei
0.47
0.54
0.96
0.72
0.63
Without outliers
Average 0.67
STDEV 0.17
COV 0.26
COUNT 6
0.48
0.65
0.5
0.87
0.66
0.47
0.62
0.63 0.75
0.45 0.51
0.55
0.10
0.18
4
0.63
0.15
0.24
7
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Table C. 2. Data for Fresh Human Islets
DNA/cell (pg DNA/cell) of fresh human islets
Isolation Da by 1-pm FDA/Date ) sections PI
5/21/2003
6/28/2004
6/28/2004
7/22/2004
9/11/2004
9/27/2004
10/7/2004
10/19/2004
11/30/2004
1/7/2005
2/1/2005
3/23/2005
3/28/2005
4/5/2005
4/14/2005
4/19/2005
6/18/2005
7/8/2005
7/25/2005
9/12/2005
10/5/2005
10/12/2005
1/3/2006
3/9/2006
4/6/2006
5/5/2006
5/25/2006
6/26/2006
7/5/2006
7/25/2006
9/29/2006
DNA Content (pg DNA/cell)
Day 0 Day 1 Day 2
NA A T
5.6
6.7 6.0
5.0
11.9
13.9
8.0
95 6.7 10.2
H05-03
H05-05
H05-06
H05-07
H05-09
H05-10
H05-14
H05-16
H05-19
H05 -2 1
H05 -22
H06-01
H06.-05
H06.-08
H06-10
H06-11
H06.-14
H06-15
H06-19
Without Outliers
Average
STDEV
COV
Count
0.73
0.59
0.53
0.79
0.72
0.53
0.63
0.10
8.5
95 5.1
90 9.7
0.47 90 5.9
0.43
0.79
0.63
0.71
0.74
0.71
0.72
0.50
0.53
0.77
0.64
0.12
0.18
18
Ratio over Day 0
Day 1 Day 2-NA
0.91 0.78
2.44
2.08
10.6
11.1 6.7 9.1
7.7
4.3
8.4
9.2 5.9
5.0 5.3
0.85
0.866.4 7.6
0.76 0.82
1.79
1.09
5.1 5.3
8.4
9.9
8.2
2.4
0.29
14
7.2
2.8
0.38
12
6.6
0.2
0.04
2
6.5
11.4
8.6
14.6
5.9
8.5
2.8
0.32
11
0.82 0.85
1.30
1.46
1.24
0.44
0.36
8
1.20
0.65
0.54
7
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OCR/cell (fmol/min-cell) of fresh human islets
Isolation IDay by 1-pm FDA/Date DayID sections PI
5/21/2003
i6/28/2004
6/28/2004
7/22/2004
9/11/2004
9/27/2004
10/7/2004
10/19/2004
11/30/2004
1/7/2005
2/1/2005
3/23/2005
3/28/2005
4/5/2005
4/14/2005
4/19/2005
6/18/2005
7/8/2005
7/25/2005.
9/12/2005
10/5/2005
10/12/2005
1/3/2006
3/9/2006
4/6/2006
5/5/2006
5/25/2006
6/26/2006
7/5/2006
7/25/2006
9/29/2006
OCR/cell (fmol/min cell) Ratio over Day 0
Day 0 Day 1 Day 2 Day 1 Day 2-NA
NA A T
1.5
1.9
4.1 4.6
1.57
2.04 2.30
1.7
95 1.4 2.4
H05-03
H05-05
H05-06
H05-07
H05-09
H05-10
H05-14
H05-16
0.73
0.59
0.53
0.79
0.72
0.53
0.63
0.10
1
H05-19 0
H05-21
H05-22
H06-01
H06-05
H06-08
H06-10
H06-1 I
H06-14
H06-15
H06-19
Without Outliers
Average
STDEV
COV
Count
2.6
95 1.2
90 2.3
0.47 90 0.7
0.43
0.79
0.63
0.71
0.74
0.71
0.72
0.50
0.53
0.77
0.64
0.12
0.18
18
3.4
2.5
2.8 3.0
3.0
2.2 3.4
2.81
1.082.0 2.3
1.77
1.39 2.08
3.1 1.6 2.3
1.68
1.22
1.33
1.85
1.5
0.5
0.31
22
2.1
0.7
0.34
13
2.6
1.1
0.40
12
1.8
0.3
0.15
2
2.2
0.5
0.21
11
1.60
0.30
0.19
7
1.19
2.18
1.15
0.53
8
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OCR/DNA (nmol/min-mg DNA) of fresh human islets
Isolation Day by 1-pm FDA/
ID sections PI OCR/DNA (nmol/min mg DNA) Ratio over Day 0
Day 0 Day 1 Day 2 Day 1 Day 2-NA
NA A T
275
0.64
294
210
95 212 240
Without Outliers
Average
STDEV
COV
Count
0.73
0.59
0.53
0.79
0.72
0.53
0.63
0.10
306
95 240
90 236
5/21/2003
6/28/2004
6/28/2004
7/22/2004
9/11/2004
9/27/2004
10/7/2004
10/19/2004
11/30/2004
1/7/2005
2/1/2005
3/23/2005
3/28/2005
4/5/2005
4/14/2005
4/19/2005
6/18/2005
7/8/2005
7/25/2005
9/12/2005
10/5/2005
10/12/2005
1/3/2006
3/9/2006
4/6/2006
5/5/2006
5/25/2006
6/26/2006
7/5/2006
7/25/2006
9/29/2006
0.43
0.79
0.63
0.71
0.74
0.71
0.72
0.50
0.53
0.77
0.64
0.12
0.18
18
226
56
0.25
23
789
296
234 514
450 633
257
79
0.31
13
323
154
0.48
9
307 300
307 282
108
0.38
9
0.98
0.47 90 114
3.29
1.25
H05-03
H05-05
H05-06
H05-07
H05-09
H05-10
H05-14
H05-16
H05-19
H05-21
H05-22
H06-01
H06-05
H06-08
H06-10
H06-11
H06-14
H06-15
H06-19
1.81 2.55
2.58
1.49
1.03
1.27
1.40
1.68
0.85
0.51
5
1.32
0.31
0.23
7
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Fraction of cells with impermeable cell membranes by 7-AAD of fresh human islets
Isolation Day by 1-pm FDA/
ID sections PI Membrane Integrity by 7-AAD (%) Ratio over Day 0
Day 0 Day 1
82
Without Outliers
Average
STDEV
COV
Count
95 90
88
95 80
90 91
Day 2 Day 1 Day 2-NA
NA A T
86
94 74
86
90 88
94
92 95 93
92 84
69
85 86
1.03 1.09
1.07 0.84
0.93
1.02 1.04
5/21/2003
6/:: 28/2004
6/28/2004
7/22/2004
9/11/2004
9/27/2004
10/7/2004
:10119/2004
11/30/2004
1/7/2005
2/1/2005
3/23/2005
3/28/2005
4/5/2005
4/14/2005
4/19/2005
6/18/2005
7/8/2005
7/125/2005
9/12/2005
10/5/2005
10/12/2005
1/3/2006
3/9/2006
4/6/2006
5/5/2006
5/25/2006
6/26/2006
7/5/2006
7/25/2006
9/29/2006
0.91
Day 0 -All
85
7
0.09
15
89
5
0.05
9
81
8
0.10
9
93
4
0.04
2
89
4
0.04
6
1.01
0.07
0.07
4
0.97
0.11
0.11
4
H05-03
H05-05
H05-06
H05-07
H05-09
H05-10
H05-14
H05-16
0.47 90 78
0.73
0.59
0.53
0.79
0.72
0.53
0.63
0.10
1
H05-19 0
H05-21
H05-22
H06-01
H06-05
H06-08
H06-10
H06-1 I
H06-14
H06-15
H06-19
0.43
0.79
0.63
0.71
0.74
0.71
0.72
0.50
0.53
0.77
0.64
0.12
0.18
18
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OCR/cell with impermeable cell membranes (fmol/min-cell) of fresh human islets
Isolation Day by 1-pm FDA/Date DayID sections PI OCR/viable cell (fmol/min cell)
Day 0 Dayl Day 2
NA A T
1.89
2.64
1.43
1.82
5/21/2003
6/28/2004
6/28/2004
7/22/2004
9/11/2004
9/27/2004
10/7/2004
10/19/2004
11/30/2004
1/7/2005
2/1/2005 HO
3/23/2005 HO
3/28/2005 HO
4/5/2005 HO
4/14/2005 HO
4/19/2005 HO
6/18/2005 HO
7/8/2005 HO
7/25/2005
9/12/2005 HO
10/5/2005 HO
10/12/2005 HO
1/3/2006 HO
3/9/2006 HO
4/6/2006 HO
5/5/2006 HO
5/25/2006 HO
6/26/2006 HO
7/5/2006 HO
7/25/2006 HO
9/29/2006
Without Outliers
Average
STDEV
COV
Count
5-03
5-05
5-06
5-07
'5-09
'5-10
5-14
5-16
0.73
0.59
0.53
0.79
0.72
0.53
0.63
0.10
5-19 0
5-21
5-22
6-01
6-05
6-08
6-10
6-11
6-14
6-15
6-19
2.78
1.28
2.48
95 1.58
2.97
95 1.51
90 2.52
2.32
1.95
1.93
2.14
0.47 90 0.86
0.43
0.79
0.63
0.71
0.74
0.71
0.72
0.50
0.53
0.77
0.64
0.12
0.18
18
1.19
1.46
4.91
1.80
5.22
Ratio over Day 0
Day 1 Day 2-NA
1.98 2.11
2.58
2.68
3.07 3.62
4.41
2.63 3.90
2.07 2.46
1.90
1.35 2.01
2.50
2.96
4.26
3.12
2.18
Day 0 -All
1.9
0.6
0.32
16
2.6
1.1
0.43
8
3.9
0.8
0.22
7
2.1 2.6
0.2
0.09
1 4
1.72
0.33
0.19
3
2.00
0.11
0.05
3
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OCR/DNA of cell with impermeable cell membranes (nmol/minsmg DNA) of fresh
human islets
Isolation Da by 1-pm FDA/Date DayID sections PI
OCR/DNA of viable cell
(nmol/min mg DNA)
Day 0 Day 1 Day 2
NA A T
Ratio over Day 0
Day 1 Day 2-NA
5/21/2003
6/28/2004
6/28/2004
7/22/2004
9/11/2004
9/27/2004
10/7/2004
10./19/2004
11/30/2004
1/7/2005
2/1/2005
3/23/2005
3/28/2005
4/5/2005
4/14/2005
4/19/2005
6/18/2005
7/8/2005
7/25/2005
9/12/2005
10/5/2005
10/12/2005
1/3/2006
3/9/2006
4/6/2006
5/5/2006
5/25/2006
6/26/2006
7/5/2006
7/25/2006
9/29/2006
H05-03
H05-05
H05-06
H05-07
H05-09
H05-10
H05-14
H05-16
0.73
0.59
0.53
0.79
0.72
0.53
0.63
0.10
H05-19 0
H05-21
H05-22
H06-01
H06-05
H06-08
H06-10
H06-11 I
H06-14
H06-15
H06-19
Without Outliers
Average
STDEV
COV
Count
95 235
348
95 300
90 259
333 0.00 0.00
322
254 612
530 736
324 323
0.00
1.77 2.46
0.47 90 146
0.43
0.79
0.63
0.71
0.74
0.71
0.72
0.50
0.53
0.77
0.64
0.12
0.18
18
302
84
0.28
16
311
111
0.36
8
491
175
0.36
5
222
0.95 0.00
1.69
324 394
77
0.19
4
1.10
0.82
0.75
4
0.61
1.23
2.00
4
Fraction of original OCR, nuclei, and DNA recovered after 2 days in culture for
fresh human islets
Isolation y 1 by 1-pm FDA/ Fraction of original OCR Fraction of original nuclei Fraction of original DNAID sections PI post culture post culture post culture
Day 2 DayZ Day 2
NA A T NA A T NA A T
95
95 0.69
95
95
1/7/2005 0
2/1/2005 H05-03 0
3/23/2005 H05-05 0
3/28/2005 H05-06 1
4/5/2005 H05-07 0
4/14/2005 H05-09 0
4/19/2005 H05-10 0
6/18/2005 H05-14 0
7/8/2005 H05-16 2
7/25/2005 1
9/12/2005 H05-19 0
10/5/2005 H05-21 0
10/12/2005 H05-22 0
1/3/2006 H06-01 0
3/9/2006 H06-05 0
4/6/2006 H06-08 0
5/5/2006 H06-10 0
5/25/2006 H06-11 0
6/26/2006 H06-14 0
7/5/2006 H06-15 0
7/25/2006 H06-19 0
9/29/2006 0
Without Outliers
Average
STDEV
COV
Count
0.44
0.41
0.34 0.29 0.63
0.67
0.65
0.56 0.29 0.85
0.61
0.73 95
0.59 90 0.58 0.26 0.84 0.53 0.30 0.84 0.46 0.20
0.53
0.79 90
0.72
0.53
0.63
0.10
0.47 90 0.63 0.35 0.98 0.14 0.15 0.28 0.24
0.94 0.26 0.12 0.38 0.36
0.43 70
0.79 80
0.63
0.71
0.74
0.71
0.72
0.50
0.53
0.77
0.64
0.12
0.18
18
0.71 0.31 0.75 0.34 0.22 0.63 0.41 0.25 0.64
0.16 0.06 0.23 0.15 0.10 0.17 0.14 0.06 0.18
0.23 0.20 0.30 0.45 0.44 0.27 0.34 0.26 0.28
4 2 11 5 4 14 4 2 11
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5/21/2003
6128/2004
6/28/2004
7/22/2004
9/11/2004
9/27/2004
10/7/2004
10/19/2004
11/30/2004
Islet volume fraction and P cell volume fraction excluding vascular space after
2 days in culture for fresh human islets
Isolation Day by 1-pm FDA/Date Day sID sections PI
D, day 2
Day 2
NA A T
Dpxv day 2
Day 2
NA A T
5/21/2003
6/28/2004
6/28/2004
7/22/2004
9/11/2004
9/27/2004
10/7/2004
10/19/2004
11/30/2004
1/7/2005
2/1/2005
3/23/2005
3/28/2005
4/5/2005
4/14/2005
4/19/2005
6/18/2005
7/8/2005
7/25/2005
9/12/2005
10/5/2005
10/12/2005
1/3/2006
3/9/2006
4/6/2006
5/5/2006
5/25/2006
6/26/2006
7/5/2006
7/25/2006
9/29/2006
H05-03
H05-05
H1105-06
H05-07
H05-09
H05-10
H05-14
H05-16
H05-19
H05-21
H05-22
H1106-01
H1106-05
H06-08
H06-10
H06-11
H06-14
H06-15
H06-19
Without Outliers
Average
STDEV
COV
Count
0.73
0.59
0.53
0.79
0.72
0.53
0.63
0.10
0.47
0.43
0.79
0.63
0.71
0.74
0.71
0.72
0.50
0.53
0.77
0.64
0.12
0.18
0.68
0.484 0.329
0.70
0.477 0.098
0.482 0.097
0.81
0.81
0.75
0.07
0.09
0.48 0.17
0.00 0.13
0.01 0.77
3 3
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Table C. 3. Data for Cultured/Shipped Human Islets
DNA/cell (pg DNA/cell) of cultured/shipped human islets
Date Center Day
7/18/2003
8/9/2003
10/7/2003
2/27/2004
7/10/2004
7/20/2004
8/3/2004
10/8/2004
10/15/2004
12/15/2004
1/18/2005
1/19/2005
2/15/2005
3/15/2005
3/25/2005
7/19/2005
7/22/2005
9/9/2005
12/15/2005
2/15/2006)
6/13/2006
8/8/2006
6/28/2004
10/21/2004
7/25/2005
MN
MN
MN
MN
MN
MN
MN
MN
MN
MN
COH
Miami
Pen
Columbia
WashU
Minnesota
COH
WashU
WashU
WashU
Joslin
Joslin
Joslin
DTZ 01 by 1-Itm
(%) sections
0 80
0 95
0 60
0 75
0 80
60
0 85
0 90
90
0 95
Day 0
6.9
5.1
6.8
9.8
9.1
8.5
8.7
8.3
11.5
6.5
7.7
0.64 7.5
0.58 10.6
11.5
0.75 6.6
7.0
DNA Content (pg DNA/cell)
Day 1 Day 2
NA A
4.3
4.8
9.7
19.8 10.3
Ratio over Day 0
Day 1 Day 2-NA
0.62
0.94
1.42
2.02 1.05
0.64
0.78
0.70
0.94
5.8 6.4
9.4 8.7
0.93
1.02
0.72
1.14
10.8 6.5 8.7
90 0.64
85
1 85
87
0.68
0.62
0.82
6.1
8.9
7.7
20.9
8.0 7.1
6.8 6.8
0.90 0.79
0.88 0.88
5.5
6.9
8.0
0.56 10.0
4/8/2006 Joslin
Without outliers
Average
STDEV
COV
Count
95 0.74 5.3
0.67
0.09
0.13
9
1.11
0.54
0.49
5
0.98
0.26
0.26
15
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OCR/cell (fmol/min-cell) of cultured/shipped human islets
DTZ 0i by i-pm
Date Center Day DTZ sections(%) sections OCR/cell (fmol/min cell) Ratio over Day 0
Day 0 Day 1 Day 2 Dayl Day2-NA
NA A T
1.8
2.2
2.2 2.3
2.0
1.5
2.4
1.9
1.4
0.64 2.4
0.58 1.6
0.9
0.75 2.2
7/18/2003
8/i 19/2003
10/7/2003
2/27/2004
7/10/2004
7/20/2004
10/8/3/2004
10/8/2004
10/15/2004
12/15/2004
1/18/2005
1/19/2005
2/15/2005
3/15/2005
3/25/2005
7/19/2005
7/22/2005
9/9/2005
12/15/2005
2/15/2006
6/13/2006
8/8/2006
6/28/2004
10/21/2004
7/25/2005
1.71
0.80
1.07 1.09
1.13
0.87
1.65
1.40
1.3 2.3
1.6 1.9
2.40
3.5 2.2 2.9
1.8 1.9
1.1 0.8
0.84
1.39
2.17
2.26
2.28
3.80 3.94
1.53 1.09
1.34
1.7
0.56 1.7
4/8/2006 Joslin
Without outliers
Average
STDEV
COV
Count
1 95 0.74 1.5
0.67
0.09
0.13
9
226
0 80
0 95
0 60
0 75
0 80
60
0 85
0 90
90
0 95
1.6
90 0.64 0.6
MN
COH
Miami
Pen
Columbia
WashU
Minnesota
COH
WashU
WashU
WashU
Joslin
Joslin
Joslin
87
85
1 85
87
0.68
0.62
0.82
2.06
1.09
0.53
5
1.60
0.82
0.51
15
OCR/DNA (nmol/min-mg DNA) of cultured/shipped human islets
Date Center Day DTZ o by 1-pmn
(%) sections
7/18/2003 MN
8/9/2003 MN
10/7/2003 MN
2/27/2004 MN
7/10/2004 MN
7/20/2004 MN
8/3/2004 MN
10/8/2004 MN
10/15/2004 MN
12/15/2004 MN
1/18/2005 COH
1/19/2005 Miami
2/15/2005 Pen
3/15/2005 Columbia
3/25/2005
7/19/2005 WashU
7/22/2005 Minnesota
9/9/2005 COH
12/15/2005 WashU
2/15/2006 WashU
6/13/2006 WashU
8/8/2006
6/28/2004 Joslin
10/21/2004 Joslin
7/25/2005 Joslin
4/8/2006 Joslin
Without outliers
Average
STDEV
COV
Count
0 80
0 95
0 60
0 75
0 80
60
0 85
0 90
90
0 95
OCR/DNA (nmol/min mg DNA)
Day 0 Day 1 Day 2 Day 1 Day 2-NA
NA A T
201
207
408
178 120
207
162
161
539
329
181
0.64 324
0.58 149
78
0.75 336
221
90 0.64
0.68 261
0.62 53
0.82 92
117
402
183
210
0.56 166
1.82
0.57
0.67 1.23
1.15
2.36
1.49
233 363
173 217
2.10
328 337 331
225 266
159 113
4.21 4.97
1.73 1.23
1 95 0.74 266
0.67
0.09
0.13
9
226
115
0.51
24
303 290 248 314
272 93 83 63
0.90 0.32 0.34 0.20
4 17 3 5
2.18
1.48
0.68
4
Ratio over Day 0
1.48
2.13
3.14
1.48
1.14
1.78
1.14
0.64
14
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Fraction of cells with impermeable cell membranes by 7-AAD of cultured/shipped
human islets
Date Center Day
7/18/2003
8/9/2003.
10/7/2003
2/27/2004
7/10/2004
7/20/2004
8/103/2004
10/8/2004
10/15/2004
12/15/2004
1/18/2005
1/19/2005
2/15/2005
3/15/2005
3/25/2005
7/19/2005
7/22/2005
9/9/2005
12/15/2005
2/15/2006
6/13/2006
8/8/2006
6/28/2004
10/21/2004
7/25/2005
MN
MN
MN
MN
MN
MN
MN
MN
MN
MN
COH
Miami
Pen
Columbia
WashU
Minnesota
COH
WashU
WashU
WashU
Joslin
Joslin
Joslin
DTZ 01 by 1-pm
(%) sections
0 80
0 95
0 60
0 75
0 80
60
0 85
0 90
90
0 95
Day 0 Day 1
91
90
89
94 94
91
94
95
93
86
88
90
0.64 88
0.58 86
84
0.75 83
1 90 0.64 65
85
1 85
87
0.68
0.62
0.82
88
93
0.56 90
4/8/2006 Joslin
Without outliers
Average
STDEV
COV
Count
1 95 0.74
0.67
0.09
0.13
9
228
Membrane Integrity by 7-AAD (%)
Day 2
NA A T
Ratio over Day 0
Day 1 Day 2-NA
0.90
84 85
92 88
0.98
0.94
1.43
0.89 0.74
87
8
0.09
22
87
11
0.12
3
85
11
0.13
8
88
6
0.06
2
87
2
0.03
2
1.11
0.28
0.26
3
0.89
0.11
0.12
4
OCR/cell with impermeable cell membranes (fmol/min'cell) of cultured/shipped
human islets
DTZ cD by 1-pmDate Center Day DTZ by i-p(%) sections OCR/viable cell (fmol/min cell) Ratio over Day 0
Dayy Day
1.53
1.18
3.13
2.19 2.35
1.96
1.86
1.49
1.43
7.19
2.42
1.55
0.64 2.78
0.58 1.83
1.07
0.75 2.65
Day 2 Day 1 Day 2-NA
NA A T
1.07
1.60 2.72
1.77 2.14
7/18/2003
8/9/2003
10/7/200:3
2/27/2004
7/10/2004
7/20/2004
8/3/2004
10/8/2004
10/15/2004
12/15/2004
1/18/2005
1/19/2005
2/15/2005
3/15/2005
3/25/2005
'7/19/2005
7/22/2005
9/9/2005
12/15/2005
2/15/2006
6/13/2006)
8/8/2006
6/28/2004
10/21/2004
7/25/2005
0.68
0.62
0.82
1.89
0.73
0.85
1.44
1.80
0.56 1.83
4/8/2006 Joslin
Without outliers
Average
STDEV
COV
Count
1 95 0.74
0.67
0.09
0.13
9
0 80
0 95
0 60
0 75
0 80
60
0 85
0 90
90
0 95
MN
MN
MN
MN
MN
MN
MN
MN
MN
MN
COH
Miami
Pen
Columbia
WashU
Minnesota
COH
WashU
WashUr
WashUL
90 0.64 0.93
2.45
2.42
1.98
3.94
4.21
2.36
1.42
2.30
85
1 85
87
Joslin
Joslin
Joslin
1.25
2.66
1.72 1.47
1.74
1.35
0.8
21
1.92
0.45
0.2
3
2.55
1.03
0.4
8
1.69
0.12
0.1
2
2.43
0.41
0.2
2
1.81
0.80
0.44
3
1.61
0.47
0.29
4
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OCR/DNA of cell with impermeable cell membranes (nmol/min.mg DNA) of
cultured/shipped human islets
DTZ iI by 1-pmDate Center Day (%) sections(%/) sections
7/18/2003 MN
8/9/2003 MN
10/7/2003 MN
2/27/2004 MN
7/10/2004 MN
OCR/DNA of viable cell
(nmol/min mg DNA)
Day 0 Day 1 Day 2 Day Day 2-NA
NA A T
222
230
457
189 128
228
0.67
1.27
7/20/2004 MN
.8/3/2004 MN
10/8/2004 MN
10/15/2004 MN
12/15/2004 MN
1/18/2005 COH
1/19/2005 Miami
2/15/2005 Pen
3/15/2005 Columbia
3/25/2005
7/19/2005 WashU
7/22/2005 Minnesota
:9/9/2005 COH
12/15/2005 WashU
2/15/2006 WashU
6/13/2006 WashU
8/8/2006
6/28/2004 Joslin
10/21/2004 Joslin
7/25/2005 Joslin
4/8/2006 Joslin
Without outliers
Average
STDEV
COV
Count
0 85
0 90
90
0 95
0.64
0.58
0.75
1 90 0.64
85
1 85
87
0.68
0.62
0.82
0.56
1 95 0.74
0.67
0.09
0.13
9
230
278 427
188 247
1.52
2.27
2.95
1.94 1.67
194
60
0.31
3
332
115
0.35
8
233
63
0.27
2
337
128
0.38
2
1.85
1.14
0.61
3
1.68
0.42
0.25
4
Fraction of original OCR, nuclei, and DNA recovered after 2 days in
cultured/shipped for cultured/shipped human islets
DTZ 4, by 1-pm Fraction of original OCR Fraction of original nuclei Fraction of original DNA
D(%) sections post culture post culture post culture
Day 2 Day 2 Day 2
NA A T NA A T NA A T
7/18/2003 MN
8/9/2003 MN
10/7/2003 MN
2/27/2004 MN
7/10/2004 MN
0 80
0 95
0 60
0 75
0 80
60
7/20/2004 MN 0 85
8/3/2004 MN 0 90
10/8/2004 MN 90
10/15/2004 MN 0 95
12/15/2004 MN
1/18/2005 COH 0 80
1/19/2005 Miami 0 95
2/15/2005 Pen 0 85
3/15/2005 Columbia 0 85
3/25/2005 0
7/19/2005 WashU 1 90
7/22/2005 Minnesota
9/9/2005 COH
12/15/2005 WashU
2/15/2006 WashU
6/13/2006 WashU
8/8/2006
6/28/2004 Joslin
10/21/2004 Joslin
7/25/2005 Joslin
85
1 85
87
0
1 60
1 85
1 90
4/8/2006 Joslin 1 95 0.74
Without outliers
Average
STDEV
COV
Count
0.32
0.17
1.04
0.88
0.65 0.29 0.94
0.73 0.32 1.05
0.68 0.40 1.08
0.26
0.15
0.44
0.59
0.47 0.52 0.99 0.44 0.40 0.84
0.39 0.21 0.60 0.24 0.15 0.39
0.30 0.28 0.58 0.46 0.26 0.72
0.69 0.41 1.10
0.51 0.54 1.05
0.73 0.23 0.96
0.68
0.61
0.56 0.99
0.95
0.70 0.33 0.89
0.27 0.06 0.25
0.39 0.17 0.29
11 3 5
0.54
0.35
0.61 0.10 0.71
0.64 0.10 0.74
0.65
1.04
0.47
0.40
0.50 0.37 0.85 0.45 0.27 0.65
0.17 0.14 0.22 0.25 0.13 0.23
0.34 0.40 0.26 0.55 0.46 0.36
14 6 8 10 3 3
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Islet volume fraction and P cell volume fraction excluding vascular space after 2
days in culture for cultured/shipped human islets
Date Center Day
7/18/2003
8/912003
10/7/2003
2/27/2004
7/10/2004
7/20/2004
S:: 8/3/2004
10/8/2004
10/15/2004
12/15/2004
1/18/2005
1/19/2005
2/15/2005
3/15/2005
3/25/2005
7/19/2005
7/22/2005
9/9/2005
12/15/2005
2/15/2006
6/13/2006
8/8/2006
6/28/2004
10/21/2004
7/25/2005
MN
MN
MN
MN
MN
MN
MN
MN
MN
MN
COH
Miami
Pen
Columbia
WashU
Minnesota
COH
WashU
WashU
WashU
DTZ I) by 1-pm
(%) sections
80
95
60
75
0I day 2
Day 2
NA A
Opxv day 2
Day 2
NA A T
0 80
60
0 85
0 90
90
0 95
0.64
0.58
0.75
1 90 0.64
85
1 85
87
Joslin
Joslin
Joslin
0.68
0.62
0.82
0.56
0.85
0.61
0.53
0.494 0.118
0.528 0.117
0.489 0.105
0.81
0.314 0.261
0.367 0.247
4/8/2006 Joslin 1 95 0.74
Without outliers
Average
STDEV
COV
Count
232
0.67
0.09
0.13
9
0.70
0.15
0.22
0.504
0.021
0.04
0.113
0.007
0.06
3 3
Table C. 4. Data for Human Non-Islet Tissue
DNA/cell (pg DNA/cell) of fresh human non-islet tissue
Time after
isolation
(hr)
3
3
3
3
5
3
DNA Content (pg DNA/cell)
Day 0
3.2
9.8
4.9
4.8
5.3
6.2
Day 1
6.2
10.6
7.7
4.6
8.8
7.0
Day 2-NA
6.8
6.3
6.4
8.3
Ratio over Day 0
Day 1
1.96
1.07
1.57
0.94
1.65
1.13
Day 2-NA
2.14
1.29
1.20
1.34
Without Outliers
Average
STDEV
COV
Count
OCR/cell (fmol/min-cell) of fresh human non-islet tissue
Time after
isolation
(hr)
3
3
3
3
5
3
OCR/cell (fmol/min cell)
Day 0
1.2
1.4
1.9
2.7
0.7
1.7
Day 1
1.5
2.4
3.0
2.6
1.9
2.1
Day 2-NA
1.8
3.4
1.8
2.0
Ratio over Day 0
Day 1
1.26
1.74
1.53
0.97
2.78
1.21
Day 2-NA
1.53
1.74
2.62
1.17
Without Outliers
Average
STDEV
COV
Count
Date
2/1/2005
3/28/2005
4/19/2005
6/18/2005
9/12/2005
10/5/2005
5.7
2.3
0.4
7.5
2.1
0.3
6
6.9
0.9
0.1
4
1.39
0.40
0.29
6
1.49
0.44
0.29
4
Date
2/1/2005
3/28/2005
4/19/2005
6/18/2005
9/12/2005
10/5/2005
1.6
0.7
0.4
6
2.2
0.5
0.2
6
2.2
0.8
0.3
4
1.58
0.64
0.41
6
1.76
0.62
0.35
4
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OCR/DNA (nmol/min'mg DNA) of fresh human non-islet tissue
Date
2/1/2005
3/28/2005
4/19/2005
6/18/2005
9/12/2005
10/5/2005
Time after
isolation
(hr)
3
3
3
3
5
3
Without Outliers
Average
STDEV
COV
Count
OCR/DNA
(nmol/min mg DNA)
Day 0 Day 1 Day 2-NA
370 238 265
139 225
274 388 576
564 581
130 217 283
281 300 245
293
161
0.6
6
325
141
0.4
6
342
157
0.5
4
Ratio over Day 0
Day 1
0.64
1.62
1.42
1.03
1.67
1.07
1.24
0.40
0.32
6
Day 2-NA
0.72
2.10
2.18
0.87
1.47
0.78
0.53
4
Fraction of cells
islet tissue
with impermeable cell membranes by 7-AAD of fresh human non-
Time after
isolation
(hr)
3
3
3
3
5
3
Membrane Integrity by
7-AAD (%)
Day 0 Day 1 Day 2-NA
84 44 51
86 73
85 80 83
89 90
90
86
Ratio over Day 0
Day 1
0.52
0.85
0.94
1.01
0.99
Day 2-NA
0.61
0.98
0.94
Day 0 -All
Without Outliers
Average
STDEV
COV
Count
87
2
0.0
6
74
18
0.2
5
72
18
0.3
3
0.86
0.20
0.23
5
0.84
0.20
0.24
3
Date
2/1/2005
3/28/2005
4/19/2005
6/18/2005
9/12/2005
10/5/2005
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OCR/cell with impermeable cell membranes (fmollmin'cell)
islet tissue
Time after
isolation
(hr)
3
3
3
3
5
3
OCR/viable cell
(fmollmin cell)
Day 0 Day 1 Day 2-NA
1.4 3.4 3.5
1.6 3.3
2.3 3.7 4.1
3.1 2.9
0.8
2.0 2.5 2.5
of fresh human non-
Ratio over Day 0
Day 1
2.41
2.05
1.63
0.96
1.23
Day 2-NA
2.52
1.78
1.24
Day 0 -All
Without Outliers
Average
STDEV
COV
Count
1.9
0.8
0.4
3.1
0.5
0.1
5
3.4
0.8
0.2
3
1.66
0.59
0.36
5
1.85
0.64
0.35
3
OCR/DNA of cell with impermeable cell membranes (nmol/min.mg DNA) of fresh
human non-islet tissue
Time after
isolation
(hr)
3
3
3
3
5
3
OCR/DNA of viable cell
(nmol/min mg DNA)
Day 0
440
162
322
634
144
327
Day 1
541
308
485
646
353
Day 2-NA
520
694
302
Ratio over Day 0
Day 1
1.23
1.91
1.50
1.02
1.08
Day 2-NA
1.18
2.15
0.93
Without Outliers
Average
STDEV
COV
Count
Date
2/1/2005
3/28/2005
4/19/2005
6/18/2005
9/12/2005
10/5/2005
Date
2/1/2005
3/28/2005
4/19/2005
6/18/2005
9/12/2005
10/5/2005
338
183
0.5
467
138
0.3
5
505
196
0.4
3
1.35
0.36
0.27
5
1.42
0.65
0.46
3
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Fraction of original OCR, nuclei, and DNA recovered after 2 days in
cultured/shipped for fresh human non-islet tissue
Date
2/1/2005
3/28/2005
4/19/2005
6/18/2005
9/12/2005
10/5/2005
Time after
isolation
(hr)
3
Fraction of original quantity after
day 2 in culture
OCR Nuclei DNA
0.16 0.10 0.22
0.70
0.29
0.35
0.78
Without Outliers
Average
STDEV
COV
Count
0.46
0.27
0.59
5
0.35
0.60
0.26
0.67
0.40
0.24
0.60
5
0.89
0.56
0.15
0.89
0.54
0.35
0.65
5
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Chapter 13.
Nomenclature
A Surface area of a well
a Half-axis of a symmetrical ellipsoid
b Half-axis of a symmetrical ellipsoid
c Half-axis of a symmetrical ellipsoid
Cp Radioactivity concentration in pellet
Cs Radioactivity concentration in supernatant
D Diffusion coefficient of oxygen in medium
EM Electron microscopy
f Fraction of cells permeable to dye
fA Number fraction of acinar cells among all cells
fD Number fraction of duct cells among all cells
fi Number fraction of cell type i
fic Number fraction of all islet cells
fo Number fraction of all "other" cell types among all cells
fN, Number fraction of non-3 cells among all cells
fNIC Number fraction of all non-islet cells
fp Number fraction of P cells among all cells
fplc Number fraction of 0 cells among all islet cells
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Fp
h
LM
nA
nc
nD
ni
nlC
nIE
NIE
(NIE)PCV/LM
(NIE )DTZ
n NIC
nNP3
no
nTC
np
nPIE
N1
N 2
OCR
P,
PNI
PV
r
t
V
VA
Vl-NT
Vch
VD
Vellipsoid
V,
Number fraction of original P cells collected from culture
Medium depth
Light microscopy
Number of acinar cells
Number of cells in the OCR chamber
Number of duct cells
Number of cells of type i
Number of islet cells
Number of cells in an islet equivalent volume
Number of islet equivalents
Number of IE calculated from packed cell volume and light
microscopy data
Number of IE calculated from DTZ staining data
Number of non-islet cells
Number of non-n cells
Number of other cells
Total number of cells
Number of 0 cells
Number of P cells in an islet equivalent volume
Number of nuclei initially labeled with dye (cells with compromised
membranes)
Total number of nuclei labeled with dye after cell lysis (total cell number)
Oxygen consumption rate
Number of points falling within the domain of islets
Number of points falling within the domain of non-islets tissue
Number of points falling within the domain of islet vascular space
Radius of a sphere
Time
Volume
Volume of acinar cells
Volume of interstitial space of p cells
Volume of OCR chamber
Volume of duct cells
Volume of an ellipsoid
Total volume of the islet domain
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VIC Volume of islet cells
VIE Volume of an islet equivalent (1.77x10 6 rn 3)
VIEC Extracellular volume within islet domain
VINT Volume of interstitial space in islet
VIxv Volume of islet cells and interstitial space within the islet domain
VNI Total volume of the non-islet domain
VNIC Volume of non-islet cells
VNIEC Extracellular volume within the non-islet domain
VN3 Volume of non-3 cells
VPC Volume of packed cell pellet
Vo  Volume of other cells
Vsphere Volume of a sphere
VIE Viable islet equivalents
VT  Total tissue volume
VTC Total volume of all islet and non-islet cells
VvI Volume of vascular voids in islet
Vvpc Void volume of packed cell pellet
Vp Volume of 0 cells
a Solubility of oxygen in medium
ýIc  Volume fraction of islet cells among all cells
ýNIC Volume fraction of non-islet cells among all cells
pli c  Volume fraction of 0 cells among all islet cells
Dpxv Volume fraction of 0 cells exclusive of islet vascular spaces
(I)D Fractional distribution volume
DI Volume fraction of islets
(I IC Volume fraction of islet cells within the islets
( IEC Volume fraction of islet extracellular space within the islets
( Ixv Volume fraction of islets exclusive of islet vascular spaces
(INIC Volume fraction of non-islet cells based on the total non-islet volume
( NIEC Volume fraction of non-islet extracellular space based on the total
non-islet volume
I , Volume fraction of vascular voids within islets
(vDPC  Void fraction of packed cell pellet
(DOI Volume fraction of p cells within whole islet volume:
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(IIC)EM ,IC calculated from electron microscopy ultrastructural analysis
(( I)DTZ D I calculated from DTZ staining data
((DI)EM (I calculated from electron microscopy ultrastructural analysis
((I )LM (DI calculated from light microscopy morphology analysis
((IXV )LM (DIT calculated from light microscopy morphology analysis
vA Cell volume of acinar cells
v D Cell volume of duct cells
VN3 Cell volume of non-f cells
v o Cell volume of other cells
VP Cell volume of p cells
VIC Average cell volume for islet cells
VNIC Average cell volume for non-islet cells
VTC Average cell volume for all of the cells
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